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Summary 
The worldwide rapid spread of antimicrobials resistance is a serious public health 
threat. In low-income countries, the expensive second- or third-line drug regimens 
required to treat resistant pathogens are often unavailable and/or unaffordable for 
patients. The correlation between the level of use of antimicrobials and resistance is 
well known. Rational use of antimicrobials is therefore essential to control resistance. 
In countries where infectious diseases are the leading cause of childhood mortality, 
the scarcity of diagnostic tools associated with the fear of life-threatening infections 
lead to an important overuse of antimicrobials. Primary care clinicians in low-income 
countries have limited training. In the 1990’s, the World Health Organization and 
UNICEF developed the Integrated Management of Childhood Illness (IMCI) 
algorithm. IMCI is a simple clinical algorithm aimed at improving the primary care 
management of the five leading causes of death in children younger than 5 years: 
pneumonia, malaria, diarrhoea, measles, and malnutrition. Implemented in more than 
75 countries, IMCI has had a limited impact on clinicians’ performance and overuse 
of antimicrobials. Insufficient compliance to recommendations, insufficient specificity 
of diagnostic classifications, and lack of guidance for the management of fever once 
malaria has been ruled-out, are the main limitations that explain the uneven impact of 
IMCI on the quality of healthcare and rational prescription of antimicrobials for 
children. To address this public health concern we undertook a project called 
PeDiAtrick, aimed at developing and testing an innovative approach for a safe and 
rational use of antimicrobials in the management of childhood illness, by primary care 
health workers, in low income countries. The project had 4 main components: 
(1) Developing a new evidence-based clinical algorithm for the management of 
children aged 2 months up to 5 years in low income countries primary care facilities, 
addressing the main treatable causes of acute illness, and assisting clinicians for 
decision-making to prescribe or withhold antibiotics in children.  
(2) Developing an electronic version of the new clinical algorithm, as an android 
application running on mobile devices. 
(3) Assessing the safety of the new clinical algorithm as compared to the current 
practices in Tanzanian health facilities in terms of health outcome and impact on 
antimicrobial prescription. 
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(4) Assessing the impact of the implementation of the new electronic algorithm on 
clinicians’ performance in term of completeness of integrated assessment, 
appropriateness of disease classifications, and appropriateness of treatment 
prescriptions. 
The overall aim of the PeDiAtrick project was to improve children health outcomes 
and rational prescriptions of antimicrobials in primary care, through the use of 
evidence-based clinical decision support system, in order to decrease childhood 
mortality and contain resistance spread. 
As a first step, we undertook structured literature reviews to better understand the 
epidemiology of acute illnesses in low-income primary health care facilities, and to 
identify the best accurate diagnostic procedures for the main treatable infectious 
diseases. We confirmed that for the majority of childhood acute illnesses no accurate 
point-of-care tests are available. Apart from two exceptions (malaria and urinary tract 
infections) diagnoses are only based on clinical features in low resource primary 
care. We designed a new clinical ALgorithm for the MANAgement of CHildhood 
illnesses (ALMANACH) for children aged 2-59 months in primary care facilities, 
based on the evidence identified and on expert opinions. ALMANACH provides 
diagnostic procedures to rule out malaria, urinary tract infection, and typhoid fever 
and thus address most of the concerns of clinicians regarding the identification of 
bacterial infections in children younger than 5 years.  ALMANACH also introduced a 
new classification entitled ‘Likely viral infection’ reached when bacterial infections are 
ruled out. This new diagnosis reminds clinicians that children often suffer from self-
limited viral conditions that do not warrant any specific treatment beside symptomatic 
treatment. This should help clinicians to decrease their unnecessary prescription of 
antimicrobials. ALMANACH was formalised both as a paper booklet and as an 
electronic clinical decision support system in an android application. 
Once ALMANACH was finalised, and before proposing it for formal implementation, 
we assessed the safety of its recommendations in terms of health outcomes. For that 
purpose we conducted a non-inferiority trial to assess children health outcome and 
antimicrobials prescriptions when managed by clinicians following strictly 
ALMANACH or following their routine practice primary care facilities, in Dar es 
Salaam, Tanzania. In these controlled conditions, ALMANACH was associated with 
significantly better health outcomes and an 80% reduction of antibiotic prescriptions, 
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as compared to routine practice. These results demonstrated the safety of 
ALMANACH in primary care, in Tanzanian, and the important positive impact on 
rational use of antimicrobials, in controlled conditions. 
In order to assess whether the use of the electronic ALMANACH improves clinicians 
performance and rational use of medicines in programmatic conditions, we undertook 
a comparative study of consultation process. For this purpose, 9 health facilities in 
Dar es Salaam were randomised into 3 arms; 3 facilities were allocated to use the 
paper ALMANACH, 3 to use the electronic ALMANACH , and 3 to continue with 
current practice in a control arm. Four months after training, an observation survey of 
clinical consultation showed that the electronic ALMANACH improved the 
thoroughness of the clinical assessment by clinicians and reduced their prescriptions 
of antibiotic by 60%. These results have confirmed the positive impact of 
ALMANACH on rational use of antimicrobials in programmatic conditions, and 
demonstrated that mobile technology can facilitate the delivery of clinical algorithms 
to the endpoint users.  
Additionally, the electronic ALMANACH is a data-collection tool. By integrating health 
information into the decision support system, it has potential to improve the 
monitoring of paediatric primary care activities, and the individual supportive 
supervision provided to the users. 
ALMANACH has shown promising results within the core of the present thesis. Many 
mobile health solutions have been developed for low income countries; some have 
been tested in small scale pilot; and very few have been scaled up largely. The 
interest shown by two of the most important international humanitarian organisations 
will now give a chance to ALMANACH to be scaled-up and reach the initial main 
objective to improve health care delivered to children in low and middle income 
countries.  
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Zusammenfassung 
Die globale und schnelle Verbreitung antimikrobieller Resistenzen stellt eine 
ernstzunehmende Bedrohung für die öffentliche Gesundheit dar. Teuren Zweit- und 
Drittlinientherapien, die für die Behandlung resistenter Erreger benötigt werden, sind 
in Entwicklungsländern oftmals nicht erhältlich und/oder für Patienten und 
Patientinnen unbezahlbar. Antibiotikaresistenz korreliert stark mit dem  Einsatz von 
Antibiotika korreliert. Deshalb ist es wichtig, Antibiotika zielgerecht anzuwenden. In 
Ländern mit geringem Einkommen sind übertragbare Krankheiten häufig die 
führende Todesursache bei Kindern—die Angst vor solch lebensbedrohlichen 
Infektionen, verbunden mit einem Mangel an Mitteln zur Diagnosestellung, führt zu 
blindem, weitgestreuten Verschreiben von Antibiotika.  Hinzu kommt, dass die 
Ausbildung von Ärzten und Ärztinnen der medizinischen Grundversorgung in 
Ländern mit geringem Einkommen mangelhaft ist.  
Demzufolge, entwickelten die Weltgesundheitsorganisation und das Kinderhilfswerk 
der Vereinten Nationen (UNICEF) n den 1990er Jahren  UNICEF das „Integrierten 
Management von Kinderkrankheiten“ (IMCI), einen einfachen klinischen Algorithmus, 
der die  Verbesserung der medizinischen Grundversorgung der fünf führenden 
Todesursachen von Kindern unter fünf Jahren zum Ziel hat: Lungenentzündung, 
Malaria, Durchfall, Masern und Mangelernährung. Obwohl IMCI mittlerweile in mehr 
als 75 Ländern eingesetzt wird, blieb die Auswirkung auf den übermässigen und 
fälschlichen Einsatz von Antibiotika, sowie die Qualität der Gesundheitsversorgng 
allgemein, gering. Dieser mangelnde Effekt wird einerseits mangelnde Einhaltung der 
IMCI Richtlinien und fehlende Genauigkeit bei diagnostischen Klassifizierungen 
seitens des Gesundheitspersonals, und andererseits  lückenhafte Anleitungen zum 
zur Behandlung von Fiebererkrankungen, die nicht durch Malaria verursacht werden 
(zum Beispiel virale und bakterielle Infektionen). Um diese Problematik der 
öffentlichen Gesundheit anzusprechen, führten wir das  PeDiAtrick Projekt durch, das 
zum  
 
Ziel hatte, Gesundheitspersonal in Entwicklungsländern einen innovativen Zugang 
zum sicheren und rationalen Umgang mit Antibiotikain der Behandlung von 
Kinderkrankheiten zu schaffen. Das Projekt bestand aus vier Hauptkomponenten: 
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(1) Entwicklung eines neuen, evidenzbasierten, klinischen Algorithmus zum 
Management von Kindern im Alter von zwei Monaten bis fünf Jahren in Einrichtungen 
der medizinischen Grundversorgung in Ländern mit geringem Einkommen, der die 
Hauptursachen für behandelbare, akute Erkrankungen anspricht, und ÄrztInnen bei 
der Entscheidung zum Verschreiben oder Zurückhaltung von Antibiotika an Kindern 
hilft. 
(2) Entwicklung einer elektronischen Version dieses neuen klinischen Algorithmus, in 
Form einer Android-App auf Mobilgeräten. 
(3) Beurteilung der Sicherheit dieses Algorithmus im Vergleich zur gegenwärtigen 
Praxis in Gesundheitseinrichtungen in Tansania hinsichtlich1) gesundheitlicher 
Folgen 2)des Einflusses auf die Verschreibung von Antibiotika.(4) Beurteilung des 
Einflusses der Anwendung des Algorithmus auf das Verhalten von 
Gesundheitspersonal bezüglich der Vollständigkeit der integrierten Einschätzung, 
Angemessenheit der Krankheitseinteilungen und Angemessenheit der 
verschriebenen Behandlungen. 
Das Gesamtziel des PeDiAtrick Projekts war die Verbesserung der Gesundheit von 
Kindern sowie die sinnvolle Verschreibung von Antibiotika in der medizinischen 
Grundversorgung:  durch den Gebrauch eines evidenzbasierten klinischen 
Unterstützungssystems zur Entscheidungsfindung, sollte die Kindersterblichkeit 
gesenkt werden und die Ausbreitung von Resistenzen eingedämmt werden. 
Als erster Schritt unternahmen wir eine strukturierte wissenschaftliche 
Literaturrecherche, um die Epidemiologie von akuten Krankheiten in medizinischen 
Grundversorgungseinrichtungen mit mangelndem Einkommen besser zu verstehen, 
und, um die besten Verfahrensweisen zu einer genauen Diagnose der 
behandelbaren, üblichen Infektionskrankheiten zu bestimmen. Wir bestätigten, dass 
für den Grossteil akuter Kinderkrankheiten keine genauen Tests zur Diagnose vor Ort 
(Point-of-care-Tests) vorhanden sind. Von zwei Ausnahmen (Malaria und 
Harnwegsinfektionen) abgesehen, beruhen dort Krankheitsdiagnosen allein auf 
klinischen Merkmalen. Als nächsten Schritt, entwickelten wir einen neuen klinischen 
ALgorithmus zum MANAgement von Kinderkrankheiten (ALMANACH) für Kinder im 
Alter von 2 bis 59 Monaten in medizinischen Grundversorgungseinrichtungen, der auf 
publizierter Evidenz sowie Expertenmeinung aufbaut.  
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ALMANACH bietet Verfahrensweisen um Malaria, Harnwegsinfektionen und Typhus 
auszuschliessen, und spricht somit die meisten Bedenken von ÄrztInnen bezüglich 
der Identifizierung von bakteriellen Infektionen in Kindern unter fünf Jahren an. 
ALMANACH führt ebenfalls eine neue Klassifizierung unter dem Namen „Likely viral 
infection“ ein, welche eintrifft, sobald bakterielle Infektionen ausgeschlossen sind. 
Diese neue Diagnose erinnert Gesundheitspersonal daran, dass Kinder oftmals an 
selbstlimitierenden, viralen Erkrankungen leiden, welche zu keiner spezifischen 
Behandlunge, abgesehen der Symptombehandlung, berechtigen. Dies sollte 
Gesundheitspersonal dabei helfen, unnötige Antibiotikaverschreibungen zu 
reduzieren. ALMANACH wurde als Papierbroschüre sowie als elektronisches 
Unterstützungssystem zur klinischen Entscheidungsfindung als Android-App 
entwickelt.  
Nach der Fertigstellung von ALMANACH und vor der offiziellen Implementierung, 
beurteilten wir die Sicherheit der Empfehlungen des Algorithmus. Zu diesem Zweck 
führten wir eine Nicht-Unterlegenheitsstudie in medizinischen 
Grundversorgungseinrichtungen in Tansania durch. Diese verglich dieden 
Gesundheitszustandsowie die Menge verschriebener Antibiotika zwischen 
PatientInnen, die gemäss ALMANACH oder gewöhnlicher Praxis versorgt wurden. Im 
Vergleich mit der gängigen Praxis wurde ALMANACH, unter diesen kontrollierten 
Bedingungen, mit signifikant besserer Gesundheitlage und einer Reduktion der 
Antibiotikaverschreibungen um 80% in Verbindung gebracht. Diese Resultate 
bewiesen, unter kontrollierten Bedingungen, die Sicherheit von ALMANACH in 
medizinischen Grundversorgungsinstituten in Tansania sowie den positiven Einfluss 
von ALMANACH auf angemessenem Antibiotikagebrauch. 
Des Weiteren, um zu beurteilen, ob die Nutzung vom elektronischen ALMANACH 
das Verhalten von Gesundheitspersonal, wie auch die sinnvolle Verschreibung von 
Antibiotika verbessert, führten wir eine vergleichende Studie zum Ablauf der 
Konsultation durch. Hierfür wurden 9 Gesundheitseinrichtungen in Dar es Salaam 
zufällig in 3 Gruppen eingeteilt; 3 Einrichtungen wurden dazu angehalten, die 
Papierversion von ALMANACH zu benutzen, 3 sollten das elektronischen 
ALMANACH-App anwenden und 3 sollten ihre übliche Praxis in einer kontrollierten 
Gruppe weiterführen. Vier Monate nach der Einweisung zeigte eine 
Beobachtungsstudie der klinischen Konsultationen, dass der elektronische 
Zusammenfassung 
xviii 
ALMANACH die Gründlichkeit der klinischen Beurteilungen des 
Gesundheitspersonals verbesserte und deren Antibiotikaverschreibungen um 60% 
reduzierte. Diese Resultate bestätigten den Erfolg versprechenden Einfluss von 
ALMANACH auf die sinnvolle Antibiotikaverschreibungen und zeigten, dass mobile 
Technologie die Anwendung klinischer Algorithmen für NutzerInnen erleichtern kann. 
Der elektronische ALMANACH ist zudem ein Datenerfassungsgerät: indem 
Gesundheitsinformationen in das Unterstützungssystem zur Entscheidungsfindung 
integriert werden, hat es zum einen Potential zur Verbesserung der Überwachung 
von medizinischen Grundversorgungsabläufen bei Kindern, als auch zur, durch die 
Überwachung geschaffene, individuelle Unterstützung des Nutzers. 
Im Kern dieser gegenwärtigen Arbeit zeigte ALMANACH vielversprechende 
Resultate. Für Länder mit geringem Einkommen wurden viele Gesundheitslösungen, 
die auf mobilen Technologien basieren, entwickelt. Manche davon wurden in 
kleinformatigen Pilotstudien getestet, und sehr wenige wurden in einem grossen 
Massstab durchgeführt. Das Interesse, welches von zwei der wichtigsten 
internationalen humanitären Organisationen gezeigt wird, gibt ALMANACH die 
Chance sich durchzusetzen und sein ursprüngliches Hauptziel, nämlich die 
Verbesserung der Gesundheitsversorgung von Kindern in Ländern mit geringem und 
mittlerem Einkommen, zu erreichen.
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Résumé 
La propagation rapide de la résistance aux antimicrobiens est une menace pour la 
santé publique mondiale. Dans les pays à faibles ressources, les médicaments 
antimicrobiens de secondes ou troisièmes lignes, nécessaires pour traiter les 
pathogènes résistants, sont souvent indisponibles ou inaccessibles pour les patients. 
La corrélation entre le niveau d’utilisation des antimicrobiens et le développement de 
résistance est bien connue. L’utilisation rationnelle des antimicrobiens est donc 
essentielle pour le contrôle des résistances. Dans les pays où les maladies 
infectieuses sont la première cause de mortalité infantile, le manque de moyens 
diagnostiques associé à la peur des infections mènent à une surutilisation des 
antimicrobiens. Les cliniciens de premier recours dans les pays à faible ressources 
reçoivent peu de formation. Dans les années 1990, l’Organisation Mondiale de la 
Santé et l’UNICEF ont développé la Prise en Charge Intégrée de Maladies de 
l’Enfant (PCIME). La PCIME est un algorithme clinique simple qui visait à améliorer 
la prise en charge initiale des cinq maladies causant le plus grand nombre de décès 
chez les moins de 5 ans : la pneumonie, le paludisme, la diarrhée, la rougeole, et la 
malnutrition. Mise en œuvre dans plus de 75 pays, la PCIME a eu un impact limité 
sur les performances des cliniciens et la surutilisation des antimicrobiens. Le manque 
de compliance des cliniciens aux recommandations, le manque de spécificité des 
classifications diagnostiques, et le manque d’orientation claire pour la prise en 
charge des fièvres lorsque le paludisme est exclu, sont les principales explications de 
l’impact inégal de la PCIME sur la qualité des soins et la prescription rationnelle des 
antimicrobiens pour les enfants. Pour adresser ce problème de santé publique, nous 
avons entrepris le projet  PeDiAtrick, afin de développer et tester une approche 
innovante pour améliorer l’utilisation des antimicrobiens et les issues thérapeutiques 
pour les maladies de l’enfant.  Le projet avait 4 composantes principales : 
(1) Développement d’un nouvel algorithme clinique fondé sur les données probantes 
pour la prise en charge, en soins de santé primaires, des enfants âgés de 2 mois à 5 
ans, dans les pays à faibles ressources, adressant les principales causes traitables 
de maladies aigues, et apportant aux cliniciens une aide à la décision pour la 
prescription des antimicrobiens.   
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(2) Développement d’une version électronique du nouvel algorithme clinique, sous la 
forme d’une application android pour appareils de téléphonie mobile. 
(3) Evaluation de la sécurité du nouvel algorithme en termes d’issues thérapeutique 
par rapport aux pratiques en vigueur dans les centres de santé Tanzaniens,  et aux 
prescriptions d’antimicrobiens. 
(4) Evaluation de l’impact du nouvel algorithme électronique sur les performances 
des cliniciens,  en particulier sur l’exhaustivité de l’examen clinique, la pertinence des 
classifications de maladies, et la pertinence des prescriptions médicamenteuses. 
L’objectif général du projet PeDiAtrick était ainsi de diminuer la mortalité infantile et 
de contenir la propagation des résistances aux antimicrobiens. 
Dans un premier temps, nous avons conduit des revues structurées de la littérature 
afin de mieux comprendre l'épidémiologie de maladies aiguës dans les structures de 
santé primaires des pays à faible ressources,  et d'identifier les méthodes 
diagnostiques les plus fiables pour les principales maladies infectieuses curables. 
Nous avons confirmé que pour la majorité des maladies aiguës de l'enfant, aucun 
test précis réalisable au chevet des patients n’est disponible. A deux exceptions près 
(paludisme et infections urinaires) les diagnostics se font uniquement sur les signes 
et symptômes cliniques, dans les centres de soins primaires à faible ressources. 
Nous avons conçu un nouvel algorithme clinique pour le traitement des maladies de 
l’enfant âgé de 2 à 59 mois (ALMANACH) dans les établissements de soins 
primaires, sur la base des données probantes identifiées complété par des avis 
d'experts. ALMANACH propose des procédures diagnostiques pour identifier ou 
exclure le paludisme, les infections urinaires et la fièvre typhoïde, et ainsi répondre 
aux préoccupations principales des cliniciens concernant les infections bactériennes 
chez les enfants de moins de 5 ans. ALMANACH a également introduit une nouvelle 
classification intitulée «infection virale probable », classification atteinte lorsque les 
infections bactériennes sont exclues. Ce nouveau diagnostic rappelle aux cliniciens 
que les enfants souffrent souvent de maladies virales bénignes qui ne nécessitent 
aucun traitement spécifique, en dehors d’un traitement symptomatique. Cela devrait 
aider les cliniciens à diminuer leurs prescriptions inutiles d'antibiotiques. ALMANACH 
a été conçu sous forme de livret papier, et sous forme d’une application android en 
un véritable système électronique d'aide à la décision clinique. 
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Après avoir finalisé ALMANACH, et avant de le déployer, nous avons évalué la 
sécurité de ses recommandations pour la santé des enfants. À cette fin, nous avons 
mené une étude de non-infériorité pour évaluer les résultats thérapeutiques et les 
prescriptions d’antimicrobiens pour les enfants pris en charge par des cliniciens 
suivants strictement ALMANACH, ou suivants leur pratique de routine, dans des 
structures de santé de soins primaires, à Dar es Salaam, en Tanzanie. Dans ces 
conditions contrôlées, ALMANACH a été associé à des résultats thérapeutiques 
significativement supérieurs, et à une réduction des prescriptions d'antibiotiques de 
80%, par rapport à la pratique courante. Ces résultats ont démontré, que 
ALMANACH, en conditions contrôlées dans les soins primaires en Tanzanie, assurait 
la sécurité des patients, et avait un impact positif important sur l'utilisation rationnel 
des antimicrobiens.  
Afin d'évaluer si l'utilisation de la version électronique d’ALMANACH dans des 
conditions programmatiques améliorerait les performances des cliniciens, et 
l'utilisation rationnelle des médicaments, nous avons conduit une étude comparative 
des processus de consultation. A cet effet, 9 structures de santé de Dar es Salaam 
ont été randomisées en 3 bras; 3 structures de santé ont été désignées pour utiliser 
ALMANACH sous format papier, 3 pour utiliser la version électronique, et 3 pour 
continuer leur pratique de routine, dans un bras contrôle. Quatre mois après une 
formation initiale, une étude d'observation des consultations a montré que la version 
électronique d’ALMANACH améliorait l’exhaustivité de l'évaluation clinique et 
réduisait les prescriptions d'antibiotiques de 60%. Ces résultats ont confirmé l'impact 
positif de ALMANACH sur l'usage rationnel des antimicrobiens dans des conditions 
programmatiques, et a démontré que la technologie mobile peut faciliter la mise à 
disposition d'algorithmes cliniques pour les utilisateurs finaux. 
De plus, la version électronique d’ALMANACH est un outil de collecte de données. 
Intégrant la collecte d’informations médicales au système d'aide à la décision 
clinique, ALMANACH a un fort potentiel d'amélioration du suivi des activités de soins 
primaires pédiatriques, et de la supervision individuelle des utilisateurs.  
ALMANACH a montré des résultats prometteurs dans le cadre de cette thèse. De 
nombreuses solutions technologiques de santé mobile ont été développées pour les 
pays à faible ressources, certaines ont été testées à petite échelle dans des 
expériences pilotes, très peu ont été déployées à grande échelle. L'intérêt manifesté 
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par deux des plus importantes organisations humanitaires internationales va 
maintenant donner une chance à ALMANACH d’être mis en place à plus grande 
échelle et atteindre son objectif initial d'améliorer les soins de santé pour les enfants 
des pays à faibles ressources. 
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Muhtasari 
Kuongezeka kwa  haraka  kwa usugu wa vijidudu dhidi ya dawa  duniani limekuwa 
tishio kubwa kwa afya ya jamii.  Katika nchi zenye kipato duni  dawa za gharama 
kubwa za daraja pili au la tatu ambayo hutumika kutibu vijidudu sugu vya magonjwa 
mara nyingi hazipatikani, au hazinunuliki kutokana na kuwa na gharama kubwa.  
Uhusiano juu ya  kiwango cha utumiaji wa dawa na usugu wake unajulikana vyema.  
Umakini katika utumiaji wa dawa hizo ni muhimu ili kuzuia usugu.  Katika nchi 
ambazo magonjwa ya kuambukiza ndiyo yanayoongoza kwa vifo vya watoto, 
upungufu wa vifaa tiba vya kupima na kugundua aina ya magonjwa pamoja na hofu 
ya maambukizi yanayohatarisha maisha, ni sababu kubwa inayopelekea utumiaji 
usio na mipaka wa dawa.  Wataalamu wa afya ya msingi katika nchi zenye kipato 
cha chini wana  uelewa mdogo, au mafunzo hafifu.  Katika miaka ya 1990, shirika la 
afya duniani (WHO) na UNICEF walitengeneza mpango wa pamoja wa kushughulikia 
magonjwa ya watoto kikamilifu, programu rahisi ambayo ililenga kuboresha utoaji 
huduma kwa afya ya msingi juu ya magonjwa matano makubwa ambayo huchangia 
sana vifo vya watoto chini ya umri wa miaka 5; yaani Nimonia, malaria, kuhara, 
surua, na utapiamlo. Pamoja na mpango huu kutekelezwa katika nchi zaidi ya 75, 
bado mpango huu haujaweza kuboresha utendaji wa wahudumu wa afya ya msingi 
hasa kwenye matumizi yasiyo ya lazima ya dawa.  Upungufu wa watendaji wa afya 
kwenye kuutumia mpango huo,  upungufu wa kutokuwepo mwongozo hasa wa 
utambuzi wa magonjwa na kutokuwepo mwongozo wa ushughulikiaji wa homa hasa 
pale mtoto anapokuwa hana malaria, vimetajwa kuwa ndiyo sababu kubwa za 
kutokuwepo na mlinganyo wa matokeo chanya ya matumizi ya mpango wa IMCI juu 
ya ubora wa huduma za afya  na hivyo kutopunguza matumizi ya dawa kwa watoto. 
Ili kulishughulikia tatizo hili la afya ya jamii, tulianzisha mradi ulioitwa PeDiAtrick, 
uliolenga kuandaa na kujaribisha njia za kitaalamu za jinsi kutatua tatizo la matumizi 
yasiyo ya lazima ya dawa katika kushughulikia magonjwa ya watoto kwa wahudumu 
wa afya ya msingi kwenye nchi zenye kipato cha chini. Mradi huu ulikuwa na maeneo 
manne makubwa.  
(1) Kuandaa mpango mpya na thabiti wa hatua kwa hatua  kwa ajili ya kuhudumia 
magonjwa ya watoto kati ya miezi miwili hadi miaka 5 katika nchi zenye kipato 
cha chini kwenye vituo vya afya ya msingi, kwa kushughulikia magonjwa 
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makuu yanayotibika, na kuwasaidia wahudumu wa afya kufanya maamuzi 
sahihi juu ya kutoa dawa au kutotoa dawa kwa watoto. 
(2) Kuandaa mpango wa kielektroniki kutokana na ule mpango mpya wa hatua 
kwa hatua utakaotumika katika  simu za mikononi zenye mfumo wa android 
(3) Kutathmini usalama wa mpango huu mpya ukilinganisha na utaratibu 
uliozoeleka hapa Tanzania katika vituo vya afya kwa kuangalia matokeo ya 
kiafya na matokeo ya utoaji wa madawa. 
(4) Kupima matokeo utendaji ya mpango wa kielektroniki kwa watendaji wa afya 
kwa maana ya kukamilisha vipimo, usahihi wa utambuzi wa ugonjwa na 
usahihi wa matibabu yaliyopendekezwa. 
Lengo kuu la  mradi wa PeDiAtrick ni kuboresha matokeo ya matibabu ya watoto na 
kupunguza matumizi yasiyo ya lazima ya dawa katika vituo vya afya ya msingi kwa 
kufuata maamuzi sahihi yatokanayo na majibu au matokeo yanayotolewa na 
matumizi ya simu za mkononi ili kupunguza vifo vya watoto na kusambaa kwa usugu 
wa vijidudu dhidi ya magonjwa.  
Kama hatua ya kwanza, tulisoma machapisho mbalimbali ili kuelewa usaambaji wa 
magonjwa hatari kwenye vituo vya afya ya msingi katika nchi zenye kipato kidogo, na 
ili kujua namna au njia bora na ya uhakika ya  kutambua magonjwa makuu ambukizi 
yanayotibika. Tulithibitisha kwamba  kwa magonjwa makuu ya watoto hapakuwa na 
njia sahihi kabisa ya vipimo na utambuzi wake. Isipokuwa kwa malaria na 
maambukizi ya njia ya mkojo, utambuzi ulitegemea tu mazoea ya muonekano wa 
mgonjwa kutokana na kutokuwepo kwa vifaa tiba vya vipimo na utambuzi katika vituo 
vya afya ya msingi. Kwa hiyo tuliandaa mpango mpya wa kushughulikia magonjwa 
ya watoto yaani ALgorithim for MANAgement of Child illnesses (ALMANACH) kwa 
watoto wenye umri kati  miezi  2 hadi 59 kwa vituo vya afya ya msingi ulioandaliwa 
juu ya misingi thabiti na maoni ya wataalamu.  ALMANACH inatoa njia ya utambuzi 
wa kuwepo au kutokuwepo kwa magonjwa ya malaria, maambukizi ya njia ya mkojo, 
na homa ya matumbo, na hivyo kuwasaidia watendaji wengi wa afya kuondoa dhana 
ya maambukizi ya bakteria kwa watoto walio chini ya umri wa miaka mitano. 
ALMANACH pia inatoa njia nyingine mpya inayoitwa “uwezekano wa maambukizi ya 
virusi” ambapo hufikiwa baada ya kuonyesha kuwa hakuna uwezekano wa 
maambukizi ya bakteria. Mpango huu mpya unasaidia kuwakumbusha watendaji wa 
afya kuwa mara nyingi watoto husumbuliwa na magonjwa ya virusi yanayopona 
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yenyewe ambayo hayahitaji matibabu yoyote maalumu isipokuwa tu kutibu dalili 
zinazojitokeza. Hii inapaswa kuwasaidia watendaji wa afya kupunguza matumizi 
yasiyo ya lazima ya dawa. ALMANACH ilitengenezwa kama kijitabu na nyingine 
ikawekwa kwenye programu ya simu zenye mfumo wa android. 
Baada ya kukamilisha uandaaji wa ALMANACH na kabla ya kuipendekeza itumiwe 
kama mpango kamili wa matibabu, tulipima usalama wa mapendekezo yake kwa 
kuangalia matokeo ya kiafya. Kwa kusudi hilo tulifanya majaribio yakiulinganifu ili 
kupima matokeo ya kiafya ya watoto na matumizi ya dawa za antibiotiki wakati 
wakitumia ALMANACH hii au wakifuata utaratibu wa kawaida hapa Tanzania katika 
vituo vya afya ya msingi. Katika njia hizi mbili za matibabu, ALMANACH ilionyesha 
matokeo mazuri zaidi na kupunguza  asilimia 80% ya matumizi ya dawa za antibiotiki 
ukilinganisha na utaratibu uliozoeleka  wa kutoa matibabu kwa watoto.  Matokeo 
haya yanadhihirisha usalama wa matumizi ya ALMANACH   katika afya ya msingi 
Tanzania na matokeo chanya muhimu ya kupunguza matumizi ya  dawa hizo kwa 
kutumia  mpango unaosimamiwa. 
 
Ili kupima kama matumizi ya ALMANACH ya kielektroniki inaboresha utendaji wa 
wahudumu wa afya na kupunguza matumizi yasiyo ya lazima ya dawa za kuua 
vijidudu katika hali ya kawaida, tulifanya utafiti wa ulinganifu wakati wagonjwa  
wakionwa na daktari. Kwa lengo hili, vituo 9 vya afya hapa Dar es Salam 
vilichaguliwa na kuwekwa katika makundi matatu kitaalamu. Kundi la kwanza ni la 
vituo vitatu ambavyo vilitumia  kijitabu cha ALMANACH,  vituo vingine vitatu vilitumia 
ALMANACH ya kielektroniki kwenye simu,  na vituo vingine vitatu viliendelea kufuata 
utaratibu wa kawaida uliozoeleka wa kutibu watoto. Miezi minne baada ya mafunzo, 
utafiti ulifanyika na ulionyesha kuwa ALMANACH ya kielektroniki iliboresha sana 
utambuzi wa magonjwa kwa madaktari na kupunguza matumizi ya dawa za antibiotiki 
kwa asilimia 60%. Matokeo haya yanathibitisha matokeo chanya ya matumizi ya 
ALMANACH katika kupunguza matumizi ya madawa ya kuua vijidudu katika 
programu za kutibu watoto, na pia yanaonyesha kuwa teknolojia ya simu za mkononi 
inaweza kusaidia kutoa huduma za tiba kwa mtumiaji wa mwisho katika vituo vya 
afya. 
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Kwa nyongeza, matumizi ya ALMANACH ya kielektroniki yanasaidia kama kifaa cha 
kukusanya taarifa.  Kwa kuingiza taarifa za kiafya katika mfumo huu wa kumsaidia 
daktari kufanya maamuzi, ALMANACH ina nafasi kubwa ya kuboresha ufuatiliaji wa 
afya ya msingi katika matibabu ya watoto na msaada wa usimamizi unaotolewa kwa 
watumiaji. 
ALMANACH imeonyesha matokeo mazuri katika msingi wa tasnifu hii ya sasa.  
Fumbuzi nyingi za kitabibu zinazotumia teknolojia ya simu za mkononi 
zimetengenezwa kwa ajili ya nchi zenye kipato cha chini;  baadhi zimejaribiwa katika 
tafiti ndogo ndogo za awali na chache sana zimetumiwa katika tafiti kubwa. Nia 
iliyoonyeshwa na mashirika mawili makubwa muhimu ya kimataifa ya misaada ya 
kibinadamu itaipa nafasi ALMANACH kutumiwa kwa kiasi kikubwa na kufikia lengo la 
msingi la kuboresha utoaji wa afya  kwa watoto katika nchi zenye kipato cha chini na 
cha kati. 
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Acronyms and abbreviations 
ALMANACH  Algorithm for the management of childhood illness 
ARI   Acute Respiratory Infection 
CDSR   Cochrane Database for Systematic Reviews 
CHERG  Child Health Epidemiology Reference Group 
CI    Confidence Interval 
CXR   Chest X ray 
DALY   Disability Adjusted Life Year 
HF   Primary care Health Facility 
HIV   Human Immodeficiency Virus 
HSROC  Hierarchical Summary Receiver Operation Characteristics  
HW   Health Worker 
IHME   Institute for Health Metrics and Evaluation 
IMCI   Integrated Management of Childhood Illness 
LR   Likelihood Ratio 
MCE   Multi Country Evaluation 
mRDT   Malaria Rapid Diagnostic Test 
PACTR   Pan African Clinical Trial Registry 
PATH   Program for Appropriate Technology in Health 
POCT   Point-of-care test 
RR   Risk Ratio 
SSA   Sub-Saharan Africa 
QUADAS  Quality Assessment of Diagnostic Accuracy Studies 
U5   Children Under the age of 5 years 
UNICEF  United Nations Children Funds 
URTI   Upper Respiratory tract Infection 
UTI   Urinary Tract Infection 
WHO    World Health Organization 
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1 Introduction 
In 2006, a project aimed at reducing the unnecessary use of antimalarial medicines 
introduced accurate and easy-to-use point of care tests for malaria diagnosis, the 
malaria rapid diagnostic tests (mRDT). In the Tanzanian health facilities where they 
were introduced, mRDT led to a dramatic decrease of the proportion of children 
under 5 years of age (U5) prescribed antimalarials, from 75% before to 15% after 
mRDT introduction. But the decrease in antimalarials’ prescriptions led to increased 
antibiotic prescriptions, that rose from 57% to 81% of the U5 attending with a 
complain of fever (D’Acremont et al., 2011).  
1.1 Antimicrobial use and resistance 
Over-prescription of antimicrobials is a worrying phenomenon observed worldwide 
(Gwimile et al., 2012) that facilitates and fasten the spread of resistant pathogens. In 
low income countries, and especially in Sub Saharan Africa, data to capture the 
extent of the problem of resistance are limited. Only few countries in Africa have an 
appropriate surveillance system for drug resistance (WHO, 2014), and an external 
audit reported weaknesses in antibiotic susceptibility testing in public health 
laboratories in many African countries (Frean et al., 2012). However, the available 
data shows that antibiotic resistance is growing in African countries as in the rest of 
the world. A recent review and meta-analysis of community-acquired bacteremia in 
neonates and infants in low income countries reported that more than 35% of the 
bacteria identified showed either resistance or reduced susceptibility to the first and 
second lines antibiotics recommended by WHO for sepsis management. i.e. 
combination of penicillin and gentamicin and third-generation cephalosporins. Two 
recent surveys conducted in Tanzanian tertiary hospitals reported high level of 
resistance in the bacteria isolated in bloodstream infections. In Mwanza, in children 
U5, isolates that were in majority enterobacteria (Escherichia coli 33.3% and 
Klebsiella pneumoniae 28.6%) were highly resistant to ampicillin (95%), co-
trimoxazole (90%), tetracycline (90%), gentamicin (80%), augmentin (80%), 
chloramphenicol (65%), ceftriaxone (35%), and ciprofloxacin (30%) (Christopher et 
al., 2013). And in a retrospective analysis of blood cultures performed from 2005 to 
2009 in the Muhimbili national hospital, pathogens isolated in bloodstream infections, 
mainly Gram-positive bacteria (coagulase-negative staphylococci 67.4% and 
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Staphylococcus aureus 13.2%), showed high resistance to penicillin G (70.6%), 
tetracycline (63.8%), cefotaxime (62.5%) and ampicillin (62.3%), and moderate to 
high resistance against chloramphenicol (45.2%), erythromycin (35.0%), ciprofloxacin 
(29.3%), co-trimoxazole (25.0%) and gentamicin (23.5%) (Moyo et al., 2010). 
Carbapenemase genes were also recently detected in about 10% of multi-drugs 
resistant Gram-negative bacteria isolated from patients in Mwanza (Mushi et al., 
2014). Still in Mwanza, in patients presenting with bloody diarrhoea, all Shigella 
strains had high resistance to ampicillin, tetracycline, trimethoprim-
sulphamethoxazole and chloramphenicol, the recommended drugs for management 
of dysentery in Tanzania (Temu et al., 2007). If the majority of data initially came from 
tertiary hospital, there is now also evidence of the presence of antimicrobial-resistant 
pathogens in the community. In Tanzania, 105 out of 300 (35%) healthy children U5 
attending a child health clinic in Dar es Salaam were found to carry Streptococcus 
pneumoniae in their nasopharynx. The majority of the isolates (78/115; 68%) were 
penicillin-non-susceptible pneumococci and multidrug resistance was detected in 19 
isolates (17%) (Moyo et al., 2012). In Madagascar, extended-spectrum ß-lactamase-
producing Enterobacteria (ESBL-PE) were isolated from the stools of 49 out of 484 
(10%) non-hospitalised patients screened (Herindrainy et al., 2011). And in 1999 in 
Ifakara, rural Tanzania, the majority of diarrheagenic E. coli isolates from children U5 
with acute diarrhoea were resistant to co-trimoxazole (87%), ampicillin (85%) and 
tetracycline (80%); 42% of the isolates were also resistant to chloramphenicol and 2 
out of the 130 isolates were resistant to nalidixic acid (Vila et al., 1999). These data 
show a worrying level of resistance of circulating pathogens to the available first and 
second line regimen of antibiotics in Tanzania, but also already the presence of 
pathogen resistant to antibiotics that are not commonly prescribed in these contexts.  
Antimicrobial resistance is associated with increased mortality and prolonged hospital 
stays (Blomberg et al., 2007; Cosgrove, 2006; de Kraker et al., 2011). Treating 
resistant pathogens requires more expensive second- or third-line drug regimen that 
are often unavailable and/or unaffordable for patients in low and middle income 
countries (Laxminarayan and Heymann, 2012). The continuous emergence of 
pathogens with new resistance profiles and the lack of new antimicrobial classes in 
the pipelines of pharmaceutics industry may soon threaten the modern medicine 
wonders, such as surgery, organ transplantation, preterm infants’ treatment, that are 
not possible without effective antibiotics (Laxminarayan et al., 2013). Infectious 
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diseases mortality declined over the 20th century; this achievement may soon be 
jeopardised if no actions are taken to tackle resistance to antimicrobials. If new 
antibiotics could help tackle this public health threat, there are few options under 
development and preserving the ones available today, by better targeting the patients 
in need of them and so decreasing the unnecessary prescriptions, is urgently 
needed. Indeed, level of resistance is associated with the level of antibiotic use, at 
the population level (Goossens et al., 2005; Stewardson et al., 2011; Vernaz et al., 
2011) and at individual level (Costelloe et al., 2010; Stewardson et al., 2011). And a 
growing body of evidence shows that the decrease of antibiotic use, or better 
selection of antibiotic classes leads to decreased level of resistance in hospitals and 
in communities (Butler et al., 2007; Dagan et al., 2008; Guillemot et al., 2005; 
Kardas-Sloma et al., 2013; Molstad et al., 2008; Smith, 1999).Improving diagnosis 
capacity is a necessary step towards decreasing the overuse of antimicrobials, and 
mRDTs may definitely improve the rational use of antimalarials. But the rise of 
antibiotic prescription observed in D’Acremont’s (2011) and other mRDT 
implementation projects (Baiden et al., 2012; Msellem et al., 2009) have brought 
concerns, and questions regarding the relevance of their implementation (Baiden et 
al., 2011). If mRDT implementation resulted in shifting the burden of unnecessary 
antimalarial to unnecessary antibiotics, this would of course be a failure. Instead of 
precluding the implementation of an accurate diagnostic tool, this should call for 
providing to clinicians better guidance for the management of the non-malaria fevers, 
from diagnosis to treatment. In settings were mRDT are to be implemented, clinicians 
were trained for decades to treat malaria presumptively in all children with history of 
fever. Malaria was therefore often the only cause of fever considered, and clinicians’ 
knowledge, skills and tools for the management of non-malaria fever, a new concept 
brought to them by the negative mRDT, are likely to be scarce in these settings. 
Improving clinicians’ access to appropriate non-malaria fever diagnoses and 
treatment procedures, while introducing mRDT, is therefore mandatory. While aiming 
at decreasing the unnecessary use of antimicrobials, the procedures should of 
course ensure appropriate identification and prompt treatment of all treatable 
potentially life-threatening infectious diseases that are till today the leading causes of 
death in children under 5 years of age (Liu et al., 2014). 
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1.2 Available guidelines for the management of childhood illness 
For primary care facilities in low income countries, a standard of care for the 
management of paediatric acute illnesses, including fever, was developed in the 
1990’s by the World Health Organization (WHO) and the United Nations Children 
Funds (UNICEF): the Integrated Management of Childhood Illness (IMCI) guidelines 
(Gove, 1997). Developed to tackle childhood morbidity and mortality in low income 
countries, the clinical guidelines propose an integrated syndromic algorithm, relying 
on simple clinical signs and symptoms to improve case management and access to 
treatment for the 5 leading causes of child death: malaria, pneumonia, diarrhoea, 
measles, and malnutrition. The clinical algorithm is part of the larger IMCI strategy 
that aims at decreasing child mortality by improving i) the diseases case 
management by health workers (HWs), ii) the overall health systems, and iii) the 
family and community health practices. In Tanzania, where D’Acremont et al. (2011) 
assessed the impact of mRDT on antimicrobials prescriptions, IMCI was the national 
standard of care recommended for the management of children under 5 years of age, 
in primary care. When using IMCI algorithm, clinicians are recommended to prescribe 
(or administer) antimalarials to children with fever or history of fever and antibiotics to 
children with classification of severe or very severe diseases, lower respiratory tract 
infection, dysentery, or acute ear infection. The introduction of mRDT changed the 
IMCI antimalarial prescription recommendation from presumptive to test-based 
treatment. However, clinicians if they had followed IMCI recommendations for the 
management of acute illnesses in children should not have prescribed antibiotics to 
80% of children as observed by D’Acremont et al. (2011), but rather only to the 
children classified as having severe or very severe diseases, lower respiratory tract 
infection, dysentery, or acute ear infection, as proposed by IMCI algorithm . Different 
elements may explain the observed high antibiotic use in this context. 
1.3  Limitations of the existing guidelines 
1.3.1 Insufficient uptake 
The United Republic of Tanzania participated in the early development of IMCI, 
piloting the IMCI case management training in 1996 and starting the national roll out 
in 1998. In Tanzanian districts participating in the IMCI - Multi Country Evaluation 
(MCE)(Bryce et al., 2004), IMCI appeared to improve the quality of care (J. 
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Armstrong Schellenberg et al., 2004), to lower U5 mortality rates, and to be cost 
effective (J. R. Armstrong Schellenberg et al., 2004). If Ethiopia also observed an 
impact on child mortality (Rakha et al., 2013), the other countries participating in the 
IMCI-MCE failed to demonstrate that IMCI reduces child mortality (Amaral et al., 
2005; Arifeen et al., 2009; Huicho et al., 2005b). Important constraints towards large-
scale IMCI implementation exist (Ahmed et al., 2010; Prosper et al., 2009) and may 
explain that the expected impact was not observed in these countries. At primary 
care level, some surveys have shown that IMCI can improve clinicians performance, 
in term of thoroughness of children’s health problems’ assessment (Amaral et al., 
2004; J. Armstrong Schellenberg et al., 2004; Chopra et al., 2005), appropriateness 
of disease classifications (Amaral et al., 2004; J. Armstrong Schellenberg et al., 
2004), and appropriateness of treatment prescribed (Chopra et al., 2005; Gouws et 
al., 2004; Naimoli et al., 2006; Zhang et al., 2007). However the low training coverage 
(Ahmed et al., 2010; Mushi et al., 2010) and clinicians’ low use of IMCI and low 
compliance to recommended procedures often impaired IMCI’s impact on HWs’ 
performance and rational use of medicines (Arifeen et al., 2005; Horwood et al., 
2009a; Rowe et al., 2012; Senn et al., 2014). A recent mixed-method study has 
explored the reasons of clinicians’ low compliance to IMCI guidelines (Lange et al., 
2014). The main reasons identified by the authors were a lack of motivation to adhere 
to IMCI guidelines, partly due to a weak belief in the importance of following the 
guidelines, and a physical and/or cognitive “overload”, resulting in lack of capacity to 
concentrate fully on each and every case. These represent important barriers 
towards guidelines implementation that should be considered and addressed when 
proposing new procedures for the management of fever in low resource settings. 
1.3.2 Insufficient diagnostic accuracy 
Another limitation within IMCI guidelines towards rational use of antimicrobial is the 
lack of specificity of some features used for diagnoses classifications. Designed to 
decrease U5 mortality and to be easy-to-use by lay clinicians, the clinical algorithm 
relies on clinical case definitions with high sensitivities. A high sensitivity is indeed 
necessary to detect children at risk and prevent death by prompt treatment for 
serious infectious diseases. But if the classification definitions have low specificities, 
they will result in important overuse of antimicrobial. Recent works have suggested 
that the definition used to diagnose pneumonia lacks specificity and that many of the 
children prescribed antibiotics may actually not benefit from them (Hazir et al., 2011; 
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Senn et al., 2014). WHO clinical case-definition of pneumonia (cough or difficult 
breathing associated with fast-breathing and/or chest indrawing) was derived from 
diagnostic test accuracy studies that initially targeted low respiratory tract infection 
(Shann et al., 1984). In usual medical language, the term ‘pneumonia’ refers to 
bacterial parenchymal lung infections, while ‘lower respiratory tract infection’ refers to 
all lung infections being either caused by viruses (such as bronchitis or bronchiolitis) 
or bacteria. In the WHO acute respiratory infections (WHO-ARI) program, the term 
pneumonia was kept although the clinical case definition encompassed other lower 
respiratory tract infections and this may lead to confusion for clinicians (Brewster, 
2015). Furthermore, in countries lacking efficient civil registration systems, mortality 
data are collected through verbal autopsy. The verbal autopsy questionnaire cannot 
differentiate bacterial pneumonia from other lower respiratory tract infections. 
Therefore when pneumonia is designated as the leading cause of childhood mortality 
in low-income countries, it doesn’t mean bacterial pneumonia. In the 1980’s bacterial 
pneumonia were maybe the dominant causes of lower respiratory tract infections. 
However, recent work has found viruses to be the main causes of WHO-defined 
pneumonia (Berkley et al., 2010; D’Acremont et al., 2014; Rudan et al., 2008), which 
is in line with surveys showing that the majority of chest radiographs taken in children 
with WHO-defined pneumonia are normal (D’Acremont et al., 2014; Hazir et al., 
2006). Therefore, this ambiguity in the use of the term ‘pneumonia’ is likely to lead to 
inappropriate use of antimicrobial by clinicians. Identifying predictors of bacterial 
pneumonia instead of predictors of lower respiratory infections used in the current 
WHO-ARI chart would help refining the algorithm to better target children in need of 
antibiotics among the many children attending primary care facilities with acute 
respiratory infections.  
The burden of the targeted diseases in term of prevalence, etiology, and case fatality 
rate and the availability of diagnostic test also modulate the relevance of diagnoses’ 
classifications. Until 2014, IMCI recommended a presumptive treatment for malaria in 
all children with fever or history of fever, where malaria risk was high. If this strategy 
may be meaningful when the majority of fever cases are due to malaria, the decrease 
in malaria transmission observed in the recent decade (Ceesay et al., 2010; 
D’Acremont et al., 2010a; O’Meara et al., 2008), together with the rapid spread of 
antimalarial resistance and the cost of the present first-line regimen (artemisin-based 
combination therapy – ACTs), made this strategy obsolete, dangerous, and costly. 
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But until accurate and affordable mRDT were developed and deployed, the lack of 
good clinical predictors made this strategy the only possible one to tackle malaria-
related child mortality. Since 2010 WHO recommends a test-based malaria treatment 
(WHO, 2010), and this strategy was endorsed by the WHO IMCI in the 2014 chart 
booklet (WHO and UNICEF, 2014). Regular and prompt updates of clinical 
algorithms when new epidemiological knowledge or technologies are available are 
mandatory, although difficult, to ensure appropriate management of the children with 
acute infections.  
1.3.3 Recommendation gap: non-malaria fever 
Before the introduction of a malaria test in IMCI, the fever chart was only considering 
malaria and measles. Although children with other associated symptoms (cough, 
diarrhoea or ear problem) were also assessed for other causes of fever within the 
dedicated symptoms charts, only malaria and measles were directly assessed in the 
fever chart. With the introduction of the malaria test in the fever chart (WHO and 
UNICEF, 2014), the following recommendation was formulated for children with 
history of fever or elevated temperature tested negative for malaria: “Give appropriate 
antibiotic treatment for an identified bacterial cause of fever”. A footnote suggest the 
HWs to look for the following clinical features in these patients: local tenderness; oral 
sores; refusal to use a limb; hot tender swelling; red tender skin or boils; lower 
abdominal pain or pain on passing urine in older children. Without further 
specifications, this may not represent a useful guidance for clinicians to achieve a 
rational management of the non-malaria fever in children. While reminding clinicians 
about the possible serious bacterial diseases, which is important to ensure the 
children suffering from these conditions receive life-saving treatment, these notes do 
not provide support to rule out bacterial diseases. Therefore, this recommendation 
formulation is likely to lead to important prescription of antimicrobials, clinicians 
fearing to miss a potentially life-threatening disease. 
Understanding the reasons for antibiotics prescription and the actual treatable causes 
of non-malaria fever is necessary to assess whether better clinical algorithm could 
and should be proposed. 
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1.4 Clinicians’ behaviour with regards to antibiotic prescriptions 
Over-prescription of antibiotics in ambulatory children is a well-documented 
phenomenon in low-income (Gwimile et al., 2012; Means et al., 2014; Risk et al., 
2013) and high-income countries (Nyquist et al., 1998). Recent trends of antibiotics 
prescription in low-income countries are not reassuring, and in Sub Saharan Africa 
the percentage of children younger than 5 years treated with antibiotics for an URTI 
almost doubled over 25 years to reach over 70% in 2004-2006 (WHO Medicines, 
2009). Interventions aimed at decreasing the overuse of antimicrobials in ambulatory 
care have shown varying impact (Arnold and Straus, 2005; Ranji et al., 2008; 
Vodicka et al., 2013). Multifaceted interventions and interventions addressing the 
prescribing behaviour and barriers to change in the particular setting are more likely 
to have a positive impact on prescriptions.(Arnold and Straus, 2005)  
Understanding the prescribing behaviour and barriers to change in Sub Saharan 
African primary care facilities is therefore of high interest. In Sub-Saharan African 
countries, the average consultation time in ambulatory care is 5 minutes (WHO 
Medicines, 2009). In surveys looking at the consultations’ process, clinicians often 
performed only a small proportion of the assessment tasks recommended by the 
IMCI algorithm (Bjornstad et al., 2014; Horwood et al., 2009a; Maestad et al., 2010; 
Rowe et al., 2012; Zurovac and Rowe, 2006). When their level of knowledge is 
evaluated, it is often much higher than what they actually apply. Excessive workload 
is a reason often mentioned by health workers to explain this know-do gap and their 
low compliance to recommendations. However a recent survey in Tanzania found no 
association between the caseload and the efforts made in the diagnostic process 
(Maestad et al., 2010). The lack of trust in the recommended tasks being an 
important reason for not performing them (Lange et al., 2014), important efforts must 
be made to both ensure requested tasks are useful for the patient, and that they are 
perceived as useful by the clinicians. Improving guidelines to be more specific on 
antibiotic needs will likely be insufficient if clinicians’ compliance to the 
recommendations is not improved.  
To better understand the use of antimicrobial drugs by clinicians, it is also important 
to look at the social psychology knowledge on behavioural change. The classical, 
rational, or ‘top-down’ model of behavioural change that rely on changing people 
thinking (knowledge, attitudes, beliefs and goals) to encourage behavioural change, 
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has shown important limits. Illustrated by the know-do gap, changing people 
conscious thoughts and motivation aren’t enough to achieve effective behavioural 
change (Webb and Sheeran, 2006). Behaviour seems more influenced by the 
environmental and situational factors than by individual’s knowledge. (Kollmuss and 
Agyeman, 2002; Thaler, 2008) And a new, contextual, or bottom-up model suggests 
behavioural change come from an automatic, associative, rapid and unconscious 
cognitive process. (Evans, 2008) In Tanzania, clinicians are trained to prescribe oral 
antibiotics for children with pneumonia, but in many health care facilities they use 
injectable drugs to treat these patients. The influence of their peers’ behaviour and 
the local informal guidelines has higher influence than their knowledge on their 
behaviour. New approaches are needed for interventions aimed at changing 
clinicians’ prescriptions behaviour to reach their goal. 
1.5 Potential benefit of mobile technology to improve clinicians’ performance 
The recent development of mobile technology and the rapid spread of mobile phones 
in low and middle income countries offer a new range of opportunities for innovative 
approaches to improve the quality of care. And in recent years, an increasing number 
of software applications to support clinical decision, patients’ management, or health 
information management have been developed. They are referred to as mobile 
health (mHealth) solutions. There is already an important body of literature describing 
the potential of electronic clinical decision support systems to improve the quality of 
care in primary care settings; both in high (Bryan and Boren, 2008) and in low income 
countries (Källander et al., 2013; Mitchell et al., 2013, 2008; Praveen et al., 2014). 
Although barriers to mHealth solutions were often identified, such as lack of access 
to computers, need for training, and fear of increased workload (Machingura et al., 
2014), the interest and willingness of health workers to use mobile technology in their 
personal and professional activities was present in high (Franko and Tirrell, 2012) 
and low income countries (Machingura et al., 2014). 
Electronic clinical algorithms may therefore be of great potential to improve health 
workers compliance to guidelines. They also may allow delivering more complex 
algorithm to lay health workers in low resource countries.
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2 Goal and objectives 
2.1 Goal 
The Goal of the present project was to improve the quality of the management of 
children aged 2 to 59 months attending low resource primary care health facilities 
(HFs) with acute illnesses, by providing health workers with evidence-based clinical 
decision support system in order to improve both the children health outcomes and 
the rational prescriptions of antimicrobials in primary care to decrease childhood 
mortality and contain resistance spread in the community. 
2.2 Objectives  
2.2.1 Objective 1 
To develop a new evidence-based clinical algorithm for the management of children 
aged 2 to 59 months in low income countries primary care facilities, addressing the 
main treatable causes of acute illness, and assisting clinicians for decision-making to 
withhold antibiotics in children who would not benefit from it. 
2.2.2 Objective 2 
To assess the safety of the new clinical algorithm as compared to the current 
practices in Tanzanian health facilities in term of health outcome, and its impact on 
antimicrobial prescription. 
2.2.3 Objective 3 
To develop an electronic version of the clinical algorithm and assess its feasibility and 
impact on HWs performance in term of completeness of integrated assessment, 
appropriateness of disease classifications, and appropriateness of treatment 
prescribed. 
  
Chapter 2 – Goal and objectives 
12 
  
Chapter 3 – Methods’ overview 
13 
3 Methods’ overview 
3.1 Study design 
3.1.1 Development of a new clinical algorithm 
Review of the available evidence 
Structured reviews of the literature have been conducted to document 
i) the clinical presentation of children aged 2-59 months attending HF in low 
income countries 
ii) the main threatening and treatable diseases responsible for acute illness in 
these patients  
iii) the most accurate and easy to use diagnostic procedures in HF in low 
income countries  
Systematic review and meta-analysis of clinical predictors of radiological pneumonia 
For pneumonia diagnosis, a systematic review of the literature and meta-analysis 
was conducted to evaluate the accuracy of the WHO clinical pneumonia case 
definition, and to look for more accurate clinical predictors. (Chapter 5) 
Search strategy: Electronic databases were searched to identify articles assessing 
clinical predictors of radiological pneumonia in children.  
Study selection: The studies selected were diagnostic accuracy studies, targeting 
bacterial pneumonia, in children <5 years, in ambulatory or hospital care, and 
assessing the accuracy of clinical features as index test as compared to chest 
radiography as reference standard.  
Quality assessment: Quality assessment was based on the 2011 Quality Assessment 
of Diagnostic Accuracy Studies (QUADAS-2) criteria.  
Analyses: For each index test, sensitivity and specificity were calculated. Meta-
analyses with the Bivariate model and hierarchical SROC plots were done for index 
tests assessed in four or more studies. 
Chapter 3 – Methods’ overview 
14 
Design of a new algorithm 
Together with the findings of these literature reviews, the results from a 
comprehensive study of the etiologies of fever in outpatient children, conducted in 
Tanzania (D’Acremont et al., 2014) were used to improve evidence on the main 
causes of fever and to look for clinical predictors of bacterial diseases. Building on 
the evidence identified through these reviews and study we developed of a new 
clinical algorithm that is presented in Chapter 6. 
3.1.2 Assessment of the safety of the algorithm 
A validation of this new algorithm was performed by conducting a prospective non-
inferiority trial in Tanzanian health facilities, that compared the health outcome of 
children aged 2-59 months managed by clinicians following their routine practice to 
the one of children managed following strictly the new algorithm recommendation, as 
well as the rate of antibiotic prescription.  
Procedures 
Children coming for a first visit for an acute medical ailment were managed in the 
intervention arm by a study clinician following strictly the new algorithm 
recommendations and in the control arm by the usual HF clinician. The details of the 
clinical presentation, diagnoses reached and treatment prescribed were collected, in 
the intervention arm by the study clinician, and in the control arm by an observer on 
standardised case report forms. Children were followed up at home on day 7 for 
health outcome. 
Primary Outcomes  
Proportion of children cured at day 7 and proportion of children who received 
antibiotics on day 0. 
The detailed methods and results of this study are presented in Chapter 7. 
3.1.3 Feasibility of implementing the new electronic algorithm 
Intervention 
The new algorithm was introduced in 6 health facilities in Dar es Salaam; 3 facilities 
received the new paper algorithm and 3 others received the new electronic algorithm. 
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Implementation involved training of the health workers, introduction of the mobile 
devices when applicable, and regular supervision. A comparative study to assess the 
HW’s performance after the pilot implementation of the new electronic algorithm in 
routine conditions was conducted in the involved health facilities.  
Procedures of the comparative study to assess HWs’ performance 
Nine HFs in Dar es Salaam were randomised into three arms; three HFs were 
allocated to use the new paper algorithm, three to use the new electronic algorithm, 
and three to continue with their current practice (control). Four months after training, 
an observational survey of clinical consultations was conducted. Children coming to 
the health facility with an acute medical ailment for a first visit for whom a caretaker 
had given a written informed consent were enrolled in the survey. An observer 
recorded the details of the consultation process on standardised case report forms. 
All children were then reassessed by an expert who followed strictly the new 
algorithm recommendation to establish the reference for classification and treatment. 
Primary outcomes  
HWs’ performance was compared between the 3 arms, using index of child’s 
assessment, appropriateness of diagnosis classification and treatment as outcome 
variables. 
The detailed methods and results of this survey are presented in Chapter 8 
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4 Study sites and setting 
4.1 Study sites 
The field work of the present project took place in two sites in the United Republic of 
Tanzania: the urban area of Dar es Salaam and a rural district in Morogoro region, 
Kilombero district. (Figure 1) 
Located in East Africa, Tanzania is a low income country with a Gross National 
Income (GNI) per capita of 630$ (World Bank, 2015). More than 70% of the 45 million 
inhabitants live in rural areas. In 2012, the life expectancy at birth was 61 years 
(World Bank, 2015).  
The Tanzanian health system structure follows the 6-level administrative structure, 
which divides the country in zones, regions, districts, divisions, wards and villages. A 
referral or tertiary hospitals is available per zone, secondary hospitals are found at 
regional level, district hospitals at district level, health centers at division level, 
dispensaries at ward levels, and village health posts are found in the villages. Health 
care services are delivered mainly by clinical officers with three years of clinical 
training through a network of 6321 health facilities, 85% of them being dispensaries 
(HRH, 2013). Children U5 represent 15% of the total population (PHC, 2012), and the 
U5 mortality was 81 per 1000 live births in 2010 (TDHS, 2010). The following child 
survival interventions are provided free of charge through both public and private 
health facilities countrywide: IMCI, vitamin A, deworming, prevention of mother-to-
child transmission of HIV, insecticide-treated nets, and focused antenatal care, 
together with routine immunisation services. The Tanzanian routine immunisations 
include vaccines for measles, diphteria, pertussis, tetanus, polio (DTP) and 
tuberculosis (BCG). In 2002, hepatitis B vaccine was added to this list and in 2009, 
Haemophilus influenza B. In 2013 after the present project ended, pneumococcal 
conjugate and rotavirus vaccines were also introduced in the routine vaccination. In 
2010 routine immunisation coverage was estimated to be 95.4% for BCG, 87.8% for 
DTP-HepB3 and 84.5% for measles.  
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Figure 1. Study sites 
The field work of the present thesis took place in Dar es Salaam, the economic capital, and in 
Kilombero, a rural district in Morogoro region. (Adapted from: http://www.lib.utexas.edu/maps/africa/ 
tanzania_pol_2003.jpg). 
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In 2010/2011 the estimated prevalence of malaria in children aged 6 to 59 months 
was 9% according to mRDT and 4% to microscopy, with important variations 
between regions. mRDT were introduced and rolled out from 2010 by the National 
Malaria Control Program, and test-based management of malaria was endorsed in 
2013 in the Tanzanian Standard Treatment Guidelines (TSTG, 2013). Tanzania was 
one of the first countries involved in the development of IMCI, piloting the case 
management training in 1996, and taking part to the IMCI-Multi Country Evaluation 
program. The IMCI national roll-out started in 1998, and in 2005 83% of the districts 
had conducted at least one training course. However national level training coverage 
was only 14% (Prosper et al., 2009).In 2010 17% of the household had access to 
electricity; 69% of households in Dar es Salaam, 33% in other urban areas an only 
4% in rural area. Nevertheless, the country counted 26 million mobile phone 
subscribers (PHC, 2012). 
Dar es Salaam 
Dar es Salaam is the economic capital of the country, located on the East coast. 
Rapidly growing, with an annual growth rate of 5.6%, the city counted 4.4 inhabitants 
in 2012 (PHC, 2012). The administrative structure divides Dar es Salaam in three 
districts or municipalities, Kinondoni, Ilala, and Temeke, from North to South. Each 
district is further divided in wards and subwards. Within the City Council is located the 
City Medical Office of Health, and 3 District Medical Offices are in charge of the 
management of the health facilities (one district hospital, health centers and 
dispensaries) that are located in their district. 
Kilombero district 
Kilombero district is a one of the rural districts in Morogoro region, in southeast 
Tanzania. The district is located in a flood plain between the Undzungwa Mountains 
and the Kilombero River, and counted about 400 000 inhabitants in 2012(PHC, 
2012). Ifakara is the administrative capital.  
In Dar es Salaam malaria prevalence was estimated to be 3.6% with mRDT, and 
0.3% with microscopy; in Morogoro region 13% and 7% respectively (THMIS, 2011).  
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4.2 Study setting 
The study on the safety of the new algorithm recommendations took place in two 
pairs of primary health care facilities: Buguruni Health Center (intervention) and 
Vingunguti Dispensary (control) in Ilala district, Dar es Salaam; and Signal 
Dispensary (intervention) and Mang’ula (control) in Kilombero districts, both located 
North-East from Ifakara. The study of the implementation of the new algorithm took 
place in 9 primary health care facilities in Dar es Salaam. These 9 health facilities 
were purposively selected because they were the only primary health care facilities 
using malaria rapid diagnostic tests at the beginning of the project. Malaria tests were 
introduced in these facilities by a research project ahead of their national roll out, and 
were maintained by the City Medical Office of Health in collaboration with the 
National Malaria Control Program. For the purpose of the survey, these 9 health 
facilities were randomly allocated to receive i) no intervention (control), ii) the paper 
algorithm intervention, or iii) the electronic intervention. In Kinondoni district, Sinza, 
Kawe, and Tandale were respectively allocated to be part of the control, paper and 
electronic arm; in Ilala district, Vingunguti, Tabata A, and Buguruni were enrolled in 
the respective 3 arms; and in Temeke district, Mbagala Kizuiani, Kigamboni, and 
Mbagala rangi tatu were enrolled in the respective 3 arms.  
 
Chapter 5 – Clinical predictors for diagnosing pneumonia 
21 
5 Clinical features for diagnosing pneumonia in children younger 
than 5 years: a systematic review and meta-analysis  
 
Clotilde Rambaud-Althaus MD1*, Fabrice Althaus MD1,2, Prof. Blaise Genton MD 
PhD1,2,3, Valérie D’Acremont MD PhD1,2 
 
1Department of Epidemiology and Public Health, Swiss Tropical and Public Health 
Institute and University of Basel, Basel, Switzerland,  
2Department of Ambulatory Care and Community Medicine, University of Lausanne, 
Lausanne, Switzerland  
3Infectious Disease Service, Lausanne University Hospital, Lausanne, Switzerland   
 
*Corresponding Author: Clotilde Rambaud-Althaus, Department of Epidemiology 
and Public Health, Swiss Tropical and Public Health Institute, Socinstrasse 57, P.O. 
Box, CH-4002 Basel, Switzerland, e-mail: clotilde.rambaud@unibas.ch  
 
 
 
 
 
 
This article has been published in Lancet Infectious Diseases (2015) 15, 439–450 
  
Chapter 5 – Clinical predictors for diagnosing pneumonia 
22 
5.1 Summary 
Background: Pneumonia is the biggest cause of deaths in children younger than 5 
years in developing countries, but early diagnosis and intervention can effectively 
reduce mortality. We aimed to assess the diagnostic value of clinical signs and 
symptoms to identify radiological pneumonia in children younger than 5 years and to 
review the accuracy of WHO criteria for diagnosis of clinical pneumonia.  
Method: We searched Medline (PubMed), Embase (Ovid), the Cochrane Database 
of Systematic Reviews, and reference lists of relevant studies, without date 
restrictions, to identify articles assessing clinical predictors of radiological pneumonia 
in children. Selection was based on: design (diagnostic accuracy studies), target 
disease (pneumonia), participants (children <5 years), setting (ambulatory or hospital 
care), index test (clinical features), and reference standard (chest radiography). 
Quality assessment was based on the 2011 Quality Assessment of Diagnostic 
Accuracy Studies (QUADAS-2) criteria. For each index test, we calculated sensitivity 
and specificity and, when the tests were assessed in four or more studies, calculated 
pooled estimates with use of bivariate model and hierarchical summary receiver 
operation characteristics plots for meta-analysis.  
Results: We included 18 articles in our analysis. WHO-approved signs age-related 
fast breathing (six studies; pooled sensitivity 0·62, 95% CI 0·26–0·89; specificity 
0·59, 0·29–0·84) and lower chest wall indrawing (four studies; 0·48, 0·16–0·82; 0·72, 
0·47–0·89) showed poor diagnostic performance in the meta-analysis. Features with 
the highest pooled positive likelihood ratios were respiratory rate higher than 50 
breaths per min (1·90, 1·45–2·48), grunting (1·78, 1·10–2·88), chest indrawing (1·76, 
0·86–3·58), and nasal flaring (1·75, 1·20–2·56). Features with the lowest pooled 
negative likelihood ratio were cough (0·30, 0·09–0·96), history of fever (0·53 ; 0·41–
0·69), and respiratory rate higher than 40 breaths per min (0·43, 0·23–0·83).  
Interpretation: No one clinical feature was sufficient to diagnose pneumonia 
definitively. Combination of clinical features in a decision tree might improve 
diagnostic performance, but the addition of new point-of-care tests for diagnosis of 
bacterial pneumonia would help to attain an acceptable level of accuracy.  
Funding: Swiss National Science Foundation  
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5.2 Introduction 
In developing countries, pneumonia is the largest cause of deaths in children younger 
than 5 years.(Liu et al., 2012) Early identification and treatment of patients with 
pneumonia cases is fundamental to reduce mortality. Identification of which 
pneumonia cases need antibiotic treatment among the large number of children 
presenting with respiratory symptoms is a challenge because cough is reported in 
two thirds of children attending outpatient facilities in low-income countries.(Van 
Hemelrijck et al., 2009) Chest radiograph, the current gold standard for pneumonia 
diagnosis(Cherian et al., 2005), is not available in resource-poor settings where the 
burden of disease is the highest. Even when available, chest radiograph cannot be 
done for all coughing children because of the very high frequency of this complaint 
and the potential long-term effects of exposure to x-rays. Therefore, clinical 
predictors are used to identify children who should receive an antibiotic drug or 
undergo assessment by chest radiograph. Since the late 1980s, pneumonia 
diagnosis in developing countries has relied on the presence of cough, fast breathing, 
and chest indrawing, as recommended by WHO (WHO-ARI, 1991; WHO and 
UNICEF, 2014). This recommendation was based on studies published in the late 
1980s and validated by other studies in the 1990s. Since then, no major innovation 
has been made in pneumonia diagnosis and no accurate point-of-care test is 
available to identify children who would benefit from antibiotics. With the rapid spread 
of antibiotic resistance worldwide, there is rising concern about over-prescription of 
antibiotics resulting from insufficient specificity of the WHO criteria used to classify 
acute respiratory infections.(Hazir et al., 2011; Scott et al., 2012) Here, we assess 
the diagnostic value of clinical signs and symptoms in identification of children 
younger than 5 years old (excluding infants <2 months) with radiological pneumonia. 
This evaluation might help to generate more accurate clinical scores from which to 
make decisions about the necessity of further investigation by chest radiograph or 
antibiotic treatment for children presenting with respiratory symptoms in low-resource 
ambulatory care facilities. 
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5.3 Methods 
5.3.1 Search strategy 
We did a systematic literature search in Medline (PubMed), Embase (Ovid), and the 
Cochrane Database of Systematic Reviews (CDSR), without date or language 
restrictions. We did our first search on Sept 30, 2013, with an update on Nov 6, 2014. 
In Medline, we used the following search terms: “pneumonia”[MeSH terms] in 
combination with: "predictive value of tests"[MeSH terms] OR "sensitivity and 
specificity"[MeSH terms] OR "reproducibility of results"[MeSH terms] OR “diagnostic 
test” OR “diagnostic tests” OR "physical examination"[MeSH terms] OR "medical 
history taking"[MeSH terms], and the following age filters: “infant 1-23 months” and 
“preschool child 2-5 years”. In Embase, we used ‘diagnostic accuracy'/exp OR 
'predictor variable'/exp OR 'breathing rate'/exp in combination with “pneumonia” OR 
“lower respiratory tract infection” OR “respiratory tract infection”, and with “child”. We 
did an additional manual search of the reference lists from eligible articles and 
identified reviews to complete our search. Two reviewers (CR-A and VD’A) 
independently did the search using a two-step process: first, assessing the title and 
abstract, and second, assessing the full text, using the seven selection criteria listed 
in the panel. Any disagreement was resolved through discussion and consensus.  
.  
5.3.2 Quality assessment 
We assessed the quality of selected studies and potential risk of bias with the 2011 
revised version of the Quality Assessment of Diagnostic Accuracy Studies 
(QUADAS-2),(Whiting et al., 2011), adapted to the review question, as recommended 
by the Cochrane Collaboration. For this Article, all clinical index tests were 
considered to be appropriate, irrespective of the way they had been assessed by the 
clinician, except for respiratory rates, which we required to be measured by 
observation in 1 min in a calm child, as recommended by WHO. Therefore, the index 
test domain of the QUADAS-2 was separated into two sections: one for the 
respiratory rate (defining fast breathing) and one for the other index tests. For the 
reference standard, the best existing one for bacterial pneumonia is end-point 
pneumonia on chest radiograph (WHO criteria).(Cherian et al., 2005; Lynch et al., 
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2010). For this review, we selected all studies using chest radiograph as reference 
standard, irrespective of criteria used for interpretation. When the interpretation 
criteria differed from WHO criteria, we reported in the methodological quality 
assessment that there were great concerns about the applicability of the results to 
the research question. The quality assessment was done independently by two 
authors (CR-A and VD’A). Any disagreement was resolved through discussion and 
consensus. 
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Panel: Criteria for studies selection 
Design We selected studies that assessed diagnostic accuracy, clinical predictors or derived 
prediction rules. Narrative reviews, letters, editorials, comments, and case series of fewer than 
20 patients were excluded. Systematic reviews and meta-analyses were considered for their 
reference lists.  
Target disease Studies that assessed pneumonia.  
Participants Studies needed to include children aged between 2 months and 5 years. We 
excluded studies including only adults or only children younger than 6 months or older than 6 
years. Studies were excluded of patients at higher risk of pneumonia because of pre-existing 
immune suppression (due to HIV infection, neutropenia, and malnutrition), comorbidities 
(cystic fibrosis, ventilated, and burned), or because of restrictive inclusion criteria (including 
only patients with wheeze).  
Setting We selected studies including either ambulatory patients or patients admitted into 
hospitals. Studies in intensive care units were excluded. Studies done in developed and 
developing countries were both considered. Index test We selected studies that assessed 
clinical features (symptoms and physical signs).  
Reference standard We selected studies in which the reference standard for pneumonia 
diagnosis was based on a chest radiograph, whatever the interpretation criteria.  
Data reporting Studies were selected if reconstruction of the two-by-two table was possible. 
Studies that included children older than 5 years of age were selected only if age stratified 
analyses were available (so that children aged above 5 years could be excluded). When the 
data for this age group were not available, authors were contacted and studies included when 
data provided. When more than one article was published on the same patients’ population, 
we selected only the most recent article with appropriate analyses to the review question.  
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5.3.3 Data extraction  
Data were extracted by one author (CR-A). A second author (VD’A) cross-checked all 
extracted data compiled in a table (Microsoft Excel version 2010) comparing them to 
the original data available from the selected full texts (or in the subset of data sent by 
authors when applicable) to ensure that each data was accurate. Identified errors 
were discussed and corrected. We recorded characteristics of the study (design, year 
of publication, study country, and health-care setting), study population (size, age 
range, inclusion and exclusion criteria, and proportion of patients with pneumonia), 
reference standard (chest radiograph procedure, masking, number of readers, and 
interpretation criteria), and index tests (definition, procedures, and link with inclusion 
criteria) on predefined forms. Index tests were categorised as related to demographic 
and environmental factors, symptoms, or signs. When it was not possible to establish 
whether the index test was obtained through caretaker interview (symptom) or 
through clinical examination (sign), the index test was not included in the review and 
meta-analysis. Combinations of signs were not considered in this review. Signs or 
symptoms assessed at different thresholds were considered as different index tests, 
with a separate analysis for each threshold.  
5.3.4 Statistical analyses 
For each individual index test identified in the chosen studies, we constructed a two-
by-two table with use of the data available in the publication or data provided by 
contacted authors. For each index test, we calculated sensitivity and specificity with 
corresponding 95% CIs. When an index test was assessed in four or more different 
studies, we calculated pooled estimates of sensitivity and specificity with a 
hierarchical random effects bivariate logistic regression model (bivariate model). 
Because of expected large differences between studies, heterogeneity in test 
accuracy between studies was presumed; therefore we needed a random effects 
meta-analysis method that provided an estimate of the average accuracy of the test 
and described the variability in this effect, rather than a fixed effect approach that 
estimated an underlying common effect. The metaanalysis method also needed to 
account for the correlation between sensitivity and specificity because their 
relationship as the threshold varies within and across studies. Therefore the bivariate 
model was chosen and computed using the metandi programme in Stata version 12, 
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(Harbord and Whiting, 2009) as recommended by the Cochrane Collaboration for 
meta-analysis of diagnostic accuracy studies(Macaskill et al., 2010). A minimum of 
four studies is required for metandi analyses; we decided not to do meta-analyses for 
index tests assessed in less than four studies because it would have little value. We 
computed summary point estimates of sensitivity and specificity, as well as the 95% 
confidence region around the summary operating point and the 95% prediction 
region. The prediction region shows the extent of statistical heterogeneity between 
studies by depicting a region within which, assuming the model is correct, there is 
95% confidence that the true sensitivity and specificity of a future study will lie. 
(Macaskill et al., 2010). We pooled only index tests with a common and clear 
definition and a common threshold. Index tests that were necessary inclusion criteria 
for the study (eg, cough in eight studies) were not considered. For fast breathing that 
was assessed at different thresholds in the selected studies, a hierarchical summary 
receiver operation charac teristics (HSROC) curve was computed using the Rutter 
and Gatsonis HSROC model, as recommended by the Cochrane Collaboration for 
analysis of index tests assessed at different thresholds.(Macaskill et al., 2010) 
 
5.3.5 Additional analyses on studies available in the 1990s  
We identified articles that provided the evidence for the WHO definition of clinical 
pneumonia in the 1990s. Most of these articles could not be included in our review 
because of inappropriate reference standards according to our selection criteria. To 
better understand the evidence that was available when the WHO definition was 
established, we did a separate review and meta-analysis on the articles from 1990s, 
with pooled estimates of sensitivity and specificity calculated with the bivariate model 
for chest indrawing and age-related fast breathing. 
5.3.6 Role of the funding source 
The funders of the study played no role in study design, data collection, data 
analysis, data interpretation, report writing, or in the decision to submit the paper for 
publication. All authors had full access to all the data in the study. The corresponding 
author had ﬁnal responsibility for the decision to submit for publication. 
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Figure 2. Flow diagram of the study selection process 
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5.4 Results 
Our search identified 1839 papers. Through the study selection process (figure 2), 18 
articles were included in the review and underwent quality assessment using 
QUADAS-2. One of the included articles reported on two separate surveys conducted 
in different health facilities in the same country but using the same procedures; 
(Lucero et al., 1990) data were extracted separately and counted as two distinct 
studies. Table 1 shows characteristics of the 19 studies. 16 studies were done in low-
income and middle-income countries—ie, Asia (n=7), Africa (n=5), Latin America 
(n=3), and the Middle East (n=1), and three took place in the USA. Seven studies 
were done in outpatient departments, seven in emergency departments or related 
structures, four in inpatient departments, and one study recruited patients at 
community level. Except for one case-control study (Palafox et al., 2000), all studies 
included consecutive patients with acute respiratory infection. In these studies, the 
inclusion criterion was cough alone (five), clinical suspicion of pneumonia as per 
specified criteria (seven), and suspicion of pneumonia without specified criteria (six; 
table 1). The proportion of radiological pneumonia in the studied populations varied 
across studies from 7% to 69% (median 30%; IQR 15 to 63%). Table 2 shows quality 
assessment of included studies (potential bias and applicability concerns).  
From the 19 included studies, we found 57 different clinical features assessed for 
their accuracy in diagnosis of radiological pneumonia: five related to demographic 
and environmental factors, 32 to symptoms, and 20 to signs. Age, duration of illness, 
duration of cough, heart rate, respiratory rate, and temperature were assessed using 
different thresholds. Seven different definitions of chest indrawing were used. 78 
index tests were assessed in the 19 studies. The number of index tests assessed per 
study ranged from one to 25 (median eight, IQR four to 12). The Annex 1 contains 
coupled forest plots for each study and the estimated sensitivity and specificity with 
95% CI for each of the 78 index tests. Of the 78 clinical index tests, 18 were 
assessed in four different studies or more.  
The most frequently assessed index tests were: fast breathing (12 studies, with four 
different definitions), chest indrawing (10 studies, with seven different definitions), 
nasal flaring (eight studies), elevated temperature (seven studies, with seven 
different definitions), crepitations (seven studies), history of fever (six studies), and 
wheezing (six studies). For each index test considered in four studies or more, the 
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HSROC plot of point estimates of sensitivity and specificity with 95% confidence and 
95% prediction regions, computed using the bivariate method, are shown in figure 3A 
(symptoms) and 3B (signs).  
Table 3 shows pooled estimates of each diagnostic performance measure 
(sensitivity, specificity, and positive and negative likelihood ratio) for these index 
tests. Although most of the index tests showed poor diagnostic performance with a 
high degree of heterogeneity, some respiratory danger signs had specificities higher 
than 0·80, such as cyanosis (two studies, 0·98 [95% CI 0·93–1·00] and 0·94 [0·89– 
0·96]), stridor (two studies, 0·92 [0·86–0·96] and 1·00 [0·94–1·00]), and grunting (five 
studies 0·87 [0·65–0·96]). Classic auscultation signs, such as crepitations, showed 
poor accuracy (table 3). Among other auscultation signs, bronchial breathing had 
high specificity in two studies 0·97 [0·93–0·99] and 0·97 [0·95–0·98]). Two symptoms 
had high sensitivity with little heterogeneity: history of fever (pooled sensitivity of six 
studies 0·94, 0·88–0·97) and cough (five studies 0·96, 0·91–0·98). Two features that 
are the backbone of the WHO definition for clinical pneumonia (WHO-ARI, 1991) 
(age-related fast breathing and lower chest wall indrawing) had a very high degree of 
heterogeneity in sensitivities and specificities (table 3). Fast breathing was assessed 
at different respiratory rate thresholds within and between studies. Figure 4 shows 
the HSROC curve of fast breathing at different thresholds. It suggests that none of 
the fixed thresholds is better than another and that having an age-related threshold 
does not improve the accuracy of the diagnostic test. 
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Table 1. Characteristics of included studies.  
Study 
Reference 
Setting 
Age 
range 
N 
Pneumonia 
prevalence 
Inclusion criteria Exclusion criteria 
Wafula 
1984 
 
 
Kenya; 
Paediatric 
observation 
ward 
<5 years 377 67% Admission to the 
observation ward with 
features of ARI.  
Patients with no CXR 
traceable excluded from 
analyses 
Campbell 
1989 
 
 
The 
Gambia, 
community 
0-4years 216 12% Cough and one of: 
respiratory rate>50, 
indrawing, wheeze, 
stridor. 
Not reported 
Wafula 
1989 
 
 
 
 
Kenya; 
outpatient 
department 
5 to 59 
months 
150 60% His of cough <2weeks Already on medication, 
heart failure, congenital 
heart disease, moderate 
to severe dehydration, 
metabolic disorders, 
and chest deformities. 
Lucero 
1990 
Research 
institute 
Philippines; 
outpatient 
department 
<5 years 199 69% Cough <3weeks' 
duration 
Not reported 
Lucero 
1990 
Health 
Center 
Philippines; 
outpatient 
department 
<5 years 199 29% Cough <1 week duration Not reported 
Harari 
 
 
  
Papua New 
Guinea; 
outpatient 
department 
8 weeks 
to 6 
years 
185 30% Cough (n= 95). Cough 
& respiratory rate ≥40 
(n=90) 
Wheeze, stridor, 
measles, pertussis 
Lozano 
1994 
 
 
 
 
  
Colombia; 
emergency 
department 
<3 years 200 65% Cough ≤7 days, and 
living at high altitude, 
and CXR part of 
emergency department 
evaluation;  
Cardio, pulmonary, or 
neurological congenital 
defects; born before 
term; chronic diseases 
(asthma, cancer, 
metabolic disorders, 
immuno-suppression). 
Dai 1995 
 
 
China; 
outpatient 
department 
2 to 59 
months 
541 63% Cough Antibiotics received in 
last 4 weeks 
 
 
 
Palafox 
2000 
 
 
 
 
 
 
Mexico; 
Clinical 
unit 
3 days to 
5 years 
110 32% Cases: Pneumonia 
clinical diagnosis by a 
paediatrician. Matched 
controls: next child with 
ARI (cough or 
rhinorrhea, and 
infectious signs) without 
pneumonia. 
Symptoms > 2weeks, 
chronic diseases, 
genetic abnormalities, 
neurological diseases, 
bronchial asthma, 
septicemia. 
Rothrock 
2001 
 
 
 
USA; 
emergency 
department  
<5 years 329 20% CXR ordered as part as 
emergency department 
evaluation 
Urgent portable CXR; 
trauma, foreign body 
ingestion, or 
submersion injury. 
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Table 1 (continued) 
Reference standard  
Index tests 
Reader(s) Blind Positve criteria 
2 independent: 
radiologist 
Attending and 
senior  
Not 
reported 
Lobar pneumonia or 
bronchopneumia 
Symptoms: Cough; Signs: stridor, nasal flaring, chest 
indrawing, cyanosis, t°>38°C, respiratory rate >50 
One paediatric 
radiologist 
 
 
Yes Lobar consolidation Symptoms: Vomiting, refusing to feed, rapid breathing; 
Signs: Chest indrawing, nasal flaring, respiratory rate >50; 
>60, heart rate>160, axillary t°>37.5°C >38.5°C, crepitation, 
bronchial breathing or reduced air entry, rhonchi, grunting. 
One paediatric 
radiologist 
Not 
reported 
Lobar pneumonia or 
bronchopneumonia 
 
 
 
 
Symptoms: fever, rapid breathing, poor feeding, Signs: 
respiratory rate >40; >60, heart rate>140, nasal flaring, 
cyanosis, chest indrawing, stridor, ronchi, crepitations, rectal 
t°>37.5°C 
Not reported Not 
reported 
Not reported Signs: respiratory rate >40, respiratory rate >50 
 
 
 
Not reported Not 
reported 
Not reported Signs: respiratory rate >40, respiratory rate >50 
 
 
 
One paediatric 
radiologist 
Yes Radiographic evidence 
of pneumonia 
Age <24 months; Symptoms: fever, cough>2 days, breath-
less, poor feeding, poor sleeping; Signs: Axillary t°>38°C, 
chest indrawing, nasal flaring, crepitations, cyanosis, 
respiratory rate >40/50; >50 
One radiologist Yes Any kind of infiltrate 
(alveolar or interstitial)  
Symptoms: fever, rapid breathing, difficult breathing, chest 
retractions, grunting, loss of appetite, food refusal (liquid, 
solid, breastfeeding), difficult to wake up, abdominal 
distension, cold to the touch, seizures; Signs: retractions, 
grunting, nasal flaring, respiratory rate, abnormal respiratory 
sounds (wheezes, crepitation, rhonchi, decreased breath 
sounds), abdominal distension, seizures. 
3 radiologists, 
independently, 
majority opinion 
prevailed.  
Yes Criteria ns. 4 cat: 
Pneumonia, Bronchitis, 
Any abnormality, 
Normal 
 
Signs: age-related fast breathing, rales, nasal flaring, chest 
indrawing (lower chest wall), cyanosis of the tongue. 
One single 
radiologist 
Yes Presence of micro or 
macro-nodular 
infiltrations or 
condensations in the 
lung 
 
 
 
Signs: age-related fast breathing, chest indrawing, alveolar 
rales. 
One attending 
senior board-
certified 
radiologists at 
time of 
emergency  
Unclear 'Pneumonia' or 
‘infiltrate’ on 
radiologist's report. 
Excl 'Isolated 
atelectasis', 'pleural 
effusion', or ‘elevated  
Chief complaint: cough, fever difficulty breathing, altered 
mental status; Symptoms: respiratory distress; Signs: 
respiratory distress, rales, diminished breath sounds, age-
related fast breathing 
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Table 1. Characteristics of included studies (continued) 
Study 
Reference 
Setting 
Age 
range 
N 
Pneumonia 
prevalence 
Inclusion criteria Exclusion criteria 
Shamo'on 
2004 
Jordan; 
inpatient 
department 
<6 years 147 61% Admitted with clinical 
pneumonia (cough with 
age-related fast 
breathing, indrawing, or 
wheezing) 
Immune deficiency, 
known asthma, foreign 
body aspiration, 
chemical pneumonitis, 
failure to thrive or 
malnutrition and severe 
URTI. 
Mahabee-
Gittens 
2005 
USA; 
emergency 
department 
2 to 59 
months 
510 8.6% Cough and at least one 
of: labored, rapid or 
noisy breathing; chest or 
abdominal pain; or 
fever. 
Currently taking 
antibiotics, smoke 
inhalation, foreign 
body aspiration, chest 
trauma, asthma, 
bronchiolitis, cystic 
fibrosis, sickle cell 
disease, chronic 
cardiopulmonary 
disease 
Hazir 
2006 
Pakistan; 
outpatient 
department 
2 to 59 
months 
1782 14% WHO clinical non-
severe pneumonia 
(cough and/or difficult 
breathing, and fast 
breathing (50/40), 
without lower chest wall 
indrawing, and without 
any danger signs) with 
readable CXR available 
Underlying chronic 
illness, history of 3 or 
more episodes of 
wheeze or acute 
bronchial asthma, 
antibiotic use during 
previous 48h.  
Enwere 
2007 
Gambia; 
outpatient 
department 
40 days 
to 30 
months 
3941 17% History of cough or 
breathing difficulty and 
either i) suspicion of 
severe pneumonia ( 
study’s first 18 months), 
or ii) raised respiratory 
rate and/or indrawing 
(study’s last 27 months) 
Serious chronic illness, 
previous DPT 
vaccination, received 
pneumococcal 
vaccination 
(intervention arm), 
absence of a readable 
CXR. 
Puumalain
en 2008 
Philippines
; inpatient 
department 
6 weeks 
to 23 
months 
1195 15% WHO clinical 
pneumonia (non-severe, 
severe and very severe)  
Not reported 
Muangcha
na 2009( 
Thailand; 
inpatient 
department 
<5 years 1396 7% Admitted to hospital 
with suspected 
pneumonia diagnosed 
by a physician 
Absence of 
parents/guardian 
consent 
Sigaúque 
2009 
Mozambiq
ue; 
inpatient 
department 
0 to 23 
months 
634 43% Admitted to hospital 
with cough or difficult 
breathing and age-
related fast breathing 
and chest indrawing 
(WHO clinical 
definition for severe 
pneumonia). 
Evidence of asthma, 
congenital heart 
disease, neonatal 
asphyxia, and chronic 
respiratory disorders. 
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Table 1. (continued) 
Reference standard  
Index tests 
Reader(s) Blind Positivity criteria 
One radiologist  Yes Lobar pneumonia or 
bronchopneumonia. 
Symptoms: Cough, poor feeding, Signs: chest indrawing, 
grunting, diminished air entry, crepitation, wheezes, age-
related fast breathing; Not defined: fever. 
 
 
 
 
2 paediatric 
radiologists 
independently 
Not 
reported 
No predefined 
criteria. Suggestive 
of pneumonia: 
confluent 
opacification 
without volume loss, 
peripheral rather 
than central 
opacification, pleural 
effusion 
Age >12 months, breast-fed, daycare or preschool, sibling, 
smokers at home, Symptoms: illness duration >48h; Signs: 
respiratory rate, grunting, nasal flaring, retractions, decreased 
breath sounds, crackles, wheezing, oxymetry. 
2 paediatric 
radiologists 
independently. In 
case of 
disagreement 
CXR read by a 
third radiologist.  
Yes Radiological 
evidence of 
pneumonia by at 
least 2/3 radiologist 
using predefined 
WHO criteria. 
 
 
  
Age >12 months; Symptoms: Fever, cough, difficult breathing, 
poor feeding, vomiting, diarrhoea, past history of wheeze, 
illness duration >3 days; Signs: wheeze 
A paediatrician 
and a paediatric 
radiologist 
independently.  
Yes WHO endpoint 
pneumonia, other 
infiltrates / 
abnormalities.  
 
 
 
 
Symptoms: Fever, cough, chest pain, difficult breathing, fast 
breathing, poor feeding, vomiting, diarrhoea, convulsion; 
Signs: Appear sick, chest indrawing, crepitation, rhonchi, 
bronchial breathing, hospital admission. 
2 radiologists 
independently 
Yes WHO criteria for 
'Primary endpoint 
consolidation'.  
WHO clinical pneumonia definitions, only 
One radiologist Yes WHO criteria: either 
i) primary endpoint 
pneumonia, or ii) 
pleural infiltration. 
Age ≤12 months, age ≤3 years; Symptoms: Illness duration >2 
days, >4 days; Signs: t°>38°C, t°>39°C. 
2 primary readers 
and one external 
WHO radiologist 
Not 
reported 
 Evidence of 
consolidation or 
pleural effusion: 
confirmed 
pneumonia. Non-
endpoint pneumonia: 
interstitial or normal 
CXR.. 
Age ≤12 months, Symptoms: duration of fever, duration of 
cough; Signs: nasal flaring, crepitations, wheezing or rhonchi, 
vomiting, prostration, hypoxemia, °≥37.5°C, t°>39°C. 
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Table 1. Characteristics of included studies (continued) 
Reference Setting 
Age 
range 
N 
Pneumonia 
prevalence 
Inclusion criteria Exclusion criteria 
Bilkis 
2010  
Uruguay 
and 
Argentina; 
emergency 
department 
1 to 4 
years* 
178* 69% Fever or his of fever 
during the past 48 
hours, and clinically 
suspected pneumonia 
Chronic resp disease, 
congenital cardiopathy, 
esophagogastric reﬂux, 
tumoral disease, cerebral 
palsy, immunodeﬁciency, 
asthmatic crisis requiring 
treatment, pneumonia in the 
last 2 months, use of 
antibiotics in the last 15 days. 
CXR already taken and 
interpreted. 
Wingerter 
2012 
USA; 
emergency 
department 
≤5 
years 
2008 16% CXR performed for 
clinical supsicion of 
pneumonia 
Preexisting medical conditions 
with increased risk for 
pneumonia: sickle-cell 
disease, complex congenital 
heart disease, immuno-
deficiency, chronic lung 
disease other than asthma (ie, 
cystic fibrosis or broncho-
pulmonary dysplasia) or a 
severe neurologic disorder. 
All studies were cross-sectional, except Palafox and colleagues,(Palafox 2000) which was a case-control 
study. ARI=acute respiratory infection. CXR=chest X-ray. URTI= upper respiratory tract infection. 
DPT= Diphtheria, pertussis, and tetanus. 
*Subgroup of participants aged below 5 years, provided by contacted author.  
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Table 1. (continued) 
Reference standard  
Index tests 
Reader(s) Blind Positivity criteria 
2 paediatric 
radiologists, together 
(diagnoses correlated 
with diagnosis of the 
evaluating 
paediatricians.) 
Yes Pulmonary consolidation or 
asymmetric inﬁltrate  
Symptoms: Fatigue, loss of appetite, 
loss of sleep, cough, chest pain, 
abdominal pain, vomiting; Signs: 
t°>39°C, grunting, intercostal 
retraction, nasal flaring, wheezing, 
rales, decreased breath sounds. 
 
 
 
 
 
One of the attending 
radiologists at the 
time of emergency 
department 
evaluation 
Not 
reported 
Definite pneumonia if 
"consolidation", "infiltrate", 
"pneumonia" on CXR report. 
Conservative definition of 
pneumonia also included 
"atelectasis versus infiltrate", 
"atelectasis versus 
pneumonia", or "likely 
atelectasis but cannot exclude 
pneumonia".  
Symptoms: his of fever, Signs: 
t°≥38°C, wheezing, WHO 
classification for pneumonia 
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Table 2. Quality assessment according to the QUADAS-2 tool: potential bias and applicability 
concerns of included studies 
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Figure 3. Hierarchical summary receiver operating characteristic (HSROC) plots for sensitivity 
versus specificity for 6 symptoms (A) and 12 signs (B) 
Each circle represents a study, with the size being proportional to the study size. The square represents 
the summary operating point of test performance and the zone outlines surrounding it represent the 95% 
confidence and 95% prediction regions of this summary estimate respectively. 
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Figure 4. Hierarchical summary receiver operating characteristics (HSROC) curve of sensitivity 
versus specificity of fast breathing assessed at different respiratory rate thresholds in 12 
different studies. 
 
In the meta-analysis, when looking at the likelihood ratios (measures that are more 
meaningful for clinical decisions), the symptoms and signs with the highest pooled 
estimates of positive likelihood ratio were respiratory rate higher than 50 breaths per 
min, grunting, lower chest indrawing, and nasal flaring (table 3). The features with the 
lowest pooled estimates of negative likelihood ratio were cough (although very 
heterogeneous), respiratory rate higher than 40 breaths per min, and history of fever 
(table 3). Table 4 shows the performance of age-related fast breathing and chest 
indrawing in the studies that generated the evidence leading to the adoption of WHO 
clinical diagnosis of pneumonia in the 1990s.(Simoes, 1994) Sensitivity estimates for 
age-related fast breathing ranged from 0·73 to 0·82 and specificities from 0·54 to 
0·89 in five studies (table 4). For chest indrawing, sensitivity estimates ranged from 
0·06 to 0·77 and specificity estimates from 0·39 to 1·00 (table 4). 
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Table 3. Pooled estimates of diagnostic performance measures of each index test assessed in 
4 studies or more 
 Number  
of 
studies 
Total 
population 
Sensitivity 
(95%CI) 
Specificity 
(95%CI) 
LR+  
(95%CI) 
LR- 
(95%CI) 
1/LR- 
(95%CI) 
Symptoms        
history of 
fever 
6 8260 0.94  
(0.88-0.97) 
0.12  
(0.06-0.23) 
1.06  
(1.00-1.12) 
0.53  
(0.41-0.69) 
1.89  
(1.46-2.45) 
cough 5 6421 0.96  
(0.91-0.98) 
0.14  
(0.03-0.46) 
1.12 
(0.90-1.39) 
0.30  
(0.09-0.96) 
3.37  
(1.04-10.89) 
difficult 
breathing 
4 6070 0.60  
(0.35-0.81) 
0.52  
(0.19-0.84) 
1.26  
(0.84-1.91) 
0.76  
(0.64-0.90) 
1.32  
(1.11-1.56) 
rapid 
breathing 
4 4474 0.79  
(0.75-0.82) 
0.31 
 (0.17-0.49) 
1.14  
(0.88-1.46) 
0.69  
(0.39-1.25) 
1.44  
(0.80-2.60) 
poor feeding 7 4984 0.64  
(0.39-0.83) 
0.52 
(0.3-0.73) 
1.34  
(1.17-1.54) 
0.69  
(0.55-0.86) 
1.46  
(1.16-1.83) 
vomiting 5 6723 0.36  
(0.22-0.52) 
0.7  
(0.55-0.82) 
1.17  
(1.06-1.29) 
0.93  
(0.86-0.99) 
1.08  
(1.01-1.16) 
Signs        
nasal flaring 8 2813 0.47  
(0.28-0.66) 
0.73  
(0.52-0.87) 
1.75  
(1.20-2.56) 
0.73  
(0.59-0.89) 
1.38 
(1.12-1.69) 
grunting 5 1251 0.24  
(0.10-0.47) 
0.87  
(0.65-0.96) 
1.78  
(1.10-2.88) 
0.88  
(0.78-0.99) 
1.13  
(1.01-1.28) 
T>38°C
†
 5 4631 0.56  
(0.39-0.71) 
0.55  
(0.40-0.70) 
1.25  
(1.14-1.37) 
0.80  
(0.70-0.91) 
1.26  
(1.10-1.43) 
respiratory 
rate >40/min 
4 1058 0.78  
(0.54-0.91) 
0.51  
(0.38-0.63) 
1.58  
(1.37-1.84) 
0.43  
(0.23-0.83) 
2.30  
(1.20-4.41) 
respiratory 
rate >50/min 
7 1834 0.53  
(0.30-0.74) 
0.72  
(0.58-0.83) 
1.90  
(1.45-2.48) 
0.65  
(0.45-0.95) 
1.53  
(1.05-2.24) 
age related 
fast 
breathing
§
* 
6 3320 0.62  
(0.26-0.89) 
0.59  
(0.29-0.84) 
1.55  
(0.44-5.42) 
0.63  
(0.16-2.55) 
1.59  
(0.39-6.42) 
crepitations 7 2510 0.53  
(0.37-0.69) 
0.58  
(0.48-0.67) 
1.26  
(0.99-1.60) 
0.81  
(0.61-1.08) 
1.23  
(0.93-1.63) 
rales 4 1158 0.49  
(0.32-0.67) 
0.45  
(0.22-0.70) 
0.90  
(0.42-1.90) 
1.13  
(0.48-2.62) 
0.89  
(0.38-2.06) 
rhonchi 4 1543 0.19  
(0.04-0.57) 
0.67  
(0.24-0.93) 
0.57  
(0.36-0.91) 
1.21  
(0.88-1.67) 
0.83  
(0.60-1.14) 
decreased 
breath 
sounds 
5 1364 0.22  
(0.12-0.38) 
0.76  
(0.29-0.96) 
0.93  
(0.15-5.67) 
1.02 
 (0.58-1.80) 
0.98  
(0.55-1.72) 
wheezing 6 4825 0.22  
(0.18-0.25) 
0.75  
(0.66-0.82) 
0.86  
(0.63-1.17) 
1.05  
(0.95-1.16) 
0.95  
(0.86-1.06) 
lower chest 
indrawing* 
4 1870 0.48 
(0.16-0.82) 
0.72  
(0.47-0.89) 
1.76  
(0.86-3.58) 
0.71  
(0.38-1.35) 
1.40  
(0.74-2.65) 
95%CI: 95% confidence interval; LR+: positive likelihood ratio; LR-: negative likelihood ratio. 
†
T>38°C: rectal 
temperature>38°C or axillary temperature>37.5°C. 
§
respiratory rate >60/min in children aged <2months, 
>50/min in children 2 to 11 months, and >40/min in children aged 12 to 59 months. *WHO criteria for 
pneumonia  
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Table 4. Performance of age-related fast breathing and chest indrawing in studies used by 
WHO to decide on criteria for clinical pneumonia 
Study 
reference 
Age 
range 
Reference 
standard 
TP FN FP TN Sensitivity 
(95%CI) 
Specificity 
(95%CI) 
Age related fast breathing§       
Shann  
1984 
<5 years crepitations 52 15 36 97 0.78  
(0.66-0.87) 
0.73  
(0.65-0.80) 
Cherian  
1988 
<5 years crepitations 
or CXR 
204 46 47 385 0.82  
(0.76-0.86) 
0.89  
(0.86-0.92) 
Harari  
1991 
8 weeks-6 
years 
CXR 41 15 47 82 0.73  
(0.60-0.84) 
0.64  
(0.55-0.72) 
Mulholland 
1992 
Philippine 
2-59 
months 
paediatrician 81 21 95 111 0.79  
(0.70-0.87) 
0.54  
(0.47-0.61) 
Mulholland 
1992 
Swaziland 
2-59 
months 
paediatrician 20 6 64 201 0.77  
(0.56-0.91) 
0.76 
 (0.70-0.81) 
Lower chest wall indrawing       
Shann  
1984 
<5 years crepitations 4 63 0 133 0.06  
(0.02-0.15) 
1.00  
(0.97-1.00) 
Cherian  
1988 
<5 years crepitations 
or CXR 
193 57 11 421 0.77  
(0.71-0.82) 
0.97  
(0.95-0.99) 
Campbell 
1989 
0-4 years CXR 15 10 117 113 0.60  
(0.39-0.79) 
0.39  
(0.32-0.46) 
Harari  
1991 
8 weeks-6 
years 
CXR  18 38 16 113 0.32  
(0.20-0.46) 
0.88  
(0.81-0.93) 
§
respiratory rate >60/min in children aged <2months, >50/min in children 2 to 11 months, and >40/min 
in children aged 12 to 59 months CXR: chest x-ray. TP:. FN:. FP:. TN:. CI: confidence interval 
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5.5 Discussion 
To our knowledge, our Article is the first systematic review with meta-analysis of 
clinical predictors of pneumonia in children. The comprehensive search, unimpeded 
by date, country, or language restrictions, allowed the consideration of large amounts 
of data, compared with previous reviews. (Ayieko and English, 2007; Pio, 2003; Scott 
et al., 2012; Simoes, 1994) We considered only data from children aged younger 
than 5 years, allowing better targeting of the population of interest. Methodological 
quality was assessed in duplicate and based on a-priori defined rules using the latest 
version of the QUADAS, which reduced subjectivity in the selection of studies and 
index tests and allowed precise evaluation of the risk of bias in several domains. 
Another, strength of our article is that the method used for analysis accounted for 
heterogeneity in results and for correlation between sensitivity and specificity. From 
the 18 selected articles, a large set of clinical indices were assessed, showing both 
the large panel of clinical signs and symptoms that can be considered in children and 
the poor consensus for the clinical sign with the highest accuracy for diagnosis of 
pneumonia. Fast breathing and chest indrawing were the most frequently assessed 
clinical signs. These two signs are the cornerstone of acute respiratory infection 
classification in the WHO pneumonia case management strategy, with antibiotic 
prescription being recommended for children with cough and fast breathing or lower 
chest wall indrawing (classified as non-severe pneumonia).(WHO and UNICEF, 
2014) Age-related fast breathing was adopted in the 1990s with sensitivity estimates 
ranging from 0·73 to 0·82, although heterogeneous specificities were reported (from 
0·54 to 0·89; table 4). In our Article, age-related fast breathing assessed in six 
different studies had poorer estimates of diagnostic performance than in previous 
studies, with highly heterogeneous sensitivities and specificities. This difference in 
the diagnostic accuracy of age-related fast breathing is possibly due to the difference 
in reference standard: in our Article, chest radiograph was used as a reference 
standard, whereas in most of the early studies (table 4), the reference standard was 
based on the subjective assessment of a physician (this is also why these studies 
were not selected for analysis here). Thus, these early studies probably included 
lower respiratory tract infections other than pneumonia, such as bronchiolitis. At the 
time that these studies were done, giving antibiotics to all children with lower 
respiratory tract infections and withholding them only for upper respiratory tract 
infections was perceived to be the best option. Since pneumonia was a major cause 
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of mortality in resource-poor settings and no simple test was available for diagnosis 
of bacterial pneumonia, WHO decided to use highly sensitive clinical criteria. The 
benefits of presumed lives saved through antibiotic treatment were estimated to 
outweigh the risks of unnecessary treatment due to poor specificity of the diagnostic 
criteria used. By contrast, in our Article, we aimed to assess the clinical predictors for 
radiological pneumonia, considered an acceptable surrogate for bacterial infection, to 
identify children that really need antibiotic treatment. As a result, the pooled 
estimates of likelihood ratios for age-related fast breathing are worse in our findings 
(positive likelihood ratio 1·55; negative likelihood ratio 0·63; table 3) than in the 
1990s’ surveys (pooled estimates from the data reported in table 4: positive likelihood 
ratio 2·92; negative likelihood ratio 0·29) , and therefore fast breathing might not be 
useful clinically, at least on its own, to identify children in need of antibiotics. This was 
also suggested in a recent study in Pakistan, in which investigators reported that the 
clinical outcome of children with WHO nonsevere pneumonia (and no chest 
indrawing) did not differ when treated with antibiotics or placebo.(Hazir et al., 2011) 
Because of the rapid spread of antibiotic resistance worldwide, the overuse of 
antibiotics when prescription is based on cough and fast breathing is a matter of 
concern and should now be addressed in policy recommendations. In our Article, 
chest indrawing, as in the studies done in the 1990s, also produced heterogeneous 
estimates of sensitivities, specificities, and likelihood ratios. Chest indrawing is 
probably an early indicator of respiratory distress that can be due to different 
disorders, such as pneumonia, but also bronchiolitis. Even if chest indrawing is 
insufficient for diagnosing radiological pneumonia, then it might still be useful to 
identify children that are at risk of hypoxaemia and would benefit from oxygen 
therapy rather than provision of antibiotics..  
Our Article has some limitations. First, to assess clinical predictors for the diagnosis 
of pneumonia in ambulatory care, a study should ideally include all patients 
presenting to the health facility without pre-selection criteria. In all our included 
studies only a subgroup of patients at higher risk of pneumonia were chosen based 
on a constellation of symptoms and signs, and diffcult-to-diagnose cases were 
potentially excluded. This inclusion might have biased the diagnostic performance 
measures. Second, the interobserver agree ment among clinicians on symptoms and 
signs, such as auscultation findings, can be very low. This concern about 
reproducibility is common to all diagnostic studies that assess clinical features. 
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Finally, there was hetero geneity between our chosen studies in terms of inclusion 
criteria, setting, and chest radiograph interpretation criteria. To do a meta-analysis in 
this context, we used the bivariate and the Rutter and Gatsonis HSROC models, 
which account for the heterogeneity inherent in diagnostic accuracy studies. 
(Macaskill et al., 2010) The small number of identified studies did not allow 
investigation of how the tests accuracies varied between studies with their 
methodological characteristics. The findings of this Article suggest that no one clinical 
feature is sufficient on its own for diagnosis of radiological pneumonia. Indeed, none 
of the assessed clinical features reached the level commonly accepted for clinical 
significance (positive likelihood ratio >5 to include the diagnosis or negative likelihood 
ratio <0·2 to exclude it). The highest pooled positive likelihood ratio observed was 1·9 
(respiratory rate >50 breaths per min) and, besides cough, the lowest pooled 
negative likelihood ratio was 0·43 (respiratory rate >40 breaths per min). The 
relatively good pooled negative likelihood ratio (0·30) for cough was probably 
overestimated because cough was part of the inclusion criteria in all selected studies 
that assessed it as an index test. Respiratory rate, which is the cornerstone of the 
present WHO criteria to classify pneumonia, is thus of poor diagnostic value, even if it 
was the best individual clinical predictor in our Article. However, according to our 
results, a threshold of 50 breaths per min for all age groups would be more 
appropriate than would the present recommendation of 50 breaths per min in infants 
(<12 months) and 40 breaths per min in children older than 1 year. History of fever 
was the second best predictor in terms of negative likelihood ratio, and adding it to 
the present WHO criteria could help to increase specificity. Combination of the 
clinical features with the best likelihood ratios in a decision tree might indeed improve 
the overall diagnostic performance of symptoms and signs. Individual data from 
selected articles would however have been necessary to appropriately assess 
combination of clinical features. This was out of the scope of our Article, but it would 
be relevant to embark on such meta-analyses prospectively, provided the 
heterogeneity in methodological quality of the included studies is mitigated. The 
development of innovative point-of-care tests for diagnosis of bacterial pneumonia is 
crucial to assist clinicians in decision making. The assessment of the diagnostic value 
of combinations of clinical features and point-of-care tests to measure host 
biomarkers or specific pathogens needs appropriately designed prospective studies 
to propose new evidence-based diagnostic procedures. Because no gold standard 
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test exists for bacterial pneumonia, investigation is important of the clinical outcome 
of children with acute respiratory infection when treated (or not) with antibiotics (Hazir 
et al., 2011) to accurately identify patients truly in need of antibiotics. Potentially 
severe forms of acute respiratory infections also include viral pneumonia and 
bronchiolitis. Therefore improvements in access to oxygen therapy, rather than 
provision of antibiotics, will often be the life-saving treatment. 
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6.1 Abstract 
Objective 
To review the available knowledge on epidemiology and diagnoses of acute 
infections in children aged 2 to 59 months in primary care setting and develop an 
electronic algorithm for the Integrated Management of Childhood Illness to reach 
optimal clinical outcome and rational use of medicines 
Methods 
A structured literature review in Medline, Embase and the Cochrane Database of 
Systematic Review (CDRS) looked for available estimations of diseases prevalence 
in outpatients aged 2-59 months, and for available evidence on i) accuracy of clinical 
predictors, and ii) performance of point-of-care tests for targeted diseases. A new 
algorithm for the management of childhood illness (ALMANACH) was designed 
based on evidence retrieved and results of a study on etiologies of fever in 
Tanzanian children outpatients. 
Findings 
The major changes in ALMANACH compared to IMCI (2008 version) are the 
following: i) assessment of 10 danger signs, ii) classification of non-severe children 
into febrile and non-febrile illness, the latter receiving no antibiotics, iii) classification 
of pneumonia based on a respiratory rate threshold of 50 assessed twice for febrile 
children 12-59 months; iv) malaria rapid diagnostic test performed for all febrile 
children. In the absence of identified source of fever at the end of the assessment, v) 
urine dipstick performed for febrile children <2years to consider urinary tract infection, 
vi) classification of ‘possible typhoid’ for febrile children >2 years with abdominal 
tenderness; and lastly vii) classification of ‘likely viral infection’ in case of negative 
results.  
Conclusion 
This smartphone-run algorithm based on new evidence and two point-of-care tests 
should improve the quality of care of <5 year children and lead to more rational use 
of antimicrobials.  
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6.2 Introduction 
The rapid spread of resistant pathogens worldwide calls for urgent action to improve 
the rational use of antimicrobials. In low and middle income countries, where 
infectious diseases childhood mortality is high(Liu et al., 2012), substandard drugs, 
auto-medication and health workers (HWs)’ over-prescription of antimicrobials are 
driving the rapid spread of antimicrobial resistance. (Mayor, 2010; WHO Medicines, 
2009) Recent experience in malaria case management has shown that using 
appropriate diagnostic tools (malaria rapid diagnostic tests – mRDT) has the potential 
to improve rational use of antimalarial(D’Acremont et al., 2011; Msellem et al., 2009; 
Thiam et al., 2011) without negative impact on health outcome. (Baiden et al., 2012; 
D’Acremont et al., 2010b; Msellem et al., 2009; Mtove et al., 2011; Senn et al., 2012) 
Unfortunately it has often been accompanied with an increased antibiotics 
prescription(Baiden et al., 2011; D’Acremont et al., 2011; Msellem et al., 2009), 
reflecting the challenge faced by HWs in front of a negative malaria test result, where 
diagnostic tools and skills to rule out bacterial diseases are scarce. 
To support HWs’ decision making in the management of a sick child in low resource 
settings, WHO and UNICEF have developed the Integrated Management of 
Childhood Illness (IMCI) clinical algorithm in the mid 90’s(Gove, 1997). The IMCI 
guidelines rely on the classification of patients based on clinical signs that can be 
recognised by trained HWs even if their educational background is limited(Gove, 
1997); no laboratory test was included in the IMCI version of 2008: presumptive 
malaria treatment was recommended for all febrile children (in high malaria risks 
area). Other causes of fever were not considered (except if the child presented also a 
complaint leading to another branch of the algorithm). With the advent of new 
evidence on etiologies and management of childhood illness and reliable point-of-
care tests (POCTs), there is a need to rethink the IMCI guidelines and to propose a 
new algorithm for the management of acute medical illness for children aged 2 to 59 
months living in low resource settings. This new algorithm should integrate reliable 
POCTs and, when the latter are not available, clinical predictors for acute illnesses, 
so that guidance based on best available evidence is provided to clinicians to decide 
on withholding antimalarials and antibiotics when not beneficial to the child. When no 
tool or strong evidence is available to propose appropriate procedures, expert opinion 
should be sought.  
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An algorithm developed for HWs in remote primary health care facilities (PHCF) 
should rely on simple clinical signs and easy-to-perform POCTs. Its structure should 
remain simple, although addressing a larger set of diseases may require a more 
complex one. The use of hand-held electronic technology to deliver the algorithm 
may facilitate the use of a complex clinical algorithm by HWs of varying backgrounds. 
Smartphones and tablets have the potential to facilitate the scale-up of standard 
recommendations in low resource settings. 
6.3 Methods 
6.3.1 Structured literature reviews 
In order to identify the relevant diseases to be addressed in the algorithm, estimated 
data on the causes of global childhood mortality and morbidity from the Child Health 
Epidemiology Reference Group (CHERG)(CHERG, n.d.) publications, and from the 
Global Burden of Disease website(IHME, n.d.) were reviewed to assess the burden 
of diseases in African children. A structured literature review was also conducted to 
understand the clinical presentation (accurate clinical predictors) and diseases’ 
distribution in children U5 attending HFs in developing countries, as well as 
appropriate POCTs for the diagnosis of the targeted diseases.  
Medline (PubMed), Embase (Ovid), and the Cochrane Database of Systematic 
Reviews (CDSR) were explored from inception to December 31st 2010, looking for 
articles assessing i) the prevalence of diseases and clinical features in U5 attending 
outpatient facilities in developing countries, and ii) the accuracy of diagnostic 
procedures for each of the targeted diseases. The detailed search strategy is 
described in Table 5. Papers involving U5 managed for acute medical conditions in 
ambulatory settings were selected. Studies involving only infants below 3 months of 
age or only adults were excluded. For prevalence of syndromes and diseases at HF, 
studies describing the clinical presentation and/or diagnoses presented by U5 
attending outpatients facilities in developing countries were selected. For diagnostic 
procedures of targeted diseases, studies assessing accuracy of either clinical 
predictors or POCT were chosen. Systematic reviews addressing the questions of 
interest were also considered. An additional hand searching of reference lists of 
selected papers completed these searches. 
In order to better explore the accuracy of the clinical diagnosis for pneumonia, a 
systematic review of the literature and meta-analyses of studies assessing the 
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diagnostic accuracy of clinical predictors was conducted, reported elsewhere 
(Rambaud Althaus et al, submitted). 
 
Table 5: Structured literature reviews: search strategy 
 Pubmed Embase 
1 "primary health care" OR "outpatients" OR "family 
practice" OR "emergency service" OR "ambulatory 
care" 
  
2 "fever/etiology"[MeSH Terms] OR 
"fever/diagnosis"[MeSH Terms] OR 
"fever/epidemiology"[MeSH Terms] 
  
3 "developing countries"   
4 prevalence OR epidemiology OR incidence   
5 "predictive value of tests"[MeSH Terms] OR 
"sensitivity and specificity"[MeSH Terms] OR 
"reproducibility of results"[MeSH Terms] OR 
diagnostic test OR diagnostic tests OR "physical 
examination"[MeSH Terms] OR"medical history 
taking"[MeSH Terms] 
'diagnostic accuracy'/exp OR 
'predictor variable'/exp  
6 "pneumonia"[MeSH Terms] 'pneumonia'/exp OR 'lower 
respiratory tract infection'/exp 
OR 'respiratory tract 
infection'/exp 
7 “typhoid fever” [MeSH Terms]  'typhoid fever'/exp  
8 “urinary tract infections”[MeSH Terms]  'urinary tract infection'/exp 
9 “otitis media”[MeSH Terms]  'otitis media'/exp 
10 “shigella”[MeSH Terms] OR “dysentery”[MeSH 
Terms] 
'shigellosis'/exp 
11 Filters: Infant: 1-23 months; Preschool Child: 2-5 
years 
'child'/exp 
Prevalence [ 1 AND ( 2 OR {3 AND 4} ) ] AND 11   
Diagnostics 6 AND 5 AND 11 6 AND 5 AND 11 
 
7 AND 5 AND 11 7 AND 5 AND 11 
 
8 AND 5 AND 11 8 AND 5 AND 11 
 
9 AND 5 AND 11 9 AND 5 AND 11 
  10 AND 5 AND 11 10 AND 5 AND 11 
 
6.3.2 Findings of the study on causes of fever in outpatient Tanzanian children 
In a recently published study on etiologies of fever conducted in outpatient clinics in 
Tanzania (Tanzanian fever study), clinical assessments and laboratory tests were 
performed in 1005 febrile children aged 2 months to 10 years (95% were U5) to 
establish the most probable causes of fever(D’Acremont et al., 2014). The distribution 
of diagnoses, overall and stratified by age, was taken into account to select the 
targeted disease included in the final algorithm. The clinical predictors for the 
targeted diseases identified in the Tanzanian fever study were also used to build the 
new algorithm (De Santis et al, in preparation). 
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6.3.3 Algorithm construction 
With the IMCI algorithm for children 2-59 months of age as departure point, the 
evidence retrieved from the structured literature reviews and from the Tanzanian 
fever study was used to propose modifications and new recommendations when 
relevant, and to design a new decision tree. Diseases were included in the algorithm 
if they were treatable, and responsible for i) high child mortality and morbidity, ii) high 
attendance rate at outpatient facilities, and, iii) high antimicrobial prescription rate. 
Clinical features that could easily be assessed by HWs of varying background and 
POCT easy to deploy in low resource ambulatory settings were integrated in the 
classification procedures, when its use improved the classification accuracy. The 
treatment options proposed in ALMANACH were in line with the 2008 WHO IMCI 
(WHO, 2008) and the Tanzanian National Standard Treatment guidelines (MoSHW, 
2007) since the algorithm was intended to be used in Tanzania and had to comply 
with local policies. Once the new algorithm was finalised, both a paper booklet and 
electronic software running on android smartphones and tablets were developed. For 
the paper booklet, the IMCI structure in 3 steps was kept - “Assess, Classify, and 
Treat” - , as well as the color-coded triage system: red for conditions that require 
urgent referral, orange for conditions requiring specific treatment, and green for 
condition needing simple counseling and symptomatic home management (Gove, 
1997). 
6.4 Results  
Flow diagrams of studies selection for the structured literature reviews are available 
in Figure 5. 
All modifications made to the IMCI content based on new findings are presented in 
Table 6. The major changes concerned: malaria and pneumonia diagnosis; otitis 
media treatment; the addition of urinary tract infection (UTI) and possible typhoid 
fever; and a new classification entitled “likely viral infection”. The most important 
modifications are discussed below. 
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803 identified articles 
801 excluded 
 559 design 
 143 participants 
 39 setting 
 50 disease 
 10 no full text 
A Prevalence of diseases 
29 full text screened 
27 other 
sources 
603 Identified articles 
542 Excluded 
 326 design 
 120 disease 
 13 participants 
 80 test 
 3 no full text 
D Urinary tract infection diagnosis 
2 articles for clinical predictors,  
44 for dipstick urinalysis, 15 reviews 
160 Identified articles 
154 Excluded 
 74 design 
 1 disease 
 54 test 
 2 no full text
 
E Typhoid fever diagnosis 
6 articles for clinical predictors,  
22 for Widal test, 1 Review 
22 articles 
7 excluded 
 1 design 
 6 insufficient data 
1697 Identified articles 
1672 Excluded 
 1005 design 
 543 disease
 42 participants 
 82 test 
B Pneumonia diagnosis 
 60 full text screened 
35 other 
sources 
18 articles for clinical predictors 
42 excluded 
 9 design 
 4 participants 
 3 test 
 9 ref standard 
 14 insufficient 
data 
 3 duplicate data 
513 Identified articles 
511 Excluded 
 355 design 
 53 disease 
 2 participants 
 96 test 
 4 insufficient 
data 
 1 duplicate data 
C Otitis media diagnosis 
6 other 
sources 
7 articles for clinical predictors, 1 review 
Figure 5. Flow diagrams of study selection process in the structured literature reviews 
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6.4.1 Selection of syndromes or diseases to be addressed by the algorithm 
Estimations of burden of diseases by CHERG (Liu et al., 2012) and IHME (IHME, 
n.d.; Lozano et al., 2012) reported that low respiratory tract infections/pneumonia, 
malaria, and diarrhoea were the leading causes of child mortality in 2010, globally 
and in Sub Saharan Africa (SSA). These 3 infectious diseases were estimated to be 
responsible for more than 40% of U5 deaths in SSA. They were also the leading 
causes of morbidity, responsible for 41% of the total 2010 DALYs in SSA (IHME, 
n.d.). Other frequent causes of child mortality were HIV/AIDS (3.5 to 4% of U5 deaths 
in SSA (IHME, n.d.; Liu et al., 2012)), meningitis (3 to 4%(IHME, n.d.; Liu et al., 
2012)), measles (1%(IHME, n.d.; Liu et al., 2012)), and tuberculosis (0.8%(IHME, 
n.d.)). In infants aged 1 to 11 months, pertussis (2.8% of deaths in 1-11months infant 
in SSA) and syphilis (2.3%) were also frequent causes of death (IHME, n.d.). In 
children aged 1 to 4 years, typhoid fever was estimated to be responsible for 0.6% of 
both DALYs and deaths, and bacterial skin diseases for 0.7% of DALYs, and 0.2% of 
deaths (IHME, n.d.).  
The structured literature review identified 22 articles assessing either symptoms or 
diagnoses distributions, or both, in children attending outpatient facilities in 
developing countries. In all selected papers assessing symptoms, fever (by history or 
measured, hereafter referred as fever), cough and diarrhoea were the most frequent 
symptoms reported, respectively by 65 to 93% (Barat et al., 1999; Kolstad et al., 
1997; Perkins et al., 1997; Rowe et al., 2007; Van Hemelrijck et al., 2009; Weber et 
al., 1997), 44 to 82% (Kolstad et al., 1997; Perkins et al., 1997; Rowe et al., 2007; 
Van Hemelrijck et al., 2009; Weber et al., 1997), and 22% to 45% (Kolstad et al., 
1997; Perkins et al., 1997; Rowe et al., 2007; Weber et al., 1997) of children. 
Diseases of potential bacterial origin reported in the studies retrieved by the 
structured literature review were: pneumonia (reported in 5 to 30% of children(Animut 
et al., 2009; Chanda et al., 2009; D’Acremont et al., 2014; Factor et al., 2001; Khallaf 
et al., 1996; Kolstad et al., 1997; Njama-Meya et al., 2007; Perkins et al., 1997; 
Salaria and Singhi, 2003; Simoes et al., 1997; Van Hemelrijck et al., 2009; Weber et 
al., 1997)), typhoid fever (3 to 13% (Animut et al., 2009; D’Acremont et al., 2014; Van 
Hemelrijck et al., 2009)), dysentery (3 to 12% (Factor et al., 2001; Kolstad et al., 
1997; Simoes et al., 1997)), otitis media (2 to 12% (D’Acremont et al., 2010b; Factor 
et al., 2001; Khallaf et al., 1996; Kolstad et al., 1997; Njama-Meya et al., 2007; 
Perkins et al., 1997; Simoes et al., 1997; Weber et al., 1997)), UTI (1 to 
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7%(D’Acremont et al., 2014; Downs, 1999; Factor et al., 2001; Njama-Meya et al., 
2007; Shaikh et al., 2008; Van Hemelrijck et al., 2009)); and meningitis (0 to 
3%(Factor et al., 2001; Kolstad et al., 1997; Salaria and Singhi, 2003)). Tonsillitis was 
reported in 1% of 1005 children in the Tanzanian fever study; all had a negative 
streptococcal diagnostic test(D’Acremont et al., 2014). Another study reported 
tonsillitis or pharyngitis in 10% of the children, but no streptococcal test was 
performed(Njama-Meya et al., 2007).  
Among the bacterial infections frequently reported, only typhoid fever, UTI and 
tonsillitis were not yet addressed in IMCI. The fear of these 3 infections is often a 
reason to prescribe antibiotics in low resource setting. With regards to tonsillitis, early 
recognition and treatment of streptococcal tonsillitis is of high importance to prevent 
rheumatic fever and its complications, but prevalence of group A β-hemolytic 
streptococcus is much lower in U5 than in older children(Shaikh et al., 2010), and 
close to zero in children under 2 years of age(Woods et al., 1999). Moreover, acute 
rheumatic fever and rheumatic heart disease are rare in U5(Carapetis et al., 2000; 
Tibazarwa et al., 2008). Therefore addressing streptococcal tonsillitis in the 
management of U5 was considered not to be necessary. UTI and typhoid fever were 
thus selected to be addressed in the new algorithm, together with the other diseases 
already addressed in IMCI. 
6.4.1 Identification of severe illnesses  
In the IMCI algorithm, urgent referral to hospital is recommended in the presence of 
any of 5 general danger signs (difficulty in drinking, repeated vomiting, had 
convulsion, lethargy or unconsciousness, convulsing) or in presence of any of the 8 
symptom-related danger signs (danger sign related to fever: stiff neck; related to 
cough: stridor or chest indrawing; related to measles features: clouding of cornea or 
extensive mouth ulcers; related to malnutrition: severe wasting or oedema of both 
feet; related to pallor: severe palmar pallor). The usefulness of these IMCI referral 
criteria were evaluated in two studies(Kalter et al., 1997; Paxton et al., 1996). These 
studies estimated the accuracy of the presence of any of the danger signs to predict 
hospital referral. Estimates of sensitivity and specificity were 46% and 79% 
respectively in the Kenyan study (Paxton et al., 1996) and 86% and 64% respectively 
in the study conducted in Bangladesh (Kalter et al., 1997). In the Kenyan study, 
accuracy of these criteria to predict death in admitted U5 patients was also assessed 
(sensitivity 89%, specificity 44%)(Paxton et al., 1996). 
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Table 6: Major changes in ALMANACH as compared to IMCI algorithm based on evidence  
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A systematic review for children in developed countries(Van den Bruel et al., 2010) 
has also identified reduced consciousness, convulsions, cyanosis, rapid breathing, 
and slow capillary reﬁll as the strongest predictors of severe illness. Meningeal 
irritation was also a strong predictor of serious bacterial infection in 3 reported studies 
[likelihood ratio (LR) ranging from 2.57 to 275] (Van den Bruel et al., 2010). While 
reviewing the underlying evidence used to build the recommendations for referral in 
IMCI, only very few studies were identified. As for IMCI, one of the main aims of the 
present algorithm is to allow early identification and referral of children with severe 
conditions and serious bacterial infections; therefore, to ensure good sensitivity, all 
the IMCI referral criteria were kept although underlying evidence was scarce , and 2 
signs predicting serious infections were added to the IMCI general danger signs, i.e. 
cyanosis that is broadly recognised as a sign of severe hypoxemia (Van den Bruel et 
al., 2010) and jaundice that was shown to be predictive of bacterial disease in the 
Tanzanian fever study(D’Acremont et al., 2014) and can also be associated with 
severe malaria (WHO, 2000). In order to improve and fasten the identification of 
severe patients, all general danger signs, were grouped together with stiff neck, 
severe wasting, and severe pallor at the beginning of the assessment chart, instead 
of having some of them included in the branches for each syndrome. Danger signs 
related to specific symptoms were kept within the symptoms related charts, such as 
chest indrawing with cough, or tender swelling behind the ear with ear problem. 
Children with general danger signs are classified as having ‘Very severe disease’. 
These children with general danger signs are at risk of severe sepsis. In 
ALMANACH, acknowledging that early antimicrobials can improve the outcome of 
these children prognosis(Dellinger et al., 2008; Gaieski et al., 2010), and realising 
that the full assessment would not modify this recommendation, a separate 
management chart was developed for patients with danger signs, allowing prompt 
presumptive treatments, and skipping assessment tasks that would only delay the 
rapid management and referral these children require. 
6.4.2 Malaria diagnosis 
Decline in the proportion of fevers due to malaria (D’Acremont et al., 2010a) together 
with the availability of easy-to-use, reliable POCTs– i.e. mRDTs – have driven the 
WHO recommendations to shift in 2010 from presumptive to test-based malaria case 
management(WHO, 2010). The safety of a mRDT-based malaria case management 
in U5 has been demonstrated(Baiden et al., 2012; D’Acremont et al., 2010b; Faucher 
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et al., 2010; Mtove et al., 2011; Mubi et al., 2011; Senn et al., 2012; Ukwaja et al., 
2010). Several African countries have now changed their malaria diagnosis policy 
and adopted the use of mRDTs in their national programs. Following the new WHO 
malaria treatment guidelines, the use of mRDTs was integrated in present algorithm. 
mRDTs were also recently added officially to the WHO/UNICEF generic IMCI 
algorithm(WHO and UNICEF, 2014). 
6.4.3 Pneumonia diagnosis 
In a recent meta-analysis of clinical predictors for radiological pneumonia (Rambaud 
Althaus et al, submitted), the clinical features with the higher pooled LR were 
respiratory rate ≥50 breaths/min (LR 1.90; 95%CI 1.45-2.48), grunting (1.78; 1.10-
2.88), lower chest indrawing (1.76; 0.86-3.58), and nasal flaring (1.75; 1.20-2.56). 
The best features to rule out the diagnosis (having the lowest pooled LR) were: no 
history of fever (0.53; 0.41-0.69), and respiratory rate <40 breaths/min (0.43; 0.23-
0.83). Cough had also a low but heterogeneous LR (0.30; 0.09-0.96). The IMCI 
criterion for pneumonia classification, i.e. age-related fast breathing (≥50/min from 2 
to 11 months, and ≥40/min from 12 to 59 months) showed low diagnostic 
performance in the meta-analysis, both to rule in the disease (presence of fast 
breathing had a pooled LR of 1.55 (0.44-5.42) and to rule it out (absence of fast 
breathing had a pooled LR- of 0.63 (0.16-2.55)). In the Tanzanian fever study, the 
best predictors to rule in radiological pneumonia among all febrile children were 
difficult breathing (LR 7.9, 2.8-22.1), chest indrawing (7.1; 2.9-17.6), nasal flaring 
(7.0; 2.5-19.4), respiratory rate ≥50/min (6.1; 3.5-10.4) and abnormal chest 
auscultation (5.5; 3.7-8.1). No feature was good at ruling out the diagnosis. In the 
present algorithm, in the absence of a reliable point-of-care diagnostic test, we 
decided to combine the best available clinical predictors (history of fever, cough, 
difficult breathing and fast breathing), except nasal flaring and grunting, and 
abnormal chest auscultation because most IMCI trained clinicians are not familiar 
with these features. Chest indrawing was kept but to decide on referral to hospital 
rather than to diagnose pneumonia, because of the relatively high proportion of these 
children that harbor hypoxemia(Subhi et al., 2009) Regarding fast breathing, because 
using an age-related threshold did not improve the diagnostic test accuracy in the 
meta-analysis (Rambaud Althaus et al, submitted), a single threshold of ≥50/min for 
all age groups was chosen; 50/min rather than 40/min was chosen to ensure a 
reasonable specificity, knowing that most of pneumonias in young children are due to 
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viruses(Feikin et al., 2013). The recommendation in the present algorithm is thus to 
prescribe antibiotics for pneumonia to children with [history of fever or elevated 
temperature] AND [cough or difficult breathing] AND respiratory rate ≥50/min, 
regardless of the malaria test result. 
6.4.4 Otitis Media 
In the structured literature review 7 articles and a systematic review that addressed 
the question of the accuracy of symptoms and signs for the diagnosis of otitis media 
were retrieved(Coker et al., 2010). In these studies, some otoscopic signs were 
strongly associated with otitis media diagnosis(Coker et al., 2010), but in low 
resource settings otoscopy is not available in ambulatory care. Other symptoms, 
such as earache, ear rubbing, and fever, although reported as associated with otitis 
media in 4 old studies (LR 3.03 to 7.3(Heikkinen and Ruuskanen, 1995; Niemela et 
al., 1994; Uhari et al., 1995)), were not associated with this diagnosis when reported 
by parents of children aged 6 to 36 months attending primary care offices in a more 
recent study(52). Otitis media is often a self-limiting condition in young children. The 
2010 Coker(Coker et al., 2010) and Sanders’ Cochrane(Sanders et al., 2010) 
reviews, looking at available evidence of the benefit of antibiotic treatment for otitis 
media, report that there is little benefit (compared to placebo) and no evidence that 
antibiotics reduce complications or recurrence(Coker et al., 2010; Sanders et al., 
2010). An individual patient data meta-analysis from 6 randomised trial reported that 
antibiotics were more beneficial in children aged less than 2 years with bilateral otitis 
media, and in those with both otitis media and otorrhoea. In children with otorrhoea, 
60% of controls and 25% of those on antibiotics still had pain, fever or both at 3-7 
days, with a rate difference of -36% (95%CI -53% to -19%) and a number needed to 
treat of 3, whereas in children without otorrhoea the rate difference and NNT were 
respectively -14% (-23% to -5%) and 8(Rovers et al., 2006). 
Otitis media being often a self-limiting condition in young children, in the absence of 
accurate non-otoscopic clinical predictors the new algorithm propose to limit antibiotic 
prescription to children presenting with ear discharge.  
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6.4.5 Urinary tract infection  
Two articles and 12 reviews assessing the accuracy of clinical predictors for the 
diagnosis of UTI in children were retrieved from the structured literature review. No 
additional article since the most recent review published in 2007 was found(Shaikh N 
et al., 2007). The following predictors were identified: temperature >40°C (2 studies, 
LR 3.3; 1.3-8.3(Hoberman et al., 1993) and LR 3.2; 0.7-15.6(Krober et al., 1985)), 
jaundice (LR 2.1; 0.3-17.4)(Musa-Aisien et al., 2003), and suprapubic tenderness (LR 
4.4; 1.6-12.4)(Shaw et al., 1998). The absence of another source of fever on 
examination increased the probability of UTI (3 studies, summary LR 2.8; 1.9-
4.3)(Shaikh N et al., 2007). Among children ≥2 years, abdominal pain (LR: 6.3; 2.5-
16.0) (Musa-Aisien et al., 2003), dysuria (LR 2.4; 1.8-3.1)(Heale, 1973) and new-
onset of urinary incontinence (LR 4.6; 2.8-7.6)(Heale, 1973) also increased the 
probability of UTI.  
In the Tanzanian fever study, the following predictors to rule in UTI were found: 
pollakiuria (LR 3.5; 1.4-8.8), temperature >40°C (3.1; 1.4-7.1), fever for more than 3 
days (2.1; 1.2-3.6) and age<2 years (1.4, 1.22-1.57); the best predictors to exclude 
UTI were: age≥3 years (LR 0.22; 0.07-0.66), headache (0.27; 0.04-1.89) and 
diarrhoea (0.33; 0.08-1.32) (De Santis et al, in preparation). Based on these 
predictors, several national and international guidelines recommend to consider this 
condition in febrile children below 2 years of age, with no obvious cause of 
fever(Downs, 1999; WHO CAHD, 2005). No symptom or sign, nor combination of 
them is predictive enough in this age group to appropriately identify children with UTI. 
The gold standard (urine culture) is generally not available in low resources 
ambulatory setting. Urinalysis with urine dipsticks detecting leucocyte esterase and 
nitrite has been evaluated in many settings: 4 systematic reviews with meta-analyses 
estimated sensitivities for leucocyte esterase and/or nitrites to be 81%(Whiting et al., 
2005), 88%(Gorelick and Shaw, 1999; Williams et al., 2010), and 93%(Downs, 1999) 
and specificities 72%(Downs, 1999), 79%(Williams et al., 2010), 93%(Gorelick and 
Shaw, 1999) and 97%(Whiting et al., 2005). A dipstick urinalysis negative for both 
nitrites and leukocyte esterase had a LR of 0.2 (95% CI, 0.16-0.26)(Shaikh N et al., 
2007). With either leucocyte esterase or nitrite positive the LR was 6.1 (95% CI, 4.3-
8.6), increasing to 28 (95% CI, 17-46) when both leucocyte esterase and nitrite were 
positive(Whiting et al., 2005). In 2005, the WHO department of Child and Adolescent 
Health and Development recommended the use of urinalysis by urine dipstick for the 
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diagnosis of UTI in children wherever dipstick were feasible(WHO CAHD, 2005). With 
the implementation of the WHO focused antenatal care guidelines, urine dipstick for 
proteinuria detection have been implemented and are thus available in HFs in many 
African countries. Based on the good diagnostic performance of urine dipstick, and 
it’s feasibility in low resource setting, the new algorithm proposes to perform urine 
dipstick for the diagnostic of UTI in the patients at higher risk of UTI, i.e. children 
below 2 years of age having fever with no cause identified during the assessment 
(but regardless of the malaria test result, due to the possibility that the parasites 
might only correspond to an incidental infection and not the actual cause of the acute 
illness). For children from 2 to 5 years of age, only those complaining of dysuria are 
proposed a dipstick urinalysis. Antibiotic treatment for UTI is recommended when 
either leucocyte esterase or nitrite, or both are positive. 
6.4.6 Typhoid fever 
Regarding the diagnosis of enteric fever, 6 articles assessing clinical predictors of 
enteric fever were retrieved (Davis et al., 1999; Hosoglu et al., 2006; Khan et al., 
1998; Kuvandik et al., 2009; Neopane et al., 2006; Vollaard et al., 2005). Only 2 were 
conducted in outpatients: one included patients above 15 years of age(Hosoglu et al., 
2006) and the other patients above 4 years of age(Vollaard et al., 2005). None of the 
studies thus included our target population of U5 outpatients. In the Tanzanian fever 
study(D’Acremont et al., 2014), the following predictors to rule in typhoid where 
identified: liver pain (LR 9.8; 2.7-35.5), abdominal tenderness (7.0; 3.3-15.2), 
jaundice (6.2; 3.1-12.4) and age >2 years (2.0; 1.6-2.4). To rule out typhoid, only ‘not 
during rainy season’ was predictive (LR 0.50; 0.27-0.92) (De Santis et al, in 
preparation). Jaundice being already included as danger sign and liver pain being 
difficult to assess in a child, the new algorithm recommends looking for abdominal 
tenderness in children ≥2 years of age having fever with no cause identified during 
the child’s assessment (regardless of the malaria test result). When present, 
antibiotic treatment for typhoid fever is indicated. 
6.4.7 Likely viral infection 
Likely viral infection is a classification proposed in the present algorithm that does not 
exist in IMCI. Unnecessary antibiotics are often prescribed in febrile children by HWs 
when they do not manage to reach a diagnosis after their assessment, because they 
fear to have potentially missed a life-threatening bacterial infection. Because in the 
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present algorithm most of the frequent bacterial infections have been assessed for, 
the probability that the child is still suffering from one is low if all findings are 
negative. Therefore, in the absence of danger signs, cough or fast breathing, 
diarrhoea, ear discharge, symptoms of measles, infected skin lesion, abdominal 
tenderness, a positive dipstick urinalysis and a positive malaria RDT, the child is 
classified as having a “Likely viral infection”. HWs are then proposed to withhold 
antibiotics and antimalarials, prescribe symptomatic treatment for fever if any, and 
advise the caretaker on when to come back if symptoms persist or worsen. 
6.4.8 Design of the algorithm 
Based on the modifications and adjunctions to IMCI that were retained, a new 
algorithm for the management of childhood illnesses (ALMANACH) was designed. 
Efforts were made to keep the ALMANACH structure simple and graphically easy to 
follow by HWs. Therefore the IMCI 3 steps assessment and color codes were kept. 
However, in order to increase the number of conditions addressed, ALMANACH has 
been divided into 3 charts. The first chart provides recommendations for assessment 
of general danger signs and management of severe patients, the second chart 
provides recommendations for patients with fever, and the last one for patients 
without fever (see Figure 6 for an overview of ALMANACH’s structure). This 3-charts 
structure allows i) fastening the assessment and management of severe children, for 
whom all recommendations are available in the very first part of the algorithm and ii) 
a more comprehensive and specific assessment of children, with pneumonia, 
malaria, UTI and typhoid fever being considered only in febrile children. In the IMCI 
algorithm, fever is one of the main symptoms. The IMCI fever box only considers 
malaria and measles for a child with acute fever (≤7 days) without danger signs. 
Within ALMANACH, the aim was to address non-malaria fever causes. Although 
parts of the algorithms, such as the diarrhoea chart, are the same in both the ‘febrile’ 
and ‘non-febrile’ algorithms, replacing the fever box by a full algorithm for children 
with fever or history of fever was necessary to propose meaningful considerations of 
fever causes in sequential pathways, allowing considering some conditions in a 
subset of patients only. In addition, this categorisation allowed limiting antibiotic 
treatment in children without fever or history of fever.  
ALMANACH was first designed as a paper booklet (Annex 2), it was then developed 
as an android application for smartphones, coding the different steps of the algorithm 
into a Java-Rosa X form run by OpenDataKit and OpenMRS software(“Open Data 
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Kit,” n.d., “OpenMRS,” n.d.). The electronic ALMANACH (e-ALMANACH) guides 
HWs through the child’s assessment up to the classification and treatment 
recommendations (Figure 7). Treatment dosages are computed according to the 
body weight or age when weight is not available. Moreover e-ALMANACH collects in 
real time information on child demographic characteristics, disease classification and 
treatment prescribed. This information is stored by the mobile device, can be sent to 
a server and feed health information systems. 
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Figure 6. Overview of ALMANACH's structure 
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A Assessment 
B Classification 
C Treatment 
Figure 7. Samples of ALMANACH in electronic format 
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6.5 Discussion 
The aim of ALMANACH is to provide guidance to health workers on antimicrobial 
prescription, in order to treat only children aged 2 to 59 months who will potentially 
benefit from them. Apart from malaria, IMCI was not directly addressing causes of 
fever, leaving HWs with their fear of life-threatening conditions once malaria was 
ruled out by mRDT. On the other hand, viral infections that represent the vast 
majority of the causes of fever in U5 children(D’Acremont et al., 2014) are never 
explicitly mentioned or proposed as diagnosis in IMCI, giving a wrong impression to 
health workers that bacterial infections are frequent and that children should often be 
prescribed antibiotics. Using the best available and feasible diagnostic procedures for 
the main causes of acute illness in children attending HFs, the present new algorithm 
should address most of the concerns of HWs regarding bacterial infections and 
remind them that children often suffer from self-limited viral conditions that do not 
warrant any specific treatment beside antipyretics. By providing tools to rule out 
malaria, UTI, and typhoid fever and by proposing a new ‘Likely viral infection’ 
classification, the use of ALMANACH has thus the potential to improve the health 
outcome of febrile children and at the same time decrease unnecessary antimalarial 
and antibiotic prescriptions. The content of ALMANACH was based on literature 
reviews and expert opinions. The level of evidence provided by the literature was 
generally low and no formal process was followed to reach a broad expert 
consensus. Within the current project, only the POCTs currently available in low 
resource settings were considered, constraining the new algorithm to rely mostly on 
the best available simple clinical predictors. To further improve the quality of the 
management of paediatric illnesses and the rational use of medicines, accurate and 
affordable POCTs for bacterial or even viral infections are highly needed.  
While broadening the spectrum of diseases to be addressed, the algorithm became 
more complex than IMCI. This might be an issue for the targeted audience, i.e. HWs 
of different background working in low resource ambulatory settings. In order to 
facilitate understanding and usability of the decision chart, the 3 steps IMCI structure 
(Assess, Classify and Treat) and the color coded triage, already known by IMCI 
trained HWs, were kept. Electronic algorithms, by guiding HWs step by step through 
the algorithm, allow to using a more complex structure with lower risk of misuse. The 
electronic version of ALMANACH running on smartphones and tablets was designed 
to address these needs. 
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Although ALMANACH broadened the spectrum of diseases addressed in the 
algorithm, some aspects of childhood illness were left uncovered. Indeed 
ALMANACH does not provide recommendations for the management of chronic or 
non-infectious conditions. Within the current project, only identifiable and treatable 
acute infections were targeted because the objective was to improve the use of 
antimicrobials in order to tackle both the risk of resistance development due to their 
overuse and the high childhood mortality related to infectious diseases. Because the 
algorithm was meant for remote HF, full algorithms for the management of severe 
conditions, for HIV-infected and/or malnourished children were not developed; only 
recommendations on how to identify children suffering from these conditions and 
advice to refer them to the second level of care were provided. We foresee that 
developing and integrating additional algorithms for the management of these 
conditions, but also for other patients, either at primary or secondary level of health 
care systems, would allow further improvement of the quality of health services, but 
also better acceptability of the tool by HWs. However this was out of the scope of the 
present project. The paper and electronic ALMANACH have the potential to improve 
the management of the sick child. This has been demonstrated in a recently 
completed feasibility study, which showed the ALMANACH algorithm to improve 
health outcome of children managed with this tool and to drastically reduce antibiotic 
prescription (Shao et al, companion paper submitted). These results were obtained in 
two settings, urban and rural, albeit with a limited number of patients enrolled. They 
do not represent a definite validation of ALMANACH, but show great promise and 
should invite researchers to further explore the potentials of this new approach for a 
rational management of children aged 2-59 months. Further improvement could be 
brought by integrating other POCT detecting key pathogens once they become 
available, or even better, by integrating host biomarkers able to predict children in 
need of antibiotics or at risk of dying.  
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7.1 Abstract 
Introduction 
The decline of malaria and scale-up of rapid diagnostic tests calls for a revision of 
IMCI. A new algorithm (ALMANACH) running on mobile technology was developed 
based on the latest evidence. The objective was to ensure that ALMANACH was 
safe, while keeping a low rate of antibiotic prescription. 
Methods 
Consecutive children aged 2-59 months with acute illness were managed using 
ALMANACH (2 intervention facilities), or standard practice (2 control facilities) in 
Tanzania. Primary outcomes were proportion of children cured at day 7 and who 
received antibiotics on day 0.  
Results 
130/842 (15∙4%) in ALMANACH and 241/623 (38∙7%) in control arm were diagnosed 
with an infection in need for antibiotic, while 3∙8% and 9∙6% had malaria. 815/838 
(97∙3%;96∙1-98.4%) were cured at D7 using ALMANACH versus 573/623 
(92∙0%;89∙8-94∙1%) using standard practice (p<0∙001). Of 23 children not cured at 
D7 using ALMANACH, 44% had skin problems, 30% pneumonia, 26% upper 
respiratory infection and 13% likely viral infection at D0. Secondary hospitalisation 
occurred for one child using ALMANACH and one who eventually died using 
standard practice. At D0, antibiotics were prescribed to 15∙4% (12∙9-17∙9%) using 
ALMANACH versus 84∙3% (81∙4-87∙1%) using standard practice (p<0∙001). 2∙3% 
(1∙3-3.3) versus 3∙2% (1∙8-4∙6%) received an antibiotic secondarily. 
Conclusion 
Management of children using ALMANACH improve clinical outcome and reduce 
antibiotic prescription by 80%. This was achieved through more accurate diagnoses 
and hence better identification of children in need of antibiotic treatment or not. The 
building on mobile technology allows easy access and rapid update of the decision 
chart. 
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7.2 Introduction 
About 7 million children under 5 years of age die each year despite the availability of 
effective low-cost interventions(Chopra et al., 2013). The Integrated Management of 
Childhood Illness (IMCI) strategy developed by the World Health Organization 
(WHO), UNICEF and other partners in mid 1990s (Gove, 1997) could potentially 
prevent two-thirds of these deaths (Claeson et al., 2003). To date, IMCI is still a good 
tool and studies that assessed its impact showed borderline reduction of childhood 
mortality(J. R. Armstrong Schellenberg et al., 2004). When health workers were 
trained to use IMCI, their performance in case management improved (Gouws et al., 
2004; Nguyen et al., 2013), although cautious interpretation is needed due to 
heterogeneities in methodologies of assessment (Nguyen et al., 2013). Worldwide, 
the impact of IMCI has been less than expected due to health system challenges, 
such as shortage of health workers (Bryan et al., 2006; Dominic A and Kurowski C, 
2005; Munga and Mæstad, 2009), poor motivation and lack of supervision (Huicho et 
al., 2005a;  Maestad et al., 2010). All this leads to low compliance to the IMCI 
guidelines (Camara et al., 2008; Kelley et al., 2001; Simoes et al., 1997) and 
probably poorer health outcomes than it could be.  
IMCI is facing additional challenges. First, a precise evaluation of the clinical outcome 
of children when managed with the IMCI algorithm is lacking, which leaves a doubt 
about its real benefit. Some studies evaluated the clinical outcome of children with 
specific diseases or conditions, such as severe pneumonia at peripheral health 
facilities (Chowdhury et al., 2008; Hazir et al., 2008; Soofi et al., 2012) or malaria and 
pneumonia at community level (Hamer et al., 2012; Mukanga et al., 2012). These 
studies also demonstrated that effectively trained and supervised community health 
workers using malaria rapid diagnostic tests (mRDTs) with  (Mukanga et al., 2012), or 
without (Hamer et al., 2012)  respiratory rate timers could adequately classify and 
treat children less than 5 years with malaria and/or pneumonia at community level. 
The overuse of antimalarials was limited, but varying degrees of antibiotics over-
prescription were observed (Mukanga et al., 2012). Secondly, patterns of disease 
and drug resistance have evolved dramatically in the last 20 years. The prevalence of 
malaria has considerably declined in the last decade across different settings 
(D’Acremont et al., 2010a). While mRDT has just been incorporated in the new IMCI 
version (WHO and UNICEF, 2014), many national IMCI guidelines still recommend to 
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treat presumptively all febrile children with antimalarials. Third, since the advent of 
mRDT, the proportion of patients receiving antibiotics has increased (Batwala et al., 
2011; D’Acremont et al., 2011; Msellem et al., 2009), probably because clinicians 
have not enough guidance on how to proceed when mRDTs results are negative. 
The new IMCI guidelines do not include precise guidance on typhoid fever, urinary 
tract infections (UTI) or other causes of unspecific fever. Even if these conditions 
might have limited impact on mortality, they are feared by primary health care 
clinicians who often prescribe antibiotics to prevent potential complications.  
Based on the IMCI algorithm, a review of the literature, and the results of an etiology 
of fever study conducted in Tanzania (D’Acremont et al., 2014), a novel ALgorithm for 
the MANAgement of CHildhood illness (ALMANACH) was developed (Rambaud-
Althaus et al, submitted). This algorithm was primarily aimed at decreasing 
unnecessary prescription of antibiotics in children, while ensuring same or even 
better clinical outcome compared to routine practice (non-inferiority trial).The 
objective of the present study was to measure the impact of its use on clinical 
outcome and antibiotic prescription in children attending primary care facilities in rural 
and urban settings of Tanzania.  
 
7.3 Materials and Methods  
7.3.1 Study sites and subjects 
The study was conducted as part of a larger project which aimed at improving the 
quality of care and rational use of medicines for children in Tanzania (PeDiAtrick 
project, registration number PACTR201011000262218 at www.pactr.org). For the 
present study, two pairs (one from urban Dar es Salaam and one from the rural 
Morogoro region) of two nearby primary care health facilities (HF), similar in terms of 
natural environment, malaria prevalence, socio-economic status of the catchment 
population, and type of services available, were conveniently selected. Then, in Dar 
es Salaam, Ilala municipality (city center), Buguruni was randomly selected as 
intervention and Vingunguti as control HF; in Morogoro region, Kilombero district, 
Signal was selected as intervention and Mangula as control. We chose to conduct 
the study in different health facilities rather than to use a parallel design or recruit 
consecutively patients in the same health facility because the latter increased the risk 
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of including patients with different disease frequency between the intervention 
(ALMANACH) and routine practice arms due to seasonal variation. There was also 
the risk of biased results due to contamination between arms because clinicians 
would have gained a better understanding of disease classification or change their 
behaviour in terms of antimicrobial prescription because of the ALMANACH training 
and use. Consecutive children aged 2 to 59 months were enrolled by trained study 
nurse if they fulfilled the inclusion criteria: 1) first consultation for the current illness; 
2) absence of severe illness requiring immediate life-saving procedures; 3) main 
complaint(s) not related to injury or trauma; 4) living in the catchment area of the HF 
and; 5) written informed consent by the caretaker. 
7.3.2 Study design and procedures 
A controlled non-inferiority trial was conducted to compare the clinical outcome of 
children managed according to ALMANACH or to standard practice. Children 
enrolled in the intervention arm were managed by two study clinicians (one for each 
setting) who were trained to strictly comply with the ALMANACH algorithm, which 
was available on paper at the start of the study and used in the first 100 patients, and 
then built in an electronic support (smartphone running Open MRS) and used for the 
remaining 742 patients. Both versions were identical. In the control arm, children 
were attended by the usual HF clinicians, of which about 80% had been trained for 
IMCI (Adam et al., 2005). In general, this training had taken place several years 
before, and compliance to guidelines was known to be rather poor, with most patients 
receiving antibiotics, especially when tested negative for malaria (D’Acremont et al., 
2011). mRDT and commonly prescribed medicines were made available throughout 
the study period in both arms.  
During the one-month pilot phase, study clinicians in the ALMANACH arm received 
face-to-face supervision with several real patients to check their ability to identify all 
relevant signs, including respiratory rate measurement. In the control arm, no 
algorithm, training or supervision was performed. Observing study clinician obtained 
oral consent from the routine clinician and observed the consultation to record key 
information such as symptoms, signs, laboratory investigation(s) performed, 
diagnosis(es), advice to caretakers and treatment(s) prescribed. He was instructed 
not to interfere with the consultation to avoid introducing additional bias to the 
observer effect.  
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7.3.3 Ethics Statement 
All procedures followed the Good Clinical Practice guidelines. The study protocol and 
related documents were approved by Ethikkommission beider Basel in Switzerland, 
by the Institutional Review Board of the Ifakara Health Institute and by the National 
Institute for Medical Research Review Board in Tanzania 
(NIMR/HQ/R.8a/Vol.IX/823).  
7.3.4 Content of the ALMANACH algorithm  
The development and content of ALMANACH is described in another paper 
(Rambaud-Althaus et al, submitted). In brief, this new algorithm was based on IMCI, 
but differed on some key features presented in Table 7. 
  
Chapter 7 – ALMANACH safety study  
75 
Table 7: Key differences between IMCI and ALMANACH, section for the management of acute 
conditions in children aged 2 months to 5 years 
 IMCI algorithm New algorithm (ALMANACH)  
Danger 
signs 
5 danger signs managed at the start: 
unable to drink or breastfeed; 
lethargic or unconscious; vomits 
everything; convulsing now or has 
had convulsions  
 
Six additional danger signs assessed 
later: stridor; chest indrawing; sunken 
eyes; skin pinch goes back very 
slowly; stiff neck; tender swelling 
behind ear 
10 danger signs managed at the start: unable to 
drink or breastfeed; lethargic or unconscious; 
jaundice; vomits everything; convulsing now or 
has had convulsions; cyanosis; severe pallor; stiff 
neck and severe wasting 
Six additional danger signs assessed later: stridor; 
chest indrawing; ; sunken eyes; skin pinch goes 
back very slowly; tender swelling behind ear; 
infected skin lesion or lump larger than 4 cm or 
with red streaks or with tender nodes or multiple 
abscesses 
Fever  1 out of 4 Main symptoms  A dividing point between a febrile branch and a 
non- febrile branch 
Pneumonia Cough  
+ age-related fast breathing
a
  
Fever + cough  
+ unique fast breathing
b
 
Urinary 
Tract 
Infection 
Not considered  
Febrile child<2 years with no source identified at 
this point
c
, and with a positive (leucocytes or 
nitrites) urine dipstick. 
Typhoid 
fever 
Not considered 
Febrile child ≥2 years with no source identified at 
this point
c
, and with abdominal tenderness 
Likely viral 
infection 
Not existing 
Febrile child with no classification at the end of the 
algorithm 
a
 50 breaths/min for children aged 2 to 12 months, 40 breaths/min for children aged 12 months to 5 
years.
  
b
 50 breaths/min for all children (aged 2 months to 5 years).
  
c
 No cough or difficult breathing, no diarrhoea, no ear problem, no measles, no infected skin lesion or 
lump.  
 
 
7.3.5 Management of children during spontaneous re-attendance 
In the intervention arm, caretakers were informed to bring the child back to the study 
HF if he/she was not able to drink or breastfeed, became sicker, developed fever, 
fast or difficult breathing, or blood in stool. During working hours, sick children were 
reassessed by the study clinician, and managed again according to ALMANACH. Out 
of working hours, children were managed by routine clinicians who were asked to 
record demographic data, laboratory results, diagnoses, treatments and need for 
referral in order to hand them back to the study clinician the day after. In the control 
arm, children were advised on when to come back and managed during re-
attendance at the discretion of the routine clinician, who were asked to record the 
same information on the re-attendances and to hand them back to the study team. In 
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both arms, information regarding visits to other health facilities than the study 
facilities, and on additional treatment received, was recorded during the follow-up 
visit at day 7.  
7.3.6 Follow-up of children at day 7 and 14 
Caretakers in both arms were asked to bring back their child on day 7 to assess if 
he/she was cured or not. Children were declared cured if the caretaker reported the 
child to be well. All children reported as not cured were attended by the clinician and 
managed again according to ALMANACH in the intervention arm and to usual 
practice in the control one. When the child had not recovered at day 7, caretakers 
were asked to return on day 14 for a new assessment. Caretakers whose children did 
not turn up at day 7 were reminded by phone about the visit and, if not reached, 
visited at home.  
7.3.7 Data collection, management and analysis 
In the intervention arm, a standardised case report form (CRF) was completed during 
the paper phase of the study. Data collection included demographics, all relevant 
symptoms and signs, laboratory investigation(s), diagnosis(es), advice and 
treatment(s) received. During the electronic phase (smartphone), a shorter version of 
the CRF was used not to repeat data that were automatically sent to the server when 
running through the decision chart. In the control arm, the observing study clinician 
filled another CRF that included all relevant information mentioned above. The CRFs 
were adapted from the health facility survey checklist questionnaire developed by 
WHO (WHO, 2003).  
Beside data sent directly from the smartphone to the server, all information was 
double-entered in Epi-info software version 3∙5∙3 (CDC Atlanta, USA). Data 
management and analysis were done using STATA software version 10∙1 (College 
Station, Texas, USA). The primary outcome measures were: i) proportion of children 
cured at day 7, and ii) proportion of children who received antibiotics on day 0. 
Secondary outcome measures were i) proportion of children admitted secondarily or 
who died, ii) proportion of children who received antibiotics during the whole study 
period. The above proportions were compared between the intervention and control 
group using Chi-square test and, when appropriate, Fisher exact test.  
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To calculate the sample size, we assumed that 95% of children managed with 
standard practice would be cured on day 7(D’Acremont et al., 2010b). To show non-
inferiority of the intervention arm with a 3% margin, 80% power and 0.05 level of 
significance, and using a ratio of 3:2 in order to have more patients in the intervention 
arm, we calculated that 816 patients in the intervention and 544 in the control arm 
were needed. Taking into account a 3% rate of loss to follow-up, the target sample 
size was thus 840 and 560 patients in the intervention and control arms respectively. 
7.4 Results 
7.4.1 Status at inclusion 
Between December 2010 and June 2011, 1467 children (median age 14 months) 
were enrolled, 844 (523 in the urban and 321 in the rural setting) in the ALMANACH 
and 623 (353 in the urban and 270 in the rural setting) in the standard practice arm 
(Figure 8). Two children were then excluded, one because he was not visiting the 
health facility for the first time for the current problem, and one who was <2 months of 
age. Baseline characteristics of patients included are presented in Table 8. The 
diagnoses distribution in the ALMANACH and standard practice arms are featured in 
Figure 9a and 9b respectively. Acute respiratory infections (ARI), either alone or in 
combination with another condition besides malaria, accounted for 57% and 58% of 
the diagnoses in intervention and control arms. However, the classification within 
respiratory infections was quite different between arms: 10∙3% (95%CI 8∙3-12∙4%) 
were classified as having pneumonia in the ALMANACH arm while 18∙5% (15∙4-
21∙5%) as having pneumonia and 17∙0% (14∙1-20∙2%) as having ARI (a diagnosis 
given by routine clinicians when they did not classify further the respiratory infection 
but for which they tended to prescribe antibiotics) in the standard practice arm. Only 
1∙0% (0∙1-1∙2%) in the ALMANACH versus 12∙0% (9∙3-14∙4%) in the standard 
practice arm were classified as having UTI. 3∙8% (2∙5-5∙1%) were diagnosed with 
malaria alone or in combination with another diagnosis in the ALMANACH versus 
9∙6% (7∙3-12∙0%) in the standard practice arm, despite full availability of mRDT in all 
HFs. 
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Figure 8. Safety study profile  
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Figure 9. Distribution of diagnoses at inclusion in the ALMANACH (A) and standard practice (B) 
arms 
* Diagnosis given by clinicians when they do not classify further the respiratory infection.  
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Table 8: Baseline characteristics of the patients in intervention (ALMANACH) and control 
(standard practice) arms (n=1465) 
 
 
ALMANACH Standard practice 
n/N % n/N % 
Gender     
 Females 407/842 48∙3 300/623 48∙2 
Age (in months)      
 2-12 426/842  50∙6 241/623 38∙7 
 13-24 216/842 25∙7 174/623 27∙9 
 25-36 106/842  12∙6 89/623 14∙3 
 37-48 64/842  7∙6 81/623 13∙0 
 49-59 30/842  3∙6 38/623 6∙1 
Main symptoms     
 Fever 571/842  67∙8 511/623 82∙0 
 Cough  498/842  59.1 355/623 57∙0 
 Diarrhoea 184/842  21∙9 76/623 12∙2 
 Vomiting 57/842  6∙8 78/623 12∙5 
 Ear problem 14/842  1∙7 13/623 1∙5 
Fast breathing     
 ≥50 breaths per minute 100/351  28∙5 42/310 13∙6 
Danger signs 1/842  0∙1 5/623 0∙8 
 Lethargic 1/842 0∙1 0/623 0 
 Vomiting everything 0/842  0 1/623 0∙2 
 Unable to drink/breastfeed 0/842  0 2/623 0∙3 
 History of convulsion  0/842  0 2/623  0∙3 
Hospitalisation at inclusion     
 Admission on day 0* 3/842  0∙4 21/623 3∙4 
*The control health facility of the rural area (Mang’ula Health Center) had a higher number of 
admissions on day zero because of the possibility to admit patients on site (unlike the 
intervention rural health facility (Signal Dispensary). 
 
 
7.4.2 Clinical outcome  
Cure rate at day 7 and 14 
0∙5% (4/842) of children in the ALMANACH and 0∙2% (1/623) in the standard practice 
arm were lost of follow-up. 97∙3% children managed with ALMANACH were cured on 
day 7 versus 92∙0% by standard practice (p<0∙001) (Table 9). In the ALMANACH 
arm, of the 23 children not cured at day 7, 11 received an antibiotic on day 7; 22 were 
cured on day 14 and one on day 28 (Figure 8). 10 of these 23 (44%) children had 
been diagnosed at inclusion with skin problems, either alone or in combination with 
another diagnosis, 7 (30%) with pneumonia, 7 (30%) with URTI, 3 (13%) with likely 
viral infection outside URTI, and one patient with acute ear infection (Table 10). In the 
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control arm, of the 50 children not cured on day 7, 48 children were cured on day 14, 
one child died and one was lost of follow-up (Figure 8).  
Among diagnoses found in at least 10 children at inclusion, pneumonia 
(7/101=7∙0%), skin conditions alone (5/84=6∙0%) and multiple conditions not 
requiring antibiotics (4/81=4∙9%) were the conditions leading to the highest 
proportions of clinical failure at day 7 in the ALMANACH arm, and ARI 
(13/119=11∙0%), skin conditions (3/28=11∙0%) and diarrhoea (3/33=9∙0%) in the 
standard practice arm. 
 
 
Table 9: Clinical outcome and antimicrobials prescribed in children managed by ALMANACH 
and standard practice 
Outcome measure ALMANACH Standard practice p 
value 
  n/N % 95%CI n/N % 95%CI  
Clinical outcome        
 Cured on day 7 815/838 97∙3 96∙1-98∙4 573/623 92∙0 89∙8-94∙1 <0∙001 
 Cured on Day 14 837/838  99∙9 96∙6-
100∙1 
621/622  99∙8 99∙5-
100∙2 
0∙8 
Antibiotics prescribed        
 On day 0 130/842  15∙4 12∙9-17∙9 525/623  84∙3 81∙4-87∙1 <0∙001 
 Between day 0 and 7 19/838 2∙3* 1∙3-3∙3 20/623  3∙2 1∙8-4∙6 0∙3 
 On day 7 11/838  1∙3 0∙7-2∙3 0/623 0 0 0∙003 
 Total (at any day) 160/838  19∙0 16∙3-21∙6 545/623  87∙5 84∙9-90∙1 <0∙001 
Antimalarials 
prescribed 
       
 On day 0 33/842 3∙9 2∙6-5∙2 41/623  6∙6 4∙6-8∙5 0∙02 
 Between day 0 and 7 1/838  0∙1 -0∙1-0∙4 7/623  1∙1 0∙3-2∙0 0∙01 
 On day 7 0/838  0 0 2/623  0∙3 -0∙1-0∙8 0∙2 
 Total (at any day) 34/838  4∙1 2∙7-5∙4 50/623  8∙0 5∙9-10∙2 0∙001 
* 10 patients received antibiotics from study clinicians during working hours and 9 from routine 
clinicians out of working hours 
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Table 10: Characteristics of the 23 patients who were not cured at day 7 in the ALMANACH 
arm. 
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Complications 
Of the 838 children managed with ALMANACH, one child with likely viral infection on 
day 0 was brought by the caretaker on day 5 to a referral hospital where he was 
diagnosed with cellulitis. He was hospitalised for 10 days, received antibiotics and 
had recovered when visited on day 28. Of the 623 children managed by standard 
practice, two children were hospitalised secondarily. One had diarrhoea on day 0 and 
received cotrimoxazole, oral rehydration salt and zinc tablets. At day 3 he was 
brought to the same HF and diagnosed with severe dehydration. He was admitted for 
one day, received ringer lactate intravenously and was discharged the next day. At 
day 7 he had recovered. The other child was diagnosed with pneumonia on day 0, 
received benzyl penicillin and amoxicillin, and was sent home. He was brought 5 
days later to another HF where he was admitted for the same diagnosis and died 4 
days later (see Figure 8). 
Spontaneous attendance before day 7 
4∙2% of children (35/838) in the ALMANACH and 5∙1% (32/623) in the standard 
practice arm re-attended spontaneously between day 0 and 7 (p=0∙4). In the 
intervention arm, 19 (2∙3%) patients were secondarily prescribed an antibiotic, 10 
because of pneumonia, 5 diarrhoea, 2 UTI, 1 cellulitis and one tonsillitis (Table 11). 
All were cured at day 7, except the one who was hospitalised with cellulitis. Among 8 
children who developed pneumonia secondarily, 6 were <12 months and had a 
respiratory rate at inclusion between 36 and 48/min, and 2 were ≥12 months and one 
had a respiratory rate of 42 (not measured for the other child due to absence of 
cough). On the other hand, 30 children ≥12 months with a respiratory rate between 
40 and 50/min at inclusion did not develop pneumonia, and were cured at D7 without 
antibiotic.
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Table 11. Characteristics of the 19 patients who received antibiotics during re-attendance in the 
ALMANACH arm 
rr: respiratory rate *Out of working hours, the patient was evaluated and managed by a routine 
clinician of the HF rather than the study clinician. 
&
This patient is the same as patient n°22 in table 10. 
 
7.4.3 Treatment prescribed 
15∙4% (130/842) of children managed with ALMANACH received antibiotics on day 0 
compared to 84∙3% (525/623) by standard practice (p<0∙001). In the ALMANACH 
arm, only 19 (2∙3%) and 11 (1∙3%) children out of 842 received antibiotics 
secondarily, during spontaneous attendance and visit at day 7 respectively. The 
cumulative proportion of children prescribed antibiotics over the whole follow-up 
period (on day 0, between day 0 and day 7 and on day 7) was 19∙0% in the 
intervention versus 87∙5% in the control arm (p<0∙001) (Table 9). In the ALMANACH 
arm, the diagnoses at inclusion present in at least 10 patients for which antibiotics 
were most frequently prescribed secondarily were pneumonia (8/101=7∙9%), likely 
viral infection (6/96=6∙3%) and skin problem (4/84=4∙8%).   
 
 
N° 
Age 
(month
s) 
Diagnosis at day 0 rr 
at D0 
Antibioti
c 
prescribe
d on D0 
Clinician 
who 
prescribe
d 
antibiotic
s* 
Diagnosis at  
re-
attendance 
visit 
Cured 
at D7 
1 10 Pneumonia 53 Yes Study Pneumonia Yes 
2 8 Pneumonia NA Yes Routine Pneumonia Yes 
3 10 Pneumonia 52 Yes Study UTI Yes 
4 8 
Pneumonia and 
measles 
52 Yes Routine Diarrhoea Yes 
5 18 Likely viral infection NA No Study Pneumonia Yes 
6 21 Likely viral infection NA No Study Tonsillitis Yes 
7 56 Likely viral infection NA No Study UTI Yes 
8
&
 11 Likely viral infection NA No Study Cellulitis No 
9 10 Likely viral infection NA No Routine Diarrhoea Yes 
10 37 Likely viral infection NA No Routine Diarrhoea Yes 
11 6 URTI 46 No Study Pneumonia Yes 
12 4 URTI NA No Study Pneumonia  Yes 
13 5 URTI NA No Routine Pneumonia Yes 
14 11 URTI  40 No Routine Pneumonia Yes 
15 13 URTI 42 No Routine Pneumonia Yes 
16 8 URTI and diarrhoea 48 No Study Pneumonia Yes 
17 5 UTI 
 
Yes Study Pneumonia Yes 
18 9 Diarrhoea 
 
No Routine Diarrhoea Yes 
19 36 Impetigo 
 
No Routine Diarrhoea Yes 
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7.5 Discussion  
When strictly applied, the new ALMANACH algorithm resulted in better clinical 
outcome than standard practice, and in 80% reduction of antibiotics prescribed to 
children with acute illness. These improvements are probably due to a better 
identification of children with likely viral infection, and hence not needing antibiotics, 
while still identifying those with bacterial infections, or at least those who were likely 
to benefit from antibiotics.  
 
The rate of clinical failure with ALMANACH was expected to be equivalent to that of 
the control arm, because the standard practice in Tanzania is to prescribe antibiotics 
to most of the febrile patients, especially when mRDT are available (D’Acremont et 
al., 2011). One could have even expected more failures with ALMANACH since the 
algorithm withholds antibiotics (compared to IMCI) in frequent clinical situations such 
as cough and respiratory rate between 40 and 50/min in children ≥12 months, or for 
children without a classification at the end of the algorithm (likely viral infection). On 
the contrary, we observed a better cure rate with ALMANACH, probably because 
clinicians were able to better identify and treat children with possible bacterial 
infection. Moreover, the better outcome at day 7 was neither at the price of a higher 
rate of spontaneous re-attendance, nor of secondary prescription of antibiotics. 
These rates were indeed almost identical in both arms. These findings suggest that 
significant bacterial infections were not missed when using ALMANACH, which is the 
big fear of clinicians and their main reason to give antibiotics. They often wrongly 
believe that antibiotics prevent secondary bacterial infections. Their behaviour is also 
due to clinical guidelines that are often ambiguous, including the latest 2014 version 
of IMCI that recommends to ‘Give appropriate antibiotic treatment for an identified 
bacterial cause of fever’ to febrile children that are negative for malaria (WHO and 
UNICEF, 2014). Such a recommendation has a high risk to increase over-
prescription of antibiotics. Policy makers sometimes argue that children will not be 
brought back if their condition worsens, because of long distance from home to 
health facilities, lack of transport and of cash money etc. The good clinical outcome 
observed in the intervention arm suggests that caretakers did come back when their 
child was worse, maybe because of clear messages given by clinicians. The present 
study thus demonstrates that giving antibiotics to all children at first place to prevent 
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re-attendances or complications is not worth; it does not improve clinical outcome, 
provided the few children who need antibiotics are accurately identified.  
Giving unnecessary antibiotics does have deleterious consequences, namely the 
rapid spread of bacterial resistance, unnecessary adverse drug reactions, and 
unnecessary cost. In Tanzania, high levels of antibiotic resistance have already been 
reported (Moyo et al., 2011; Temu et al., 2007). Also, children infected with resistant 
microorganisms are more likely to die (Blomberg et al., 2007). Unfortunately the 
different approaches to reduce antibiotic prescription have been largely ineffective. In 
a systematic review, educational/training interventions successfully improved 
targeted antibiotic prescribing outcomes by only 20%, and these changes were not 
sustainable over time(WHO and DMP., 2001). Holistic strategies are needed to 
contain antibiotic resistance, including the use of electronic decision support to 
improve clinician’s compliance to guidelines. Such a strategy using electronic 
algorithms for the management of childhood illness in a rural dispensary in Tanzania 
showed promises (DeRenzi et al., 2008). The next step is thus to further evaluate this 
e-ALMANACH in programmatic conditions.  
Clinical failure and/or secondary antibiotic prescription according to diagnosis in 
ALMANACH arm 
Among children managed using ALMANACH, the diagnosis that led to the highest 
rate of clinical failure was pneumonia (7%), which also led to the highest rate of 
secondary antibiotic prescription (8%). In contrast, URTI was rarely associated with 
clinical failures (1 %) or secondary antibiotic prescription (2%). Because the vast 
majority of ARI are located in the upper tract and of viral origin, these children do not 
require antibiotics and cure by themselves. In young children, even most of lower 
respiratory tract infections, including pneumonias, are due to viruses and will thus not 
improve with the provision of antibiotics. This also explains why a significant number 
of these patients were not cured at day 7. 
The second diagnosis that led to the highest rate of clinical failure (6%) and 
secondary antibiotic prescription (5%) was skin conditions. Skin problems are not 
included in the main algorithm of IMCI algorithm. Half of the skin problems were mild 
infections such as impetigo that had worsened enough to require antibiotics at day 7. 
The other half corresponded to skin problems that took longer than 7 days to cure 
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such as fungal infection or stable impetigo, but that did not require secondary 
antibiotics. 
A ‘likely viral infection’ was the third diagnosis that led to a relatively high rate (6%) of 
secondary antibiotic prescription, but to a rather low rate (3%) of clinical failure at day 
7. Antibiotics were given during follow-up because of the emergence of various 
conditions such as pneumonia, tonsillitis, UTI, cellulitis and diarrhoea. This diversity 
shows that it is not possible to predict at day 0 if, and what these children may 
develop in the following days. The only safe and rational solution is thus to evaluate 
them again when they do not improve. The aim of an efficient clinical algorithm is 
indeed not to have zero follow-up visits, but rather to have no child dying because of 
a delay once antibiotic are required. The message to bring the child back in case of 
persisting or worsening condition, or emergence of a new health problem seems to 
have been followed appropriately, as only one child has been secondarily admitted. 
When used wisely, it prevents a lot of unnecessary prescription of antibiotics during 
first clinical encounter.  
7.5.1 Limitations of the study 
One can argue that the appropriate control arm would have been a perfectly 
complied to IMCI algorithm. However, no study on the clinical outcome of children 
strictly managed according to IMCI has been performed in the past, so such results 
could not be used as gold standard. Also a perfectly implemented IMCI does not 
exist, which shows its limitation in terms of feasibility. We opted thus for the use of 
IMCI in real life conditions (routine practice) for the control arm to assess more 
precisely the public health benefit of the ALMANACH.  
 
The new algorithm was implemented in controlled conditions, which is a necessary 
step before implementation in routine conditions. Its real impact, which should directly 
depend on the level of uptake and compliance by clinicians, needs to be precisely 
evaluated. We already performed this step in a study investigating health worker’s 
performance when using ALMANACH in pragmatic conditions (reported in Rambaud-
Althaus et al, submitted).  
No formal assessment of health worker satisfaction when using electronic devices 
was made in the present study. Previous findings from a pilot study conducted in 
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Tanzania assessing the use of electronic IMCI showed that clinicians were 
enthusiastic to use it. However, this was not enough justification to believe that the 
clinicians would indeed follow the “standard practice ALMANACH” better than 
standard/routine practice. We also performed subsequently a qualitative study to 
assess health workers’ perception on barriers and facilitators for uptake of the 
ALMANACH algorithm in pragmatic conditions over time (reported in Shao et al, 
submitted).  
7.6 Conclusion 
The new ALMANACH algorithm for the management of childhood illness, primarily 
aimed at the rational use of antimicrobials, improved clinical outcome and led to a 
drastic reduction of unnecessary antibiotic prescription when compared to standard 
practice. This achievement was related to more precise diagnoses and better 
identification of children with infections that required and did not require antibiotics. 
These results, obtained in both urban and rural places, are probably generalisable for 
most locations in Sub-Saharan Africa, and even wider, since the distribution of 
diagnoses in small children does not vary so much across regions and over-
prescription of antibiotics is a widespread problem in low resource settings (WHO., 
2013). The building on mobile technology allowed easy access for clinicians and 
rapid update of the decision chart when new recommendations are put in place. 
Further studies are underway to assess the appropriateness and feasibility of using 
this electronic algorithm in routine practice. 
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8.1 Abstract 
In low resource settings, rational antimicrobial prescription for childhood illnesses is a 
challenge.  
To assess whether smartphones running  guidelines, as compared to paper support, 
improves consultation process and rational use of medicines for children, a pilot 
cluster-randomized controlled study was conducted in Tanzania.  Nine primary health 
care facilities (HFs) were randomized into 3 arms (i. paper algorithm, ii. electronic 
algorithm on a smartphone, iii. control). All health workers attending children aged 2 
to 59 months for acute illness in intervention HFs were trained on a new clinical 
ALgorithm for MANAgement of CHildhood illness (ALMANACH) either on paper or 
electronic support Four months after training consultations were observed. An expert 
consultation was the reference for classification and treatment.  Main outcomes were 
proportion of children checked for danger signs, and antibiotics prescription rate. 
A total of 504 consultations (166, 171, and 167 in control, paper, and phone arms) 
were observed. The use of smartphones versus paper was associated with a 
significant increase in children checked for danger signs (41% vs 74%, p=0.04). 
Antibiotic prescriptions rate dropped from 70% in the control to 26%, and 25% in 
paper and electronic arms. The HWs-expert agreement on pneumonia classification 
remained low (expert’s pneumonia identified by HWs in 26%, 30%, and 39% of 
patients respectively).  
Mobile technology in low-income countries is implementable and has a potential to 
improve HWs’ performance. Additional point–of-care diagnostic tests are needed to 
ensure appropriate management. Improving rational use of antimicrobial is a 
challenge that ALMANACH can help to take up.  
Registration: Pan Africa Clinical Trial registration number PACTR201011000262218 
Funding: Swiss National Science Foundation (Grant Number IZ70Z0 – 124023) 
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8.2 Introduction 
In the context of the global rapid spread of resistance to antimicrobials, there is an 
urgent need to reduce the overuse of these life-saving medicines worldwide. In low 
income countries, where childhood mortality due to infectious diseases is high(Liu et 
al., 2012), rational use of antimicrobials in children is a challenge for health workers 
(HWs) lacking accurate tools and skills to make appropriate diagnoses(Risk et al., 
2013). Providing HWs with guidelines allowing them to identify patients in need or not 
of antibiotics and antimalarials may help them to rationalise their antimicrobials 
prescription. For these guidelines to reach their goal, high HWs’ compliance is 
necessary. The current reference standard for the management of children in primary 
care setting in low income countries is the Integrated Management of Childhood 
Illness (IMCI). Two main limitations made IMCI guidelines suboptimal to tackle 
antimicrobials over-prescription where implemented. First, the IMCI algorithm, 
designed in the 1990’s to tackle the high childhood mortality(Gove, 1997), had to rely 
on poorly specific diseases classification that leads to over-prescription of both 
antibiotics and antimalarials. Antimalarials over-prescription that resulted from the 
presumptive treatment recommended for all febrile children in endemic areas, has 
recently been addressed by IMCI that now recommends test-based malaria 
treatment(WHO and UNICEF, 2014) (D’Acremont et al., 2008). However, regarding 
bacterial diseases, both the low specificity of the criteria used to classify pneumonia 
(Hazir et al., 2011; Rambaud-Althaus et al., 2015; Senn et al., 2014) and the lack of 
clear recommendations for the management of non-malaria febrile illnesses prompt 
clinicians to prescribe antibiotics to be ‘on the safe side’(Baiden et al., 2011; 
Bruxvoort et al., 2013; D’Acremont et al., 2008). The second limitation lies in the low 
compliance of HWs to IMCI recommendations(Lange et al., 2014; Senn et al., 2014).  
To address these limitations, a new algorithm for the management of sick children 
aged 2 to 59 months (ALMANACH) was developed, both on paper and electronic 
support.(Rambaud-Althaus et al., 2015) Derived from IMCI, ALMANACH integrates 
evidence-based diagnostic procedures targeting the main infectious diseases 
including the use of a rapid diagnostic test for malaria diagnosis (mRDT), a urine 
dipstick for the classification of urinary tract infection (UTI) and abdominal tenderness 
for the classification of typhoid fever. For children with fever or history of fever, a new 
disease classification, namely ‘likely viral infection’, is proposed at the end of the 
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child’s assessment when no cause of fever has been identified, and bacterial disease 
and malaria have been ruled out, which encourages HWs to withhold unnecessary 
antibiotic prescription. The electronic version of ALMANACH was developed using a 
set of open-source software from Open Data Kit(“Open Data Kit,” n.d.) and 
OpenMRS(“OpenMRS,” n.d.), to be run on android mobile devices (smartphones and 
tablets) (Rambaud-Althaus et al., 2015). The impact of ALMANACH’s use in term of 
children’s health outcome and antibiotic prescriptions has been demonstrated in 
controlled conditions in Tanzanian primary care health facilities (HFs). The use of the 
new algorithm achieved a better cure rate at day 7 and a dramatically lower rate of 
antibiotic prescription than routine practice (15% with ALMANACH vs 84% in the 
control; p<0.001). (Shao et al., 2015) Used in controlled conditions, ALMANACH was 
thus able to improve the rational use of antibiotics in a safely manner. 
In this paper we present the results of a comparative study to assess the impact of 
the e-ALMANACH on HWs’ performance and antimicrobials prescription when used 
in programmatic conditions. Performance, in term of completeness of assessment, 
appropriateness of diseases classification and treatment prescription, was assessed 
for HWs trained on and provided with paper or electronic ALMANACH, and compared 
to that for HWs without specific training or tool.  
8.3 Material and Methods 
8.3.1 Study setting 
The study took place between April and December 2011 in Dar es Salaam, the 
economic capital of the United Republic of Tanzania, with 4’360’000 inhabitants in 
2012(PHC, 2012). Dar es Salaam has 3 municipalities with a public health system 
organized in 4 levels (reference hospitals, district hospitals, health centres and 
dispensaries). Tanzania adopted the IMCI protocols as national policy in 1998(Mushi 
et al., 2010). In 2011, Tanzania was in the process of mRDT implementation at 
national scale, but the administrative region of Dar es Salaam was not yet covered. 
For this study we conveniently selected 9 public HFs (3 health centres and 6 
dispensaries) that had been using mRDT routinely since a previous research project 
(IMALDIA 2006-2009)(D’Acremont et al., 2008). The 3 selected HFs per municipality 
were randomly allocated to: i) e-ALMANACH (electronic arm), ii) paper ALMANACH 
(paper arm), and iii) standard practice (control arm), by a block stratified 
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randomisation(Piantadosi and Cedars-Sinai Medical Center, n.d.). In each arm a total 
of 3 HFs were thus enrolled (Table 12). 
 
Table 12. Characteristics of the 9 public health facilities involved in the survey and detailed list 
of health workers trained and supervised 
Health 
facility 
Arm District Type Total number 
of health 
workers 
Number of 
health 
workers in 
OPD 
Number of 
health workers 
trained 
Number of health 
workers supervised 
1 Control Kinondoni HC 17 6 - - 
2 Control Ilala D 8 7 - - 
3 Control Temeke D 10 6 -  - 
4 Paper Kinondoni D 5 4 4 4 
5 Paper Ilala D 9 6 6 5° 
6 Paper Temeke HC 12 8 8 8 
7 Electronic Kinondoni D 17 11 11 9° 
8 Electronic Ilala HC 13 8 7* 6° 
9 Electronic Temeke D 16 12 12 11° 
*Clinicians in OPD not trained: HF8: 1 transferred out 
°Clinicians trained not supervised: HF5: 1 transferred out; HF7: 1 maternity leave and 1 long leave; HF8: 1 long 
leave; HF9: 1 transferred out. 
 
8.3.2 Intervention: ALMANACH pilot implementation 
In April and May 2011, a total of 48 HWs (18 in the paper, 30 in the electronic arm) 
involved in children’s management in the 6 enrolled intervention HFs received a 2-
day training. The training was conducted by the study team (CRA, AS, SJ, NS, SP), 
with the support of external experts (acknowledged), in both English and Kiswahili 
(both Tanzanian official languages). Clinicians from both intervention arms were 
trained together, through lectures and practical exercises on the problem of antibiotic 
resistance and on the ALMANACH’s content and rationale. In the afternoon of the 
second day, HWs were trained separately on the use of ALMANACH with clinical 
case studies on either the booklet or the smartphone application, according to their 
HF’s arm. In both arms clinicians received a paper version of ALMANACH12, written 
in Kiswahili. The electronic version contains all and only the information available in 
the booklet, both in English and Kiswahili.  
After the training, 3 to 5 smartphones (according to the number of working places) 
were brought in the electronic arm HFs. During the following 3 months, one day of 
face-to-face supervision was delivered in the 6 intervention HFs to 43 HWs (17 
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paper, 26 electronic) by one of the study supervisors (CRA, AS, SJ, NS, SP) while 
the clinician was attending real patients. After all HWs had been trained and 
supervised, monthly supervision visits were carried out in the 6 HFs. Throughout the 
study period, the study team made sure that antimalarials and mRDTs were always 
available both in intervention and control HFs. 
8.3.3 Study design and subjects  
A cross sectional comparative survey was conducted in September and October 
2011 in the 9 involved HFs to assess HWs’ performance four months after the initial 
training and face-to-face supervision. All consecutive children aged 2 to 59 months 
presenting during the working hours of the study team were recruited if they fulfilled 
the following inclusion criteria: 1) first consultation for an acute medical problem; 2) 
absence of severe illness requiring immediate life-saving procedures; 3) main 
complaint(s) not related to injury or trauma; 5) written informed consent by the 
caretaker. Because they valued the intervention and the access to an expert 
consultation, none of the caretaker of eligible children refused to participate. The 
sample size estimation was based on an expected 90% proportion of children 
assessed for danger signs in the electronic arm. This indicator was selected for the 
calculation as it is a key element for patients’ safety. With individual patient 
randomization, 72 patients per arm would have been required to detect a 20% point 
one-sided difference with 80% power and 5% significance for this indicator. In this 
cluster-randomized pilot study, the number of health facilities and children we could 
enroll were limited. We decided to enroll 50 children from 3 health facilities in each 
arm, allowing the detection of a minimum difference from 19 to 30% point in the 
indicator, with an assumed intracluster correlation between 0.01 and 0.05, with 80% 
power and 5% significance.  The targeted sample size was 150 children per arm. 
 
8.3.4 Procedures  
After oral consent was given by the HW and written consent by the child’s caretaker, 
the consultation was observed by an external study-trained clinical officer (hereafter 
referred to as the observer) who recorded details of the HW’s assessment of the 
child, including symptoms and signs found, laboratory investigation(s) performed; 
classification(s) reached; advice to caretakers; and treatment(s) prescribed, without 
intervening. Following the HW’s consultation, each enrolled child underwent a second 
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full clinical assessment by an experienced clinician following strictly the e-
ALMANACH (expert). During the study, the classification, treatment, and advice of 
the expert were the basis for the final treatment of the child. The study protocol and 
related documents were approved by the Ethikkommission beider Basel in 
Switzerland, and by the Institutional Review Board of the Ifakara Health Institute and 
the National Institute for Medical Research Review Board in Tanzania.  
8.3.5 Data collection, management and analyses 
For each enrolled child, the observer completed a standardised paper case report 
form (CRF) where he/she recorded HW and child’s demographics, tasks performed 
by the HW, and findings. The CRFs were adapted from the health facility survey 
checklist questionnaire developed by WHO(WHO, 2001). Data from the expert 
consultation were collected through the smartphone-run e-ALMANACH. All paper 
collected data were double entered in EpiInfo (version 3.5.3). Data cleaning, 
management, and analyses were conducted using Stata software version 10 
(College Station, Texas, USA). A set of indicators was derived from the Health 
Facility Surveys tool in IMCI multi-country evaluation(WHO, 2001) to assess HWs’ 
performance outcomes in term of i) completeness of assessment, ii) accuracy of 
disease classification, and iii) appropriateness of antimicrobial prescription, as 
compared to the expert assessment. The list of indicators and their definition is 
presented in Table 13. The unit of analysis was the patient. Proportions were 
compared by calculating odds ratios using a multilevel mixed-effects logistic 
regression model to account for health facility clustering. Adjusted risk ratios (aRR) 
were calculated from the fitted values for each cell of the 2 by 2 tables, for each 
intervention arm (paper and electronic) as compared to the control arm, and then 
compared to paper arm. The 95% confidence intervals of the aRR of each 
intervention arm were compared to explore the added value of the electronic 
intervention over the paper one.  Venn diagrams were computed using Venn 
Diagram Plotter software (“Venn Diagram Plotter | Pan-Omics Research,” n.d.) to 
illustrate the accuracy of the HWs’ bacterial and viral classifications as compared to 
the expert’s classifications.  
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Table 13. List and definition of health workers’ performance outcomes indicators 
Performance indicator Definition 
Completeness of assessment  
Assessment tasks requested for all children 
Danger signs Proportion of children asked for all of the 3 following danger signs: 
‘difficulty to drink’, ‘vomits everything’, and ‘history of convulsion’ 
Main symptoms Proportion of children asked for all of the 3 following main symptoms: 
‘fever’, ‘cough’, and ‘diarrhoea’ 
Palmar pallor Proportion of children checked for palmar pallor 
Index of integrated assessment Proportion of the 11 assessment tasks required for each child actually 
performed (3 danger signs, 3 main symptoms, other problem, weight, 
temperature, RCH card, palmar pallor; total=11 tasks) 
Assessment tasks requested for a subset of children 
Respiratory rate Proportion of children with fever and cough who had their respiratory rate 
counted 
Malaria test Proportion of febrile children who had a malaria rapid test ordered for 
Classifications 
appropriateness 
 
Children appropriately 
classified 
Proportion of children with all classifications of HWs matching the expert 
classifications 
Bacterial classifications 
identified 
Proportion of children with at least one expert classification potentially due 
to a bacteria (pneumonia, dysentery, ear infection) identified by the health 
worker 
Viral infection identified Proportion of children with expert classifications likely due to a virus 
(cough or cold, likely viral) identified by the health worker 
Treatment appropriateness 
Children appropriately 
managed 
Proportion of children who were prescribed antimalarial, antibiotics, ORS, 
and zinc when needed and no antibiotic nor antimalarial when not needed. 
Children in need of antibiotic 
for whom it was prescribed 
Proportion of children in need of an antibiotic as per expert classifications 
for whom at least one antibiotic was prescribed by the health worker 
Children not in need of 
antibiotic for whom it was not 
prescribed  
Proportion of children not in need of an antibiotic as per expert 
classification for whom no antibiotic was prescribed by the health worker  
Children in need of 
antimalarial for whom it was 
prescribed 
Proportion of children in need of an antimalarial as per expert classification 
for whom an antimalarial was prescribed by the health worker 
Children not in need of 
antimalarial for whom it was 
not prescribed 
Proportion of children not in need of an antimalarial as per expert 
classification for whom no antimalarial was prescribed by the health worker 
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8.4 Results  
8.4.1 Characteristics of the study population 
From 2nd September to 23rd November 2011, 504 children with a median age of 15 
months (inter quartile range [IQR]: 8-29) were enrolled (166 in the control, 171 in the 
paper, and 167 in the electronic arms). Fever was reported in 71% (95%CI: 67-75%) 
and cough in 66% (62-70%) of the 504 children. The most frequent classification 
given by the expert was ‘Cough or cold’ reached in 55% (51-60%) of the children, 
followed by ‘acute diarrhoea without dehydration’ in 19% (16-23%) and ‘pneumonia’, 
10% (8-13%). According to the expert, 63 (13%) out of these 504 children had a 
condition requiring antibiotics, and 7 (1%) antimalarials. The detailed characteristics 
of the 504 enrolled children as per expert assessment are presented in Table 14.  
 
Table 14. Demographic characteristics, symptoms and disease classification as per expert’s 
evaluation of the 504 enrolled children 
  Electronic 
(N=167) 
Paper  
(N=171) 
Control  
(N=166) 
Overall 
(N=504) 
  Proportion 
(3 HFs Range
§
) 
Proportion  
(3 HFs Range
§
) 
Proportion  
(3 HFs Range
§
) 
Proportion  
Demographics  
 
 
 
Children aged 2-11 
months 
43% (41-47) 36% (28-40) 32% (25-41) 37% 
Girls 48% (38-57) 46% (43-52) 51% (44-55) 48% 
Symptoms  
 
  
Fever* 75% (69-80) 64% (59-67) 73% (72-75) 71% 
Cough 69% (65-72) 64% (57-74) 65% (63-69) 66% 
Fever* and cough 55% (51-57) 44% (39-51) 46% (42-49) 49% 
Diarrhoea 23% (22-24) 17% (12-24) 20% (17-24) 20% 
Skin lesion 7% (2-13) 12% (7-21) 5% (2-7) 8% 
Ear problem 0% 4% (3-4) 2% (0-4) 2% 
Disease classification 
(expert) 
 
 
 
 
Severe disease 1% (0-2)
$
  2% (0-4)° 0% 1% 
Malaria 1% (0-2) 1% (0-4) 2% (0-5) 1% 
Pneumonia 14% (12-15) 6% (4-7) 11% (4-20) 10% 
Cough or cold 55% (51-57) 57% (54-63) 53% (47-59) 55% 
Acute diarrhoea 22% (20-24) 17% (12-24) 19% (17-24) 19% 
Dysentery 1% (0-2) 0% 1% (0-4) 1% 
UTI 1% (0-2) 1% (0-2) 1% (0-2) 1% 
Likely viral 11% (7-15) 10% (4-18) 16% (11-21) 12% 
HF: Health facility. UTI: urinary tract infection. *history of fever as mentioned by the caretaker 
§
Range of proportions in the 3 health facilities. °3 severe classifications: 1 severe malnutrition,  
1 severe anaemia, 1 ‘vomits everything’; $severe anaemia. 
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8.4.2 Completeness of integrated assessment 
In the control arm, some of the assessment tasks that should be systematically 
performed in every child were rarely performed by the clinicians. Dangers signs were 
checked in only 3% of the children (range: 2-4% among 3HFs) and palmar pallor in 
14% (6-20%). In this arm, only 21% of the children (18-24%) had an index of 
integrated assessment ≥50% (meaning that only one child out of five had at least half 
of the systematic assessment tasks performed) and 11% (9-14%) an index above 
75% (Table 15). In the paper arm, danger signs were checked in 41% of the children 
(range 16-71% among 3 HFs; adjusted risk ratio as compared to control arm (aRR) 
[95%CI]: 14.4 [3.4-69.7]) and palmar pallor in 30% (11-50%; 2.1 [0.8-5.7]). In this 
arm, 58% of the children (33-85%; 2.9 [1.4-6.3]) had an index of integrated 
assessment ≥50%, and 16% (7-27%; 1.5 [0.7-3.1]) an index above 75%. In the 
electronic arm, danger signs were checked in 74% of the children (63-94%; 30.9 [9.2-
120.2]) and pallor in 69% (56-80%; 5.2 [3.1-9.1]). In this arm, the proportion of 
children with an index ≥50% was 87% (80-98%; 4.2 [3.1-5.6]) and with one ≥75%, 
43% (40-46%; 4.0 [2.5-6.4]) (Table 15). Main symptoms were checked in two thirds 
of the children in the control (77%, range 64-91%) and paper arm (75%, range 68-
82%; aRR 1.0 [0.8-1.2]), and in almost all children in the electronic arm (99%, range 
98-100%; aRR 1.3 [1.2-1.3]).  
Assessment tasks to be performed in a subset of children (such as malaria test, or 
respiratory rate count) were not included in the index of integrated assessment. 
Respiratory rate was counted in only 4% (0-7%) of eligible children in the control arm, 
and in 53% (25-70%; 12.8 [3.6-53.5]) and 41% (32-56%; 9.4 [3.1-30.9]) in the paper 
and electronic arms respectively. The proportion of febrile children tested for malaria 
was not significantly different in the 3 arms (84%, range 75-88% in the control; 92%, 
range 88-95%, aRR 1.1 [1.0-1.2] in the paper; and 72%, range 56-88%, aRR 0.9 
[0.7-1.0] in the electronic arms) (Table 15). 
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Table 15. Indicators of completeness of assessment and appropriateness of classifications and 
treatments 
*NA: Not applicable, due to a too small patients’ effective 
AB antibiotic. AM antimalarial. HW health worker. *NA: Not applicable, due to a too small patients’ effective 
Indicators Arm N 
total 
Indicator  
% (3 HFs 
Range) 
Risk ratio accounting for clustering 
aRR (95%CI) 
 
    
Versus control p 
value 
Versus paper p value 
Assessment            
Danger Signs Control 165 3% (2- 4) - - - - 
Paper 168 41% (16-71) 14.4 (3.4-69.7) <0.001 - - 
Electronic 152 74% (63-94) 30. 9 (9.2-120.2) <0.001 2.0 (1.0-3.5)  0.04 
Main symptoms Control 163 77% (64-91) - - - - 
Paper 168 75% (68-82) 1.0 (0.8-1.2) 0.68 - - 
Electronic 158 99% (98-100) 1.3 (1.2-1.3) 0.001 1.3 (1.2-1.3) <0.001 
Palmar pallor Control 166 14% (6-20) - - - - 
Paper 171 30% (11-50) 2.1 (0.8-5.7) 0.12 - - 
Electronic 167 69% (56-80) 5.2 (3.1-9.1) <0.001 2.5 (1.5-4.3) 0.001 
Prop with an index of 
integrated 
assessment ≥50% 
Control 166 21% (18-24) - - - - 
Paper 171 58% (33-85) 2.9 (1.4-6.3) 0.004 - - 
Electronic 167 87% (80-98) 4.2 (3.1-5.6) <0.001 1.6 (1.1-2.0) 0.027 
Prop with an index  
of integrated 
assessment ≥75% 
Control 166 11% (9-14) - - - - 
Paper 171 16% (7-27) 1.5 (0.7-3.1) 0.273 - - 
Electronic 167 43% (40-46) 4.0 (2.5-6.4) <0.001 2.7 (1.7-4.1) <0.001 
Respiratory rate 
measured 
Control 69 4% (0-7) - - - - 
Paper 73 53% (25-70) 12.8 (3.6-53.5) <0.001 - - 
Electronic 79 41% (32-56) 9.4 (3.1-30.9) <0.001 0.8 (0.5-1.3) 0.34 
Malaria test ordered Control 123 84% (75-88) - - - - 
Paper 112 92% (88-95) 1.1 (1.0-1.2) 0.06 - - 
Electronic 116 72% (56-88) 0.9 (0.7-1.1) 0.16 0.8 (0.7-0.9) 0.07 
Classifications        
Children 
appropriately 
classified 
Control 166 34% (22-56) - - - - 
Paper 171 39% (35-42) 1.1 (0.7-1.9) 0.60 - - 
Electronic 167 53% (47-59) 1.6 (1.0-2.5) 0.045 1.6 (1.0-2.5) 0.07 
Bacterial 
classifications 
identified 
Control 22 27% (0-38) - - - - 
Paper 11 36% (20-100) 1.3 (0.4-3.6) 0.59 - - 
Electronic 26 46% (0-70) 1.8 (0.5-8.4) 0.41 1.0 (0.3-8.7) 0.949 
Viral classifications 
identified 
Control 114 36% (17-74) - - - - 
Paper 115 33% (10-43) 0.9 (0.3-2.8) 0.81 - - 
Electronic 110 70% (59-77) 2.1 (1.0-4.0) 0.04 2.2 (1.4-3.5) 0.001 
Treatment        
Children 
appropriately 
managed  
Control 166 37% (29-44) - - - - 
Paper 171 62% (55-74) 1.7 (1.3-2.2) <0.001 - - 
Electronic 167 63% (52-72) 1.7 (1.3-2.2) <0.001 1.0 (0.8-1.3) 0.91 
Children 
prescribed 
antibiotic by HW 
Control 166 70% (60-85)   - - 
Paper 171 26% (14-37) 0.4 (0.2-0.6) <0.001 - - 
Electronic 167 25% (17-33) 0.3 (0.2-0.5) <0.001 1.1 (0.6-1.6) 0.825 
Children in need of 
AB for whom it 
was prescribed 
Control 22 100% (100-100) - - - - 
Paper 14 36% (20-67) 0.4 (0.3-0.7) 0.002 - - 
Electronic 27 48% (0-80) 0.5 (0.4-1.0) 0.04 1.2 (0.4-6.7) 0.823 
Children not in need 
of AB for whom it 
was not prescribed 
Control 144 34% (18-47) - - - - 
Paper 157 75% (63-87) 2.3 (1.5-3.4) <0.001 - - 
Electronic 140 80% (72-90) 2.4 (1.7-3.3) <0.001 1.1 (0.9-1.0) 0.474 
Children in need of 
AM for whom it was 
prescribed 
Control 3 100% (100) - - - - 
Paper 2 50% (50) NA* - - - 
Electronic 2 50% (0-100) NA* - NA*  
Children not in need 
of AM for whom it 
was not prescribed 
Control 163 93% (87-98) -   - 
Paper 169 100% (100-100) 1.1 (1.0-4.0) 0.03  - 
Electronic 165 96% (89-100) 1.1 (0.9-1.1) 0.37 1.0 (1.0-1.0) 0.466 
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8.4.3 Appropriateness of disease classification 
The proportion of children with all HWs’ disease classifications matching the expert’s 
ones was low in both control (33%, [range in the 3 HFs 22-56%]) and paper arms 
(39%, [35-42%]; aRR 1.1 [0.7-1.9]) and slightly higher in the electronic one (53% [47-
57%]); 1.6 [1.0-2.5]). This was due to a higher proportion of viral conditions identified 
by HWs in the electronic arm (70%) than in the control arm (36%; aRR 2.1 [1.0-4.0]). 
The proportions of bacterial conditions identified by HWs was however not 
significantly different between the three arms and highly heterogeneous between the 
HFs (27%,range 0-38% in control; 36%, range 20-100% in paper; and 46%, range 0-
70% in electronic arm)(Table 15). Figure 10 presents Venn diagrams illustrating the 
agreement between HWs and expert in term of viral and bacterial classifications, and 
the proportion of children prescribed antibiotics by HWs. 
8.4.4 Appropriateness of treatment 
The proportion of children appropriately managed (antimalarials, antibiotics, zinc and 
rehydration prescribed when needed only) was similar in the two intervention arms 
and significantly higher than that in the control arm (37%, range 29-44% in control; 
62%, range 55-74%, aRR 1.7 [1.3-2.2] in paper; and 63%, range 52-72%, aRR 1.7 
[1.3-2.2] in the electronic arm). The proportion of children prescribed antibiotics was 
much lower in the interventions than in the control arm (70%, range 60-85 % in the 
control; 26%, range 14-37%, aRR 0.4[0.2-0.6] in the paper; and 25%, range 17-33%, 
aRR 0.3[0.2-0.5] in the electronic arm). Thereby, the proportion of children not in 
need of antibiotics and for whom it was not prescribed was higher in the paper (75% 
(aRR 2.3 [1.5-3.4]) and the electronic HFs (80% (aRR 2.4 [1.7-3.3]) than in the 
control HFs (34%). However, the proportion of children in need of antibiotics and for 
whom it was not prescribed was also higher in the intervention arms: only 5 of the 14 
children in need of antibiotic were prescribed it by the attending HW in the paper arm, 
and only 13 of the 27 children in the electronic arm. In the control arm, where 70% of 
all children were prescribed an antibiotic, all the 22 children in need of an antibiotic 
were prescribed one by the HW; however more than half of the antibiotic 
prescriptions in the control arm were inappropriate (Table 15). Among the 7 malaria 
cases, 5 were appropriately treated and 2 were not prescribed any antimalarial by the 
HW (1 in the paper and 1 in the electronic arm). Some children received an 
unnecessary antimalarial treatment (11 in the control and 6 in the electronic arm). 
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8.4.5  Identification of serious conditions by health workers 
Table 16 presents for each HF the list of serious conditions, i.e. either severe 
diseases or infections requiring antimalarial (malaria) or antibiotic treatment 
(pneumonia, dysentery, UTI), identified in the three arms compared to that identified 
by the expert. Overall only 30 (43%) out of 70 conditions were appropriately identified 
by the HWs. Pneumonia, that was the most frequent serious condition identified by 
the expert, was also the condition most often missed by the HWs in all three arms: 
only about one third of pneumonia was identified by the HWs (5/19, 3/10, and 9/23 in 
control, paper and electronic arms respectively). These proportions varied a lot 
among the different HFs involved. The other conditions requiring antibiotics or 
antimalarials, though rare, were more often recognised by the HWs. When looking at 
the 35 expert pneumonia that were missed by HWs (14, 7, and 14 in the control, 
paper and electronic arms respectively), cough was not identified in 2 children in the 
control arm and therefore pneumonia was not considered (2/14,0/7, 0/14) and the 
others were classified as ‘Cough or cold’, either without respiratory rate measured 
(9/14, 1/7, and 9/14), or with a respiratory rate below the threshold (2/14, 5/7, 5/14). 
For the latter children, the median respiratory rate measured by HWs was 45/min 
(range 38-49) for eight children <1 year and 43/min (38-49) for children ≥1 year, while 
it was 53/min (52-57) and 54/min (51-58) respectively when the child was assessed 
by the expert around half an hour later. One child in the paper arm had a respiratory 
rate above the threshold that was misinterpreted, and one child in the control arm 
had a cough attributed by the HW to worm infestation.  
8.4.6 Direct comparison of paper and electronic arms’ results 
The indicators of the completeness of assessment were significantly higher in the 
electronic arm compared to paper, with aRR electronic vs paper (aRR-e/p) above 2 
for proportion of children checked for danger signs  (aRR-e/p: 2.0 [p=0.04]), checked 
for palmar pallor (aRR-e/p: 2.5 [p=0.001]), and with an index test of integrated 
assessment >75%.  (Table 15) However, for respiratory rate measure (aRR- e/p:  0.8 
[p=0.34]), and malaria test (aRR- e/p: 0.8 [p=0.07]), the proportion of children 
assessed in the electronic arm was lower than in the paper, although not significantly.  
Except for viral classifications that were more often correctly identified in electronic 
arm (aRR-e/p: 2.2 [p=0.001]), there was no difference in the identification of bacterial 
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infections, and overall classifications. With regards to treatment, similar outcomes 
were observed in the 2 interventions arms.
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Figure 10. Venn diagram illustrating the level of agreement (in %) between the expert and the 
HWs’ bacterial and viral classifications, as well as the total proportion (in %) of children 
prescribed an antibiotic in each study arm 
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Table 16. Detailed list of serious
§
 conditions identified by health workers among conditions 
validated by the expert 
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8.5 Discussion 
Our findings show that the implementation of ALMANACH on either paper or 
electronic support has the potential to tackle some of the difficulties of HWs when 
managing childhood illnesses. In the control arm, HWs’ compliance to integrated 
assessment tasks was low, and antibiotics were prescribed to more than 2/3 of the 
children, even when the classification did not require antibiotics according to IMCI. 
The use of ALMANACH (in both paper and electronic arms) was associated with a 
significantly higher proportion of children having an index of integrated assessment 
≥50%, being checked for danger signs, having their respiratory rate measured when 
necessary, and being appropriately managed. A significantly lower prescription of 
unnecessary antibiotics as compared to the control was equally observed in paper 
and electronic arms. Observed in both intervention arms, these results were likely 
due to the recent training received by clinicians on ALMANACH’s content. The use of 
the e-ALMANACH was further associated with a significantly higher proportion of 
children checked for danger signs, main symptoms and palmar pallor, children having 
an index of integrated assessment ≥75% and having an appropriate classification 
than in the control. The proportion of children identified both by the expert and the 
HW as viral infection was significantly higher in the electronic arm than in the control 
and paper arms. Although improved in intervention arms, the respiratory rate 
remained infrequently measured in children with cough. And the proportion of febrile 
children tested for malaria was lower in the electronic than in the control and paper 
arms. 
In this pilot study, the small number of HFs involved and the limited number of 
consultations observed did not allow to observe significant differences in the impact 
of the electronic versus paper intervention as compared to the control arm (the 
95%CI of the aRR always overlapped, Table 15), however the results show that the 
use of hand-held technology can improve the training’s impact on simple easy-to-
perform tasks, such as asking for danger signs and main symptoms, or looking at a 
child’s palm. However, in this survey, the use of mobile device was insufficient in 
itself to convince HWs to perform more time-consuming tasks systematically, such as 
measuring respiratory rate over a full minute, or sending a child to the laboratory for a 
malaria test.  
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The most frequently missed serious condition was pneumonia. In previous studies 
assessing HWs’ performance after IMCI training, pneumonia identification was 
always a challenge, with only 41% of pneumonia correctly identified in South Africa 
(Horwood et al., 2009a), and only 40 to 50% of pneumonia prescribed the 
recommended treatment in Benin (Rowe et al., 2012). This may be explained by 
problems in pneumonia definition that were not addressed by our intervention. In 
IMCI and ALMANACH, the pneumonia classification relies on respiratory rate. 
Respiratory rate fluctuates over time, and HWs have low motivation to measure it. 
Indeed, in our study, most of missed pneumonia had either no respiratory rate 
measured, or a rate below the expert one, the difference being either due to the 
variability over time or to the low inter-rater reproducibility of the measurement. 
Respiratory rate that need to be counted over a full minute is perceived as time 
consuming by HWs both in low and high income countries (Thompson et al., 2008). 
Moreover, the low performance of fast breathing to predict bacterial pneumonia 
render this sign in fact not very useful (Rambaud-Althaus et al., 2015) and efforts are 
ongoing to find better clinical ways to diagnose pneumonia. Both issues call for novel 
diagnostic assays or devices to identify this serious condition.  
For malaria, the availability of mRDT, improves HWs’ diagnoses. In this survey, all 
malaria cases were identified by the HWs, except one (Table 16). This missed 
malaria case, occurred in a 21 months old boy, who had no fever nor history of fever, 
but for whom the expert identified a non-severe anemia, based on palmar pallor, and 
therefore ordered a mRDT. The HW in this case did not assess the child’s palm, and 
missed both anemia and malaria. The very few cases of anemia and malaria in our 
survey do not allow assessing the impact of our intervention on this critical issue. 
However the trends in the proportion of children assessed for palmar pallor (14%, 
30%, and 69% in control, paper, and electronic facilities,Table 16) suggests 
ALMANACH could help improving anemia detection. 
The use of ALMANACH resulted in an important decrease in the unnecessary 
antibiotic prescription. However, because of the inability of HWs to properly classify 
pneumonia, some of the children in need of antibiotics according to the WHO clinical 
pneumonia definition were not prescribed such treatment, even in the intervention 
HFs. In the present study, all these children actually received antibiotics from the 
expert, but this could be a matter of concern if real bacterial pneumonia would remain 
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untreated by HWs in programmatic conditions. One study on the health outcome of 
untreated non-severe pneumonia in children in a low-income country showed no 
difference in clinical outcome with the treated control group (Hazir et al., 2011), which 
suggest that, in young children, a high number of clinical pneumonia episodes are of 
viral origin, as it is the case in Northern countries. Therefore the low specificity of the 
present criteria used to diagnose pneumonia, even when using a higher threshold for 
respiratory rate (Rambaud-Althaus et al., 2015), together with the fact that most 
children can be followed up to look at the clinical course, must balance the concern of 
missing a true bacterial pneumonia case. It has often been argued that follow-up 
visits are difficult to organise in low resources setting due to transport and cost 
constraints. That was one of the reasons for encouraging presumptive treatment for 
malaria and having a low clinical threshold to give antibiotics for pneumonia. There is 
now more and more awareness that this strategy leads to over-prescription of 
antimicrobials and the development of resistance. While using the e-ALMANACH, the 
HWs were more likely to appropriately deliver messages on when to bring back the 
child in case his conditions would not improve or even worsen (data not shown). 
Follow-up is an important part of outpatient management of non-severe children and 
if this strategy is not promoted, there is little hope to tackle the antibiotic overuse and 
the spread of drug resistance. 
Strengths and limitations 
To our knowledge, this study was the first implementation in programmatic conditions 
of an electronic algorithm for the management of childhood illness. A previously 
published study also reported improved HW’s performance when using an electronic 
IMCI compared to the paper IMCI (Mitchell et al., 2013) and a positive users’ 
experience (Mitchell et al., 2012), but these results were observed within a short 
study period of 3 to 6 days, HWs using the electronic tool only over these few survey 
days.  
The present project has demonstrated the feasibility of using innovative technology in 
resource limited settings, and its high potential to improve the quality of health care 
delivered to children. The use of this technology also allowed data collection and 
activity monitoring that are essential assets to monitor and improve quality of health 
care. 
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The small number of health facilities involved, their disparities in size, and the 
relatively small number of consultations observed limits the power of the analyses, 
but the results still show the potential of such a tool that deserves further 
assessment.  
In the present survey, a high proportion of children were prescribed an antibiotic in 
the control health facilities. This is in line with observation made 4 years earlier in the 
same health facilities, after the introduction of mRDT(D’Acremont et al., 2008). In Dar 
Es Salaam, where the prevalence of malaria is rather low, antimalarial drugs, 
formerly prescribed presumptively for fever, were indeed replaced by presumptive 
antibiotics. In a setting where malaria prevalence would be higher, we can expect the 
level of antibiotic prescriptions to be lower, but in the absence of appropriate patient 
assessment, not more appropriate. 
The choice of routine practice as a control and the deliberate short training (2 days) 
in the intervention HFs were decided to be as close as possible to programmatic 
conditions. Although IMCI is the standard of care for children in Tanzania since the 
1990’s, the HWs involved in the control arm had no recent IMCI refresher training. 
This control group does not allow comparing ALMANACH versus IMCI algorithms, 
but rather the difference in HWs performance when using a new tool on paper or on 
electronic support, as compare to the previous practice.  
Potential to scale up 
This pilot intervention comprised a short training followed by one day of HW face-to-
face supervision, and monthly HF supervision visits. This short duration mitigates the 
resources needed for the initial training and may facilitate scale up. It raises the need 
for resources in the immediate aftermath that may be a bottleneck to scale up. 
However, close follow-up and regular supportive supervision are acknowledged as a 
key for sustainable improvement of the quality of care.   
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8.6 Conclusion 
The use of mobile technology to support health care delivery in low-income countries 
is feasible and has a huge potential for improvement of quality of care and 
monitoring. As long as no automated devices are available to replace the key signs 
required for clinical diagnosis or selection of patients for testing, training of health 
workers on the basic clinical skills is still essential. As any other clinical support 
system, it also requires continuous supportive supervision to encourage HWs using it 
appropriately. Improving the rational use of antimicrobial is a challenge that 
ALMANACH can help to take up. It has to be acknowledged and accepted that, 
because no diagnostic tool is fully sensitive, the reduction in antibiotic prescriptions 
will always be accompanied by a small risk of withholding them in a child that would 
have benefited from them. Proposing the best available accurate diagnostic 
procedures to HWs, and enforcing good compliance as well as the delivery of 
appropriate counseling to caretakers on when to bring the child back, are needed to 
reach a rational use of antibiotics and slow down the development of resistance. 
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9 Discussion  
The main purpose of the present PhD thesis was to develop and test an innovative 
approach for a safe and rational use of antimicrobials in the management of 
childhood illness by health workers in primary level of care in low and middle income 
countries. 
Incentives for health workers to prescribe antimicrobial medicines are many and 
varied, such as fear of serious bacterial infections and malaria, limited diagnostic 
capacity, easy access to antimicrobials, limited side effects, perceived patient’s 
expectations, and lack of knowledge on viral diseases. Medical training often focuses 
on serious bacterial infections that drive the high childhood mortality. Clinician 
awareness on the prevalence of self-limiting viral diseases in children is low. The 
positive health outcomes of the children with viral diseases, unnecessarily treated 
with antimicrobials, are attributed by clinicians to the antimicrobial, and not to the 
natural history of a self-limiting viral disease. The practical knowledge clinicians build 
on their experience – ‘I prescribe an antibiotic and the child get cured’ whatever 
diagnosis was reached during the assessment – is thus encouraging the over-
prescription of antimicrobials. Therefore, there is an urgent need for robust 
interventions to decrease antimicrobials inappropriate prescriptions.In the core of the 
present project, we designed ALMANACH, a new standardised clinical algorithm for 
the assessment and treatment of children aged 2-59 months at resource-limited 
primary care level (Chapter 6); we assessed the safety of ALMANACH as compared 
to routine practice, in term of children clinical outcome, when applied strictly (Chapter 
7); and we assessed the impact of its pilot implementation either as an electronic 
algorithm or as a paper booklet on antimicrobial prescriptions in primary care facilities 
(Chapter 8). In controlled conditions, ALMANACH improved the children clinical 
outcome with an 80% reduction of antibiotic prescriptions. During the pilot 
implementation, ALMANACH improved the thoroughness of children assessment by 
HWs and reduced the antibiotic prescriptions by 60%. With regards to the primary 
objective of reducing antibiotic prescription this was a very successful intervention. 
These highly promising results were obtained in a pilot project, using a new clinical 
algorithm to deliver evidence-based recommendations for the management of 
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children, algorithm that was provided to clinicians either on a paper or electronic 
support.  
In this section we will discuss questions that have arisen throughout the project on 
clinical algorithms and electronic decision support systems. We will also discuss the 
challenges that can be faced while trying to maintain these good results over time 
and within scale up pilot interventions.  
9.1 Design of clinical algorithms 
9.1.1 Clinical algorithm: Bringing evidence-based guidelines into clinical 
practice 
Clinical pathways and clinical algorithms are a way to implement evidence-based 
guidelines in the daily care practices. They have the potential to improve the quality 
of care and decrease the over-prescription of antibiotics both in low- (Gouws et al., 
2004) and high-income countries (Jenkins et al., 2013). Many hospitals in high-
income countries have implemented clinical pathways to improve quality of care 
(Rotter et al., 2010). IMCI algorithm, with its syndromic approach, is also a clinical 
pathway, integrating into a single algorithm management charts developed 
separately for pneumonia, diarrhoea, malaria, and measles. Evidence-based 
guidelines have been developed to reduce subjectivity in clinical decision making 
(Sackett et al., 1996). Historically, medical books and guidelines proposed diseases 
descriptions listing the classical signs and symptoms a patient with the disease 
should present, the expected clinical course, laboratory and imaging findings. The 
weight or predictive values of all clinical, laboratory, and imaging features taken 
individually were not stated. The clinicians, after having learned all the diseases 
characteristics, had to develop, while seeing patients, their clinical common sense in 
order to establish a diagnostic and therapeutic plan. Acknowledging that this 
individual empiric approach led to a highly subjective way of making decision for 
individual patients, evidence-based medicine was developed, with the aim to apply 
scientific method in medical decision-making.  
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9.1.2 Challenges towards evidence-based diagnoses 
Evidence-based medicine is a revolution underway, but the lack of evidence available 
for some area of clinical decisions hinders its development and applications. With 
regards to treatment recommendations, methodology to generate evidence and 
critically appraise it has been well defined and described, as for its implementation 
into evidence-based guidelines (Guyatt et al., 2011). The results of evidence reviews 
and the level of evidence grading are easy to apprehend for clinicians when dealing 
with interventions’ outcomes.  
With regard to diagnosis, the methods to generate (Bossuyt et al., 2003), critically 
appraise (Whiting et al., 2003), and use evidence of diagnostic test accuracy studies 
are more recent and more difficult to apprehend and translate into clinically sound 
recommendations (Singh et al., 2012).  
The lack of quality of published diagnostic accuracy studies (Korevaar et al., 2014) 
and of their statistical methods of meta-analyses (Willis and Quigley, 2011) is 
hampering the objective appraisal of the performance of studied diagnostic tests. The 
main focus of diagnostic research being on complex tests performed in secondary 
care specialties, insufficient evidence are generated for the performance of clinical 
tests in primary care settings, where the majority of patients are seen in practice 
(Willis and Quigley, 2011). 
Often the lack of appropriate reference (gold) standard (Lynch et al., 2010), 
especially in primary care setting hampers the production of diagnostic test accuracy 
studies. Methods have been developed to overcome this barrier of an imperfect or 
missing reference standard. They are not straightforward for clinicians. Some of 
these methods attempt to fix the imperfections of the reference standard. When fixing 
the standard’s imperfection is not possible, moving away from the classical ‘‘gold 
standard’’ diagnostic accuracy paradigm is warranted. Validation is a way to leave 
this paradigm and its indicators, such as sensitivity and specificity, and to look at 
whether a test result is useful for the patient management rather than if the test is 
identifying the target condition (Reitsma et al., 2009). 
The case of pneumonia is an interesting example of the challenge that a clinical 
diagnosis can represent. No appropriate reference standard exist for pneumonia 
diagnosis (Lynch et al., 2010). Confusion in the definition of the targeted condition, 
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i.e. pneumonia versus lower respiratory tract infection, occurred in the first studies 
looking for their clinical predictors (Brewster, 2015). And when the accuracies of 
potential clinical predictors were estimated, and fast breathing identified as a good 
predictor, international experts disagreed on the choice of an appropriate respiratory 
rate threshold to define clinical pneumonia. The experts had different interpretations 
of the estimated indicators of diagnostic test accuracy. They had different perceptions 
of the level of sensitivity and specificity required for the test to be implemented, and 
different perceptions on the applicability in the remote settings of the different 
threshold options (single versus age-related threshold) (Shann, 1992). The objective 
of the clinical case definition was to identify with simple and reliable clinical features 
the children who should receive and would benefit antibiotics. Pneumonia was 
acknowledged to be a condition that warranted antibiotics. The diagnostic test 
accuracy studies in this field were hampered by the lack of appropriate reference 
standard for pneumonia. When reviewing the available evidence on clinical predictors 
for pneumonia (Chapter 5), we only selected studies relying on an objective 
reference standard that is accepted to be the best available reference for bacterial 
pneumonia: chest X-ray. Although the reference standard was similar in the reviewed 
studies, the remaining heterogeneity in study design, especially patients’ selection 
process, brought heterogeneous results and the meta-analyses estimated a low 
performance of clinical predictors. If improvements in the reference standard for 
pneumonia diagnosis, improvements in the design of new prospective diagnostic test 
accuracy studies, or development of new point-of-care diagnostic tests could help 
improve our knowledge and evidence on pneumonia and its meaningful predictors, all 
this will require a lot of resources and time. A large multi-centric study on the 
etiologies of pneumonia in children has been recently completed and there are high 
expectations for the results to help better understanding the pneumonia 
epidemiology, presentation, and possible diagnostic procedures in low income 
countries (Scott et al., 2012). Meta-analyses on individual patients’ data to identify 
clinical predictors could also bring better insight. But if we consider the initial 
objective of the clinical case definition, i.e. identifying children in need of antibiotics, 
the test validation method is an interesting way of addressing the research question 
in the absence of pneumonia reference standard (Reitsma et al., 2009). The study 
design proposed by Hazir et al (2011) was an interesting clinical test validation. 
Instead of verifying test results with a reference standard, Hazir et al directly 
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assessed whether the children identified by the WHO clinical definition of non-severe 
pneumonia would benefit of antibiotics in terms of health outcome. Although the 
study primary outcome, treatment failure at day 3, can be discussed, the results of 
the 14 days follow up showed that children’s health outcome did not differ when 
receiving amoxicillin or placebo. Analyses of a passive morbidity surveillance system 
within a malaria prevention trial in Papua New Guinea also observed the same rate of 
re-attendance in children classified as having non-severe pneumonia when they had 
been prescribed antibiotics (according to IMCI guidelines) or not (lack of compliance 
to IMCI guidelines).(Senn et al., 2014) None of these studies proposed better 
alternative diagnostic approaches but they provided valuable evidence on the lack of 
accuracy of fast-breathing to identify patients in need of antibiotics. Extending this 
approach in clinical diagnostic research may help generating valuable evidence and 
clinically sounds recommendations that are needed to encourage broader adoption of 
diagnostic procedures.  
9.1.3 ALMANACH development and validation 
While designing ALMANACH we faced all these challenges. For malaria, accurate 
POCT have been developed, a large body of evidence supports their accuracy (Abba 
et al., 2011) and validity in children U5 (D’Acremont et al., 2010b; Odaga et al., 
2014), and therefore these tests have been deployed in malaria endemic countries. 
But malaria is the exception rather than the rule, and for most of the other conditions 
addressed in ALMANACH, as for pneumonia, no POCT exist and we had to rely on 
clinical definitions that had either low performance or were lacking underlying 
evidence.  
Majority of published research articles and guidelines focus on in-patients with severe 
conditions. The health outcome of patients with severe conditions is highly depending 
on their early management. Therefore bringing expertise in severe cases prompt 
management has been the priority of medical research. From medical training to 
clinical pathways, material given to clinicians mainly focus on serious, potentially life-
threatening diseases. This is highly meaningful, as recognising early severe cases is 
the only way to deliver on time life-saving treatments for these patients. Tackling 
childhood mortality requires delivering appropriate and prompt case management for 
the infectious diseases that are the leading causes of deaths. However, not all 
ambulatory patients have serious infections, and if hospital experts are asked to 
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prepare recommendations for ambulatory care they might over-emphasise the weight 
of serious conditions in ambulatory patients, experts being biased by their in-hospital 
experience. 
Clinicians with limited experiences who may lack confidence in their clinical 
assessment skills will often fear to miss a serious disease. This is an important 
trigger of unnecessary antibiotic prescription, clinicians preferring to give the drug to 
be ‘on the safe side’, when they lack confidence in their capacity to rule-out serious 
infections. In low-resource settings, the perception that patients follow up is 
impossible is also encouraging clinicians to prescribe antibiotics largely to patients 
with no features of bacterial infection, in order to i) prevent bacterial infections, or ii) 
treat a ‘prodromal phase’ of a bacterial disease. There is now clear evidence that 
prescribing antibiotics for upper respiratory tract infections have limited benefit on the 
patients outcome, and that they do not prevent the occurrence of bacterial 
suppurative complications (Ahovuo-Saloranta et al., 2014; Kenealy and Arroll, 2013; 
Rosenfeld and Kay, 2003; Venekamp et al., 2013). The majority of the patients with 
upper respiratory infections have a positive outcome without antibiotics, and this is 
why recent guidelines in high income countries now recommend a ‘watchful waiting’ 
strategy for antibiotic use in respiratory infections (Spurling et al., 2013). But even 
with this knowledge and recommendations available in high income countries, the 
antibiotic prescriptions remain high. In low-income countries, this knowledge is 
unavailable (data on natural history and antibiotic impact in suppurative complications 
are lacking) and the fear suppurative complications that are more frequent there than 
in wealthy countries, encourage the antibiotic use.  
Within this project, we acknowledged that generating evidence to evaluate the 
diagnostic accuracy of all diseases diagnostic procedures would require resources 
that were not available in the project. And the lack of appropriate reference standards 
will hamper the production of diagnostic test accuracy studies in coming years. 
Therefore, we decided to design a pragmatic algorithm, based on the available 
evidence, common sense and few experts’ opinions, and to perform a clinical test 
validation method to assess the appropriateness of ALMANACH recommendations 
(Chapter 7). The aim was to test the hypothesis that withholding antimicrobials for 
children with no danger signs and no clinical features of bacterial infections would be 
safe for the children in term of health outcome. Doing this validation survey without 
Chapter 9 – Discussion 
117 
diagnoses confirmation allows us to operate in the same conditions than in the 
targeted field of intervention. This survey provided valuable information regarding the 
relevance and safety of ALMANACH recommendations, and showed that the majority 
of antibiotics prescribed in the Tanzanian primary care facilities was not beneficial to 
the children. In ambulatory care, where available data is scarce, and access to 
confirmed diagnoses low, extending these validation methods and identifying 
evidence-based predictors of the benefit of antibiotics may help design better clinical 
algorithm for a rational use of medicines. 
Documenting the health outcome of children managed with ALMANACH in other 
African settings would help validating these recommendations. However, we believe 
that strategies to decrease the high unnecessary antibiotics use are urgently needed, 
and that building evidence should not delay clinicians to have access to guidelines 
that are likely to improve their performance in childhood illnesses management. 
Adapting the recommendations to the epidemiological context where it is to be 
implemented and monitoring the impact of its introduction should help refine the 
algorithm in an iterative process. It is also important to remember that to improve 
rational use of drugs and children’s safety, improved monitoring and follow-up of 
patients are required. Improving patients monitoring by clinicians and by family 
members, together with increased access to primary and secondary care, is likely to 
have a higher impact on health outcome than the current broad antibiotic use. 
Structural barriers towards patients’ follow-up and timely referral must therefore be 
addressed in resource-limited settings. 
The main objective of the present thesis project being to improve the rational use of 
antimicrobials, the research focused on identifying appropriate diagnostic procedures 
for clinicians to better target their prescription for children in need of antimicrobials. In 
the core of the present project, therapeutic options were not reassessed but taken 
from other WHO or Tanzanian accepted guidelines. 
 
9.2 Health workers compliance to guidelines  
The main reasons identified for HWs’ lack of compliance to IMCI recommendations 
were first, a lack of motivation due to a weak belief in the importance of following the 
recommendations, and secondly a perception that IMCI consultations require 
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additional time not compatible with their overload (Horwood et al., 2009b; Lange et 
al., 2014).  
9.2.1 Work overload 
With regards to the HWs’ perceived overload as a barrier to compliance, it is 
interesting to notice that if the thoroughness of assessment was improved in the 
interventions HFs, the time-consuming tasks, such as respiratory rate count, 
remained insufficiently performed where ALMANACH had been implemented 
(Chapter 8). This suggests that the paper and e- ALMANACH shared the same time-
related barrier to compliance with IMCI, due to the HWs high workload. We may 
conclude that in order to reach good quality of care more HWs are needed in 
Tanzanian HFs. If this is a truism, and if improving HWs density in low income 
countries is necessary to improve services delivery, the taken for granted assumption 
that the high caseload reduces the level of effort per patient in the diagnostic process 
was not confirmed in a recent study that assessed Tanzanian HWs’ performances in 
primary care. This survey revealed that HWs had ample amounts of idle time but 
performed only 22% of the assessment tasks required by guidelines on average, and 
that the performance was not related to the caseload (Maestad et al., 2010). The 
perceived overload may however be due to extra duty cognitive overload not 
addressed in this survey (Lange et al., 2014).  
The time constraint and high workload in low-income countries’ HFs, also calls for 
better diagnostic tools. HWs are reluctant to measure respiratory rate. They do not 
trust it is an important task to perform and prefer to prescribe antibiotics to all children 
with fever and cough. Together with sensitisation on the need for rational use of 
antimicrobials, automated methods for respiratory rate measure may help increasing 
the uptake of this assessment task, but if this task has limited value to identify 
patients in need of antimicrobials, alternative tools are necessary. 
Reassessing the relevance of the tasks HWs are required to perform for all children 
may also be necessary, to ensure only useful tasks are requested from HWs, 
especially when moving to an electronic support that can make all tasks mandatory.  
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9.2.2 Clinicians’ trust in guidelines 
With regards to the weak belief in the IMCI recommendations, the lack of guidance 
for the management of fever cases with negative malaria test are likely to further 
weaken the motivation of HWs to use IMCI algorithm after mRDT implementation. 
Indeed one of the main reasons for antibiotic prescription is the fear of potentially 
serious bacterial diseases. In the absence of guidance on how to identify or rule out 
these feared bacterial diseases, it is easier for clinicians to prescribed antibiotics to 
all children with fever, to be on the safe side. During our pilot experience, an 
important decrease in unnecessary antibiotics prescription was observed in both 
intervention arms, and the overall antibiotics prescriptions dropped from 70% of the 
children in the control to 26% in the paper and 25% in the electronic arm. Three 
elements in ALMANACH structure and implementation may explain these results. 
First, within the ALMANACH algorithm, bacterial diseases feared by HWs, such as 
typhoid fever and UTI, were addressed, allowing clinicians to rule out these 
conditions with simple clinical or lab tests. Secondly, ALMANACH clinical pathway 
proposed a new classification entitled ‘Likely viral infection’ reached after the 
assessment had ruled out the serious bacterial diseases and malaria, and pointing to 
the clinicians the possibility of self-limiting viral diseases. This notion is absent from 
the Tanzanian and many treatment guidelines. Having added this classification in 
ALMANACH offers the clinician the support of the guidelines when deciding to 
withhold an antibiotic for a patient and relying on the guidelines may offer them 
protection against critics if a child worsens after the first encounter. Thirdly, during the 
HWs training, the data of the ALMANACH validation survey, and especially the good 
clinical outcomes of children managed without antimicrobials were shared with the 
HWs. These data allowed reinforcing the message that non-severe febrile illnesses in 
children were often self-limiting viral infections in their own working context. All these 
three features of ALMANACH may have contributed to an improved confidence of 
HWs in the clinical algorithm, and a following improved motivation to comply with the 
recommendations. 
However it is important to notice that the fear of negative outcomes may often be 
stronger than available evidence and guidelines. And the minority of children that 
may develop secondary bacterial infections or complications will always have more 
weight in the clinicians’ perceptions of their patients than the majority of children with 
positive health outcomes. The first will always be more visible for the clinicians than 
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the latter and they will have more influence on their practices, a single child negative 
outcome being likely perceived by the clinicians as a failure. That is why we need 
evidence-based medicine and science grounded decision-making process, but 
overcoming the barriers of individual experience and fostering the use of available 
evidence is a huge challenge. The high level of antibiotic prescription for upper 
respiratory infections still occurring in high-income countries despite the available 
body of evidence showing their low benefit illustrates this issue. For clinicians to 
accept that a secondary infection is not a failure of the initial assessment, but rather 
part of the clinical care process, is difficult. Accepting to withhold an antimicrobial, 
and to give the patient a chance to improve without it, requires a lot of courage in 
settings where clinicians are taught since decades that infectious diseases kill their 
patients. Teaching clinicians that a single negative outcome does not make the full 
guidelines inappropriate, and that good clinical care requires more than a single time-
point assessment but rather monitoring and follow-up of the children, is therefore 
essential. Ensuring that danger signs are recognised by clinicians and that referral to 
good-quality secondary care for severe cases and appropriate follow up for non-
severe cases is feasible is necessary to allow clinicians complying with ALMANACH 
recommendations. 
9.2.3 Behavioural change  
If designing appropriate clinical algorithms and offering good training and supportive 
supervision to clinicians is essential, it is also important to consider the new insights 
from social psychology science on behavioural change. It is now well known that 
behavioural change require more than only improving knowledge and attitudes 
(Webb and Sheeran, 2006). From tobacco to global warming, the information on the 
potential risks of unhealthy behaviour (at individual or collective level) is not sufficient 
to directly foster behavioural change (Kollmuss and Agyeman, 2002; Peterson et al., 
2000). Information on the potential development of resistance may be in itself 
insufficient to operate changes in antibiotic prescription behaviour. This illustrates the 
limits of the classical rational (or top-down) behavioural change model. Recent 
psycho-neuroscience works have shown that the context in which people find 
themselves influence their decisions and behaviour through unconscious cognitive 
processes (Thaler, 2008). This is the basis for the contextual (or bottom-up) model. 
This theoretical model suggests that contextual signals have a direct impact on 
behaviour by influencing automatic processes without requiring any change in 
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knowledge or beliefs. This model brought new approaches to foster behavioural 
change. One of the new approaches is the normative effect approach. It aims at 
fostering behavioural change by indicating the desired behaviour is what other people 
do in a given situation. Normative messages have shown to induce behavioural 
change, although their influence was underestimated by the intervention participants 
(Nolan et al., 2008). Another interesting approach called priming relies on exposing 
people to environmental signals that make people behaving differently. Studies have 
shown that exposing people to library pictures made them talk slowly (Aarts and 
Dijksterhuis, 2003), and that exposing them to citrus scents in a restaurant made 
them keep their table cleaner (Holland et al., 2005).  
Within the current project we did not explore these new approaches. Exploring their 
usefulness with regards to prescription behavioural change would be of great 
interest. 
 
9.3 New technologies to support clinical decision making 
9.3.1 Specificities of an algorithm meant to be an electronic clinical decision 
support system 
In order to formalise an electronic clinical decision support system the clinical 
algorithm must be written with specific characteristics. Most of clinical guidelines and 
paper based pathways leave a lot of room for interpretation on which tasks to be 
performed, and within which sequence. On an electronic support, the navigation 
through the recommendations will be driven by the software. When using an 
algorithm on paper support, things that can be deducted from the general 
appearance of the child will not be assessed by the clinician. In an electronic 
algorithm, all the programmed steps will have to be assessed one after the other and 
documented in the application. These characteristics of the electronic algorithms are 
one of its strength, as it will encourage systematic and thorough assessment. 
However, the program steps need to be carefully organised to ensure consultation 
process is coherent and not delayed. Repetitions that may occur in paper algorithm 
need to be avoided in the electronic version. This is required when the tool is meant 
to be used in every consultation, in settings where the workload is high or perceived 
as high by clinicians. Electronic algorithms provide much stronger guidance than 
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paper algorithms. While transposing the paper algorithm, programing its logic into the 
application raised many clinical questions that were left unanswered in the paper 
algorithm, although ALMANACH paper algorithm was designed with the initial aim to 
provide strong guidance. Therefore close collaboration between clinicians 
responsible for the content and software developers designing the application is 
requested to ensure final electronic algorithm relevance. Intensive validation of all 
possible pathways was also required to ensure the application delivered the expected 
recommendations within the project. To perform this validation of the electronic 
decision support system we had no formal approved methodology to use. Although 
the US Food and Drug Administration (FDA) has developed guidance on medical 
mobile applications, no regulation was proposed yet by this institution for clinical 
decision support systems (Karnik, 2014). Therefore registration of an electronic 
algorithm as a medical device is not possible today neither in the USA nor elsewhere. 
However, going through a comprehensive systematic validation and certification 
procedure, and identifying appropriate ways to report the potential occurrence of 
risks, would facilitate new partners acceptability of the tool and thus facilitate scaling-
up the intervention.  
9.3.2 Acceptability, uptake and sustainability of an electronic algorithm in low-
income countries 
HWs received very positively the introduction of new mobile technology in their daily 
life. The majority of HWs learned very quickly how to use the smartphones and the 
ALMANACH android application, even the ones who had no previous computer 
literacy, and no previous experience with smartphones. Some clinicians with 
decreased visual acuity benefited from the option to increase the texts font size. The 
connectivity required to send the data collected by the app to the central server daily 
was ensured by a low cost pre-paid 3G data package that was available in Dar es 
Salaam during the study period. In the interventions HFs, both in Dar es Salaam and 
in Kilombero valley, the network coverage was good, and sending the data was never 
an issue of network. Availability of credit to send the data has been an issue in one 
HF in Dar es Salaam, where clinicians had used the smartphone to access other 
internet services, and the data package was fully used before the end of month. 
Restricting internet access to the job aid apps, or providing unlimited internet access 
should overcome this issue. 
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With regard to material security, maintenance, and access to power charge, no major 
barriers were encountered within our pilot implementation. In each intervention HF, 
the team in charge managed to identify a safe place where to store and charge the 
material when not in used, and established an appropriate procedure for the HWs to 
access the smartphone. Thus, during this pilot project, no smartphones disappeared 
and none were broken. With regards to power issues, during the pilot 
implementation, Dar es Salaam underwent frequent full-day power blackouts. During 
these periods of power shortage, the HFs management team together with the HWs 
adapted the smartphones management schedule, and ensured tablets were charged 
overnight, when the power supply was more regular. No additional sources of power 
were therefore needed.  
Although the introduction of connected mobile technology was well received, the 
phone uptake was limited over time. The first barrier reported by the users was their 
high workload. The additional time required to conduct a consultation with the e-
ALMANACH was felt incompatible with their workload. As discussed earlier, this 
barrier was also identified as a reason for the low compliance of HWs to the IMCI 
algorithm. An important attention was taken while designing the electronic algorithm 
to avoid unnecessary delay in the consultation process, but while driving the HWs 
through each step of the assessment it may result in an increased time spent with 
children, as would happen if the HWs followed strictly the paper guidelines step by 
step. Repeating the same tasks in all children may seems fastidious to clinicians, but 
these repetitions are necessary to ensure each child is appropriately assessed. And 
tasks repetition is a good learning process. Therefore the additional time, providing 
only useful tasks are requested, should be perceived as a positive outcome if it 
results in better care for children. In the present project, the use of ALMANACH led to 
improved health outcome (Chapter 7). Policy makers have thus a responsibility to 
ensure the available human resources in HFs allow appropriate patients 
management. 
9.3.3 Potential for data collection, activity supervision, monitoring, and 
evaluation  
An additional promising feature of e-ALMANACH that was not fully explored within 
this present thesis project is the data collection and management. Indeed, while 
guiding the clinicians through the child’s assessment and treatment 
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recommendations, the application collected anonymous data on the child’s clinical 
presentation, his/her diagnostic classifications and the treatment prescribed by the 
HWs. The data were sent daily to a central server, and throughout the pilot 
implementation monthly reports on activity, diagnoses distribution, and prescriptions 
were manually computed. These reports were distributed to the districts and health 
facilities management teams. Within the framework of the present thesis, insufficient 
follow-up and guidance on the use of these data were provided to the management 
teams. These reports and data were not integrated into the existing health 
information system. We foresee that appropriate integration and use of these data 
could strongly strengthen the individual HW and HF-based supportive supervision. 
Indeed the use of the electronic algorithm allows providing clinicians with their 
individual activity reports with details on the diagnoses they reached in the patients 
they assessed and on their level of antibiotics prescriptions. Comparison with their 
peers’ practices could also be provided to clinicians, and all these data could help the 
supervisor to prepare tailored supportive supervision to clinicians taken individually. 
These data, allowing activity monitoring and diseases surveillance, could inform 
policy-making and planning within the health system. All these benefits the tool can 
bring to the health system should be utilised and capitalised on, as they should 
encourage the use of the algorithm and the HWs’ compliance to guidelines 
recommendations. 
 
9.4 Scale up challenges 
Many mobile Health solutions have been tested in small scale pilot projects, but failed 
to scale up even when the pilot showed promising results (Lemaire, 2011). 
ALMANACH has shown promising results within the core of the present thesis. In 
order not to stay stuck in the pilot phase as so many other mHealth projects, 
challenges of scale-up will have to be addressed. 
9.4.1 Hardware and software 
For electronic algorithms to be sustainable the chosen hardware and software should 
be easy to deploy and to interconnect with other existing electronic tools used in the 
health system.  In the absence of broadly validated or accepted standards of 
interoperability, chosing software is difficult. Within this project we decided to use 
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open-source softwares (Open Data Kit and Open MRS) to formalise our algorithm. 
We chose open-source software to avoid licensing fees, hoping to facilitate future 
uptake and use in low-income countries. These two softwares initially meant for data 
collection (Open Data Kit) and electronic patients file (OpenMRS) had been use to 
formalise clinical algorithms by other research teams. However they were not ready 
to support the complex logic a clinical algorithm necessitates. We did manage to 
program our clinical algorithm within this software, but it ended up being so complex 
that any maintenance and modification tasks required a lot of investment, and the 
support of informatics specialist.  Flexiblity is an essential characteristic for an 
electronic algorithm towards sustainability and scalability. Indeed, a clinical algorithm 
should be easily modified to adapt to a new implementation setting, or to new 
National treatment guidelines. Ane the modification should not hamper the overall 
stability of the algorithm. Our initial software solution lacked this flexibility. 
If the maintenance and update of the algorithm necessitate highly specialised human 
resources, open-source software will not be free of charge for the long-term users, 
and this may represent a challenge for low income countries where qualified 
computer scientists are lacking. 
Although several electronic clinical algorithms have been developed, there is no 
broadly recognised standard software that meets the requirements for algorithms’ 
broad use. Within the present project, the only software we identified that was 
specifically meant for the formalisation of complex clinical algorithm into mobile 
health applications was Mangologic. (Things Prime, 2015) Mangologic was 
developed by a private software developer; it may represents an interesting 
alternative to the currently available open-source software that seemed not ready to 
handle the complexity clinical algorithm . Whatever software solution is adopted, 
ensuring long-term funding for the software update and maintenance is absolutely 
needed to scale up. 
With regards to hardware, we used both smartphones and tablets, under android 
operating system. Smartphones have the advantages of reduced cost, and may be 
easy to carry in a pocket. Tablets have a larger screen and improve the user 
experience while navigating through the algorithm. Both hardwares are usable and 
the choice should be made according to each particular context and to the funds 
available. 
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9.4.2 Connectivity and electricity 
For our electronic algorithm, sustainable access to electricity and mobile network is a 
key issue.  
Planning for solar panel or long-life extra battery when electricity is scarce, or using 
innovative connectivity means for areas where the mobile network coverage is poor 
may be necessary, and should always be adapted and planned according to the 
context.  
Peer-to-peer wireless communications are under development. Partnership with 
industry or academic partners to develop such connectivity solutions should be 
considered. Where mobile network are available partnership with mobile network 
operators could help ensuring connectivity for the data transfer. 
9.4.3 End-users and community  
While planning to introduce the tool in a new context particular cautious should be 
taken to explore the community needs and perceptions of mobile health solution and 
to prepare appropriate information and sensitisation activities.  
Adapting the tool to the end-user is also necessary, by translating the algorithm into 
the local languages or adapting the consultation process to be compatible with the 
local work organisation. End-users should be engaged in processes to refine the tool. 
9.4.4 Monitoring and evaluation 
Monitoring and evaluation activities should be planned. The data collected through 
the algorithm allows real time monitoring of the use of the algorithm, from the number 
of consultations to the diagnoses reached and treatment prescribed. Formalising the 
use of these data by the clinician, by the health facility and by all supervision chain in 
the health system will allow easy monitoring. 
Additionally the evaluation of the impact of the intervention on clinicians performance, 
through observational surveys of the consultation process, should be planned on a 
regular basis. 
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9.4.5 Integration into the health system 
Last but not least, close collaboration with the Ministry of Health for the integration of 
the intervention into the existing health system and policies is needed for a 
successful scale up. 
For ALMANACH to be sustainably scaled up, the embedded recommendations 
should be endorsed by the Ministry, and the intervention integrated into the strategy 
to improve child care. 
The interoperability with existing mobile health solutions and the integration of the 
data generated by ALMANACH into the National Health Information System should 
be ensured. 
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10 Conclusion and recommendations 
10.1 Conclusion 
Clinical algorithms have the potential to improve the quality of health care by 
providing to clinicians standard procedures designed by experts. ALMANACH has 
shown very positive impact on health outcome and rational use of medicines for 
children aged 2 months up to 5 years.  The electronic ALMANACH, by integrating 
health information into the decision support system, has a huge potential to improve 
the monitoring of paediatric primary care activities and the individual supportive 
supervision provided to the users.  
Many mobile Health solutions have been tested in small scale pilot in low income 
countries, but very few have been successfully scaled up. ALMANACH has shown 
promising results within the core of the present thesis. The interest shown by two of 
the most important international humanitarian organisations will now give a chance to 
ALMANACH to be scaled-up and reach the initial main objective to improve health 
care delivered to children in low and middle income countries.  
10.2 Recommendations 
10.2.1 Diagnoses procedures 
- In the absence of evidence-based diagnostic procedures, building algorithms 
on experts opinion is acceptable in order to deliver expertise in diagnostic 
procedures to endpoint prescribers, and therefore improve the current low 
quality of childhood illness management. 
- Meanwhile efforts must be made to identify and integrate newly available 
evidence that could help refine the recommendations and that will be obtained 
from research in the following areas: 
o Epidemiology and mapping of acute illnesses in ambulatory settings: 
More standardised research to document and confirm etiologies of 
acute illnesses in outpatient children in multiple sites would help refining 
the algorithm by informing the pre-test probabilities of the different 
diseases in the context of intervention. Data on the resistance profile of 
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the pathogens encountered in these studies would help adapting the 
first line regimen of antimicrobials. 
o Point-of-care diagnostic tests: There are currently global efforts to 
develop new accurate and validated point-of-care tests, either for 
pathogen identifications or for biomarkers predicting serious bacterial 
infections. When validated, the newly tests should be considered for 
use in a new algorithm. Their added value and usefulness in the 
management of ambulatory children could be assessed in prospective 
studies comparing well defined clinical outcome endpoints and use of 
drugs when using an algorithm that integrate or not the new validated 
test. 
o Benefit of antibiotics: Actual benefit of antibiotics in children presenting 
without danger signs at initial assessment needs to be evaluated. This 
could be done through prospective documentation of children health 
outcomes when treated or not treated with antibiotics. Well-defined and 
standardised primary endpoint to measure health outcomes should be 
used. Mortality or hospitalisations are too rare events in outpatients to 
be used as primary endpoint. Patients-reported or observed outcome 
on the resolution of the symptoms could be used, as well as time to 
resolution. The sample size should allow identifying a difference of 5% 
or more in the primary endpoints. ALMANACH recommendations 
endorsement, monitoring and evaluation. 
For ALMANACH to be implemented and scaled up in new settings the following 
elements are needed: 
- The content and recommendations should be endorsed by local health 
authorities on the basis of a clear report of the underlying evidence and 
rationale. Further validation of the recommendations could be performed in the 
new contexts by reproducing the non-inferiority trial that assessed the impact 
of ALMANACH on children health outcome. 
- Appropriate monitoring will also be required to allow identification and 
analyses of adverse events or negative outcome in children managed using 
the tool. 
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- Further development in the electronic algorithm into a full electronic patient file 
would allow prospective documentation in programmatic conditions of the 
rates of re-attendance and complications. If such a data collection tool could 
be maintained and scaled up, the information would allow evaluating the 
impact on health outcome of different versions of the algorithm. 
10.2.2 Electronic algorithm characteristics 
The technology selected to formalise the electronic algorithm should allow to: 
- Design user friendly applications. 
- Easily visualise and validate the logic programmed into the application as 
compared to the recommended clinical pathways. 
- Easily update the content or logic when new tools or evidence are available 
- Program options to adapt the tools to its context of intervention, especially 
adapting the pathways to address an outbreak, or to consider the use of a 
diagnostic tool available in a particular setting.  
- Easily send the data regularly to the server when connectivity is available. 
- Safely store the data into the smartphones/tablets when offline. 
- Integrate the data generated into the existing Health Information System 
For further development the technology should also support an electronic patient 
file. The patient file should be accessed by the clinicians whenever the child 
presents to the health facility. It should propose follow up recommendations for 
acute illness episodes but also for the follow up of the child’s development and 
growth as well as of all preventive interventions proposed in the health facility, 
including immunisation. 
 
10.2.3 Challenges towards ALMANACH scale up 
Success in scaling up the implementations of ALMANACH will require: 
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- Involving key actors in the preparation and evaluation of the implementation to 
ensure successes and failures would be appropriately documented and 
reported. 
- Adapting the recommendations to the implementation settings and ensuring 
they are relevant with regards to HWs, diagnostic tools, referral structures 
available and to the known epidemiology. 
- Ensuring the project meet the country, region, district health priorities. 
- Ensuring the tool is integrated into the existing health system, from the 
endpoint prescribers workplace, the training and supervision systems, and up 
to the health information system, where data and interoperability standards 
must be put in place in order to ensure information collected can be used in 
the quality of care monitoring and evaluation.
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